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Introduction 3 
'River blindness - SOOIl all image of the past' 
In 1990 the World Health Organization (WHO) coordinated Onchocerciasis Control 
Programme in West Africa (OCP) used this slogan for evaluating fifteen years of 
control of the parasitic disease onchocerciasis and for expressing its optimism about 
the future. Based on the obvious success of OCP and on the availability of a safe 
and effective drug (ivermectin), the UNDP/World BanklWHO Special Programme 
for Research & Training in Tropical Diseases (TDR) has announced onchocerciasis 
to be one of the tropical diseases with good prospects for worldwide elimination, at 
least as a public health problem (the others being Chagas disease, Lymphatic 
filariasis, and Leprosy!). 
To judge slogans and statements like these, and in particular to determine under 
which circumstances and with what strategies they could become a realistic perspec-
tive, one should perform an integrated and detailed study of the dynamics of the 
disease and the impact of control. Such a study should preferably be embedded in a 
comprehensive quantitative approach. In the light of this, the objectives of the work 
reported in this thesis were (1) to develop, quantify, and validate a model for the 
transmission and control of onchocerciasis in West African savanna and (2) to use 
this model for aiding decision making in the OCP. Through achieving these objec-
tives we have tried to contribute to a better understanding of the dynamics of the 
parasite that causes the illness and the impact of intervention measures, and to the 
as yet successful combat against the disease. 
In this general introduction an outline will be given of the epidemiology and 
control of onchocerciasis. Secondly, an overview of the achievements of the OCP in 
controlling the disease in West Africa will be provided. Finally, a short history will 
be presented of the role of quantitative modelling within OCP prior to the work 
reported in this thesis. 
I See 'TDR-News' No. 49 (March 1996). 
1.1 Onchocerciasis: the disease, its transmission 
Geographical distribution and magnitude of the problem 
Onchocerciasis is especially endemic in Western and Central Africa and in Central 
and Southern America (see Fig. 1). Current estimates suggest that about 17,7 
million of persons are infected, of whom some 270,000 are blind and a further 
500,000 severely visually disabled. Lacking accurate data from a number of coun-
tries, these figures will certainly be an underestimate (WHO, 1995). Most of the 
blinding form of onchocerciasis is found in sub-saharan Africa (outside the areas 
covered by the OCP, see below). Although onchocerciasis is not a lethal disease as 
such, there is clear evidence that blindness may cause early death. It has been 
estimated that the average lifespan at the onset of blindness is only 7 to 9 years 
(prost, 1986) and that blindness related excess-mortality varies between 3.3 (in 
trachoma endemic areas; see Taylor et al., 1991) and 4 times (Prost and Vaugelade, 
1981) the mortality of non-blind persons. While blindness is still the most important 
public health problem, severe skin lesions and troublesome itching are also widely 
prevalent in large parts of Africa (Renmle, 1995; Remme, in press) and constitute a 
major health problem too. 
Figure 1 Geographical distribution of onchocerciasis (based 011 WHO, 1995). 
Not only is onchocerciasis infection and morbidity a serious health problem in 
endemic areas, it has also important social and economic implications. In severely 
afflicted connnunities blindness, prevalences of up to 15 % in the total population 
and 40% among the adult males may exist (Duke, 1990; Remme and Zongo, 1989; 
Prost and Vaugelade, 1981). It has been estinlated that, in the absence of control, in 
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hyperendemic villages in Burkina Faso 45% of males and 35% of females aged 15 
are likely to become blind before they die (prost, 1986). These unbearable condi-
tions gave rise to depopulation of the river basins, leading to a poor utilization of 
the fertile river basins. In 1972 only about 7% of the valleys of the White and Red 
Volta river basins were used for agricultural cultivation (Remme and Zlngo, 1989). 
Biology of parasite alld vector 
Onchocerciasis is a parasitic infectious disease. The parasite Onchocerca volvulus is 
a filarial nematode which lives in subcutaneous nodules, from where it expels 
millions and millions of living embryos or microfilariae (Mf) (Duke, 1990; Schulz-
Key, 1990). The lifespan of the adult parasite is estimated at 10-11 years on average 
(Plaisier et al., 1991). The sessile female parasite can reach a length of 20-50 cm 
(Duke, 1990). The mobile male worm is much shorter (5 cm). Microfilariae (220-
300 I'm) invade the skin and Can be engorged by a blood-sucking fly of the genus 
SimuliulII. Some of the engorged Mf succeed in developing to infective (L3) larvae 
which can be transmitted to man during one of the subsequent blood-meals of the 
fly. The life cycle (see Fig. 2) is closed when invading L3-larvae grow in the 
human host to the stage of adult male or female worm. 
For its reproduction, SillluliulII dalllnosulII s.l. ('blackfly') depends on fast flowing 
streams and rivers. About 3 days after bloodsucking, female flies shed their eggs in 
the rivers (Thompson, 1976). Together, the egg, pupa, and larva stage takes 12 - 14 
days (Greene, 1990). In the absence of control, in the most notorious onchocerciasis 
foci of Western Africa - the area considered in this thesis - atmual man biting rates 
(ABR) close to breeding sites are in the range of 50,000 to 250,000 and even higher 
(philippon et al., 1990). 
Morbidity and diagnosis 
The most severe complications of onchocerciasis, or 'river blindness', are irrevers-
ible ocular lesions resulting in impaired vision and finally total blindness (prost, 
1986). Ocular pathology is mainly related to inflammatory reactions to dead micro-
filariae which invaded the eye-tissue. For the progress of lesions of the posterior 
segment of the eye also immune-complexes and auto-immune mechanisms are 
thought to be responsible evan der Lelij et al., 1990). Functional blindness can be 
the result of opacification of the cornea (reduced visual acuity) and a reduced visual 
field (key-hole vision). Other clinical manifestations of onchocerciasis include 
dermal, lymphatic and systemic complications. Dermal involvement is often accom-
panied by troublesome itching. 
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Figure 2 Life cycle of Onchocerca volvulus. 
Onchocerciasis is usually diagnosed by obtaining a small skin biopsy (skin-snip) 
in which, after incubation in saline, micro filariae can be observed and counted. 
Though skin-snipping is the most reliable way of discovering the infection, other 
less invasive methods are being explored to assess the endemicity in an area. These 
methods include ocular examination (observing and grading lesions and counting 
microfilariae), palpation of sub-epidermal nodules with adult worms. observing the 
presence of dermal lesions, interviewing for complaints like itching, and immuno-
diagnosis (though field-applicable specific tests are still not available). Another 
indication of endemicity can be obtained by catching blackflies and determining Ole 
presence of O. volvulus larvae_ 
1.2 Treatment and control 
Vector cOII/rol 
By its nature of vector borne disease, onchocerciasis can be controlled by eliminat-
ing the vector S.damllosuIII or preventing its contact with man. Control of blackflies 
can be achieved by killing the adult flies, by killing the larvae or by modifying the 
environment to prevent breeding of the flies (which could be a consequence of the 
construction of dams for power-generation). Blackflies bite during daytime and 
outside the houses. This complicates control of the adult stages by insecticides 
(adulticiding). The only successful attempts have been helicopter spraying of gallery 
forests to destroy blackflies which were found to reinvade controlled areas (WHO, 
1987a). However, the most effective way of vector control is killing fly-larvae by 
applying larvicides to rivers and streams. A variety of biodegradable formulations is 
currently available which are highly effective against the larvae and relatively safe 
for the rest of the environment. These include chemicals like temephos (the pre-
ferred one in view of effectivity and safety), phoxim, pyraclofos, and permithrin 
and biological compounds like Bacillus tlllIrillgiellsis. Given the development time of 
eggs to pre-adult stages (1-2 weeks), larvicides should preferably be applied weekly. 
Furtllermore, rotational use of tile different formulations is recommended to prevent 
or control resistance to specific larvicides (Kurtak, 1990). Larvicides are usually 
applied by helicopter-spraying to achieve an instant killing of larvae in the often 
very large breeding sites. However, also with limited means remarkable results have 
been achieved. Especially effective local control by DDT has been reported in the 
period 1945-1970, i.e. the period between the invention of this chemical as a very 
successful insecticide and tile detection of its persistence and environmental damage 
(Walsh, 1990). 
Chemotherapy 
Until the registration of ivermectin in 1987, no effective and safe drug was available 
for the treatment of human onchocerciasis. The two standard drugs before that time 
were suramin, which kills the adult worm, and diethylcarbamazine (DEC), which 
kills microfilariae. Suramin is highly impractical because it has to be given intra-
venously and, because of its toxicity, under strict medical supervision (Thylefors 
and Rolland, 1979). DEC, whilst being a safe drug for the treatment of the related 
disease lymphatic filariasis (Ottesen, 1985), excites severe and dangerous reactions 
in skin and eyes especially in persons with high skin microfilarial loads (Mazotti-
reaction, see WHO, 1987a). 
Ivermectin, a broad antiparasitic agent widely used in veterinary medicine, 
underwent intense clinical testing for its efficacy and safety and has become the 
drug of choice since 1987 (Goa et al., 1991). Given at a standard dose of 150 I'g I 
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kg body weight, it effectively eliminates microfilariae without the severe inflamma-
tory response induced by DEC. Though also effects on the adult worms are 
observed (Duke el al., 1992; Chavasse el al., 1992; Plaisier el al., 1995), micro-
filariae production restarts soon after treatment and, hence, repeated treatment is 
required to keep Mf levels low enough to prevent progression of ocular lesions 
(Dadzie el al., 1991). 
1.3 The Onchocerciasis Control Programme in 
West Africa (OCP) 
The extremely high levels of endemicity in many foci in the savanna areas of seven 
of the most afflicted West African countries (I to 1.5 million people infected), the 
associated high burden of blindness (35,000 persons blind), and the related socio-
economic consequences (underpopulated river valleys) gave birth to the 
Onchocerciasis Control Programme in West Africa (OCP) in 1974. To pave the way 
for OCP, in 1970 the WHO - in association with the Food and Agriculture Organiz-
ation (FAO) and financed by the United Nations Development Programme (UNDP) 
- instituted the 'preparatory assistance to government' (p AG) mission. The task of 
this PAG-mission was to perform field investigations, make plans for vector control, 
and assess the costs of control. The report (PAG, 1973; Hunter, 1981) led to the 
conclusion that large scale vector control was a feasible option and gave rise to the 
formal establislllllent of OCP as a corporate undertaking of seven participating 
countries, donor communities (countries, foundations, and development banks) and 
four United Nations agencies (UNDP, FAO, the World Bank, and the WHO). The 
WHO executive agency and headquarters were located in Ouagadougou, Burkina 
Faso (Upper Volta). The original progrannne area comprised most of the savanna 
area of Burkina Faso, Mali, Ivory Coast, Ghana, Togo, Benin, and Niger covering 
as much as 764,000 sq. km (WHO, 1987a). 
Lacking a safe drug for treatment of onchocerciasis patients, the only control 
option available to the OCP was aerial larviciding of river stretches where the 
breeding sites of the vector are found. Armed with helicopters and planes, the 
objective of OCP is "to eliminate onchocerciasis as a disease of public health and 
socioeconomic importance throughout the area covered by the Progranlllle and to 
ensure that there is no recrudescence of the disease in the future, thus allowing the 
repopulation and development of those valleys previously almost deserted because of 
onchocerciasis" (WHO, 1987a). Based on limited information on the longevity of 
onchocerciasis infection in man derived from East African control progrannnes 
(Roberts ef al., 1967), the Programme was initially planned to last for a period of 
20 years. 
Evaluations performed 7 to 8 years after the start of the Progralrmle demonstrated 
that operations have been highly successful. Marked reductions were found in the 
intensity of infection in most of the communities (as measured by the CMFL, i.e. 
the geometric mean no. of Mf per skin-snip in adults) (Renlllle ef aI., 1986), the 
viability of the parasite population (Karam ef al., 1987), and in the risk of develop-
ing ocular disease and blindness (Dadzie ef al., 1986). Furthermore, throughout 
these first 7-8 years the Annual Biting Rate (ABR) and Ammal Transmission Poten-
tial (ATP; i.e. the product of ABR and the average no. of L3-larvae found per 
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biting fly} was kept close to zero in most of the Programme area (philippon et al., 
1990). 
However, already during the first years of operations the long-distance migratory 
movements of S.dallllloslIlII s.l. appeared to be a major threat of the success of 
control. Especially at the start of the rainy season the southwestern sector of the 
Programme became re-invaded by the flies leading to unacceptably high man biting 
rates. In response to this re-invasion phenomenon, the Programme was extended 
considerably to the West and Soutlleast. A map of the Central Programme area and 
the extension areas is provided in Fig. 3. Inclusion of (parts of) Guinea, Guinea-
Bissau, Senegal, and Sierra Leone increased the number of participating countries 
from 7 to 11, the covered area from 764,000 to 1,235,000 km2, and the protected 
population from 16,5 to 24,5 million people (WHO, 1987a). 
The availability of ivermectin, since 1987, has considerably broadened the possi-
bilities of control and has changed the strategy of OCP. Especially in the extension 
areas, vector control is supplemented with annual treatment with ivermectin (dose 
150 I'g/kg body weight) leading to a more rapid improvement in ocular morbidity 
and a better control of transmission in re-invaded areas (Molyneux, 1995). 
Already in the early years of operations it had been recognized that the second 
part of OCP's objective, the prevention of recrudescence of the disease, can only be 
achieved if the achievements will be maintained by the participating countries when 
OCP would cease to exist as a strongly centralized 'vertical' organization. The 
process of 'devolution' is now one of the major activities of the Programme and 
comprises the provision of support for country activities to enhance their capacity 
and ensure that this capacity is sustainable to detect and manage recrudescence of 
onchocerciasis (Molyneux, 1995). 
The conclusion of a recent 'mid term review' is that the Programme has thus far 
been highly successful and that, to achieve its long term goals, OCP should continue 
its present strategy of combined larviciding and ivermectin distribution until the year 
2002 (WHO, 1994). In a recent analysis it has been argued that OCP has been and 
will be a highly cost effective programme. It has been estimated that during 1974-
1994 a total of 265,000 cases of blindness have been prevented and that this resulted 
in 1,708,000 additional years of productive labour. Furthermore, for 1994 the total 
area of new available agricultural land (previously abandoned land, now freed from 
onchocerciasis) is estimated at almost 10 millions hectares (Kinl and Benton, 1995). 
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Figure 3 The area covered by OCP operations (detailed map from Samba, 1994). 
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1.4 A short history of modelling within the OCP2 
During the first 8 years of larviciding from 1975 to 1983, vector control was quite 
successful in most of the Programme area according to Ole results of entomological 
evaluations which indicated that transmission had been brought down to insignificant 
levels. However, epidemiological evaluations had not been able to demonstrate a 
major epidemiological change during the initial years of control. The routine analy-
sis of skin-snip data had not yet revealed a significant decline in the parasite reser-
voir. No children below the age of 5 years were found to be infected, but only few 
infections would have been expected in this age group even if there had been no 
control. The standardized prevalence of microfilariae (Mf) in Ole skin-snip, which 
was the epidemiological index at that time, had shown only a limited decline during 
the first eight years of control (Kirkwood el al., 1983). To most observers these 
results appeared to be unsatisfactory and the question was raised if vector control 
really had interrupted transmission and if reinfection was not still occurring at an 
undetected but nevertheless significant level. For long term planning and financing 
of the Programme it was therefore urgent to arrive at a better understanding of the 
epidemiological impact of vector control and to make credible predictions of the 
expected trends in onchocerciasis infection during the remaining control period. 
Force-oI-infection model 
A new analytical methodology was introduced which took the dynamics of the 
parasite and of the human population into account. The basis of this work was the 
development of a simple force-of-infection model (or catalytic model; see Muench, 
1959) for onchocerciasis, and its application for a study of the age-specific 
epidemiological trends during a period of vector control (Remme el al., 1986). The 
most important factors included in the model are the longevity of an infection, the 
aspect of super-infection, age-specific exposure, and the intensity of transmission 
during the pre-control period. 
The epidemiological trends calculated by this simple model were tested against 
the observed trends in the prevalence and mean load of micro filariae in skin-snips 
taken from a cohort population in 23 villages in an area with 8 years of successful 
vector control. This resulted in a crude (but first ever) estimate for the duration of 
the patent period of the infection of 10 years. The model predictions had important 
implications for the epidemiological evaluation of the impact of vector control. They 
showed that epidemiological trends during the control period are not uniform but 
depend on the initial endemicity level of the population and vary between age 
groups. Moreover, it became clear that the prevalence of infection is too insensitive 
2 Based on Renmle et al., 1995. 
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to be useful for the evaluation in hyperendemic villages during most of the control 
period. A much more sensitive and meaningful statistic for a comparative analysis 
and for the assessment of epidemiological changes would be the mean number of 
infections, or the mean number of productive female worms per person above the 
age of 20 years. The number of adult worms cannot be measured directly. How-
ever, the microfilarial load in the skin provides an indirect measure, assuming that 
the Mf production per adult female worm and the survival of Mf are not regnlated 
by density dependent mechanisms. This reasoning led to the introduction of an 
alternative epidemiological index, the Community Microfilarial Load (CMFL) which 
is the geometric mean microfilarial load per skin-snip among the popUlation above 
the age of 20 years (Remme et al., 1986). Within and outside the OCP, the CMFL 
has now become the preferred index of endemicity of onchocerciasis, partly because 
it could later be demonstrated that the prevalence of onchocercal blindness is linear-
ly related to the CMFL (Remme et al., 1989a). The use of the CMFL in epi-
demiological evaluation enabled a much better appreciation of the significant epi-
demiological impact of 8 years of vector control in the OCP, and it could be shown 
that in 90% of the original Programme area, vector control had already achieved a 
reduction in the parasite reservoir of more than 70% (WHO, 1987b). 
Host-parasite model: prediction of trends during vector colllrol 
Once the new analytical methodology had provided the epidemiological evidence of 
the effectiveness of the first 8 years of vector control, the focus of attention shifted 
toward the epidemiological trends to be expected in subsequent years. Of particular 
interest were predictions of the ultimate decline in tile prevalence of infection as this 
would indicate how many years of vector control would be required. The force-of-
infection model, with the assumption of a constant longevity of infection, was 
clearly not appropriate for such predictions and it became necessary to develop a 
more sophisticated model which would take the variability in the duration of infec-
tion into account. Furthermore, for the interpretation of the observed epi-
demiological trends in different parts of the Programme area it became increasingly 
important to have predictions of the trends to be expected in the distribution of 
microfilarial loads in different age groups, and not only in the prevalence and mean 
Mf load in adults. 
In order to respond to these needs, the so-called "Host-Parasite" model was 
developed (Remme et al., 1990a). This is a stochastic computer simulation model 
which uses the technique of microsimulation (Habbema et al., in press). It involves 
tile simulation of the life histories of all individual human hosts living in a commun-
ity, and of the individual life histories of all adult parasites harboured by these 
human hosts. The life histories are generated from probability distributions for 
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which the parameters were estimated using demographic information, results from 
specific parasitological studies (Karam et al., 1987) and by fitting the model to the 
epidemiological evaluation data for selected reference villages in the OCP. The 
major parameters of the host-parasite model which govern the epidemiological 
trends are the pre-control force-of-infection (which determines the endemicity level), 
exposure heterogeneity between individuals, the longevity of the adult worm and 
worm-age specific Mf production. Model output shows the predicted trends in the 
distribution and sununary statistics of skin Mf loads by age and sex during the 
vector control period. The host-parasite model provided much more realistic predic-
tions of the epidemiological trends during the later years of control. The first pre-
dictions with this model were made in 1985, after to years of control, and indicated 
that the prevalence of infection would fall to levels close to zero after 14-15 years 
of interruption of transmission. For several years the host-parasite model became 
the principal epidemiological tool for the interpretation of the epidemiological 
evaluation data collected in dozens of indicator villages. 
ONCHOSIM: a microsimulatioll model for onchocerciasis transmission and control 
When the duration of vector control approached 12 years, and the prevalence of 
infection started to show the predicted accelerated decline throughout the central 
OCP area, it became urgent to answer the next major question: when could the 
expensive larviciding operations be stopped without rumting an unacceptable risk of 
recrudescence of infection and disease. The host-parasite model could not be used 
for addressing this question since it does not include the transmission by the vector. 
Hence, it became necessary to develop again another, and this time a much more 
complicated, model which describes the full transmission cycle. The resulting 
ONCHOSIM model is a comprehensive transmission model which allows simulta-
neous simulation of a human population, the popUlation of parasites inside the 
humans, the dynamics of the vector population and the impact of interventions based' 
on larviciding, chemotherapy, or a combination of these two. The development and 
application of ONCHOSIM is the subject of this thesis. 
The basic structure of the model was finalized during a workshop at OCP head-
quarters in January 1987, which was attended by scientists from all technical units 
of the OCP and by several external experts. The meeting identified the most import-
ant operational questions for which a model should be developed. It also recom-
mended that, in order to ensure a sufficiently flexible model which could be adapted 
according to new scientific insights or new operational needs, the same technique of 
stochastic microsimulation be used as in the host-parasite model. 
I. 5 Contents of the thesis 
The ONCHOSIM model and computer simulation program is presented in Chapter 
II. Section ILl describes the model in a semi-formal way and explains how the 
model has been implemented in a microsimulation computer program. A complete 
mathematical description, including the most recent estimates of the parameters is 
given in section 11.2. As argued before, one of the most crucial determinants of the 
required duration of vector control is the reproductive lifespan of O. volvlIllis. A 
detailed account of the estimation of this parameter is provided in Chapter III. For 
making valid predictions of the impact of interventions it is not only important to 
have a valid model for the dynamics of the parasite in the human and vector popula-
tion, but also to make proper assumptions on the effectiveness of the control 
measures themselves. The effects of vector control can be simply translated into a 
reduction in the man-vector contact, and does not require complicated modelling. 
However, describing the effects of ivermectin treatment, both in terms of the effi-
cacy of the drug in individual patients and in terms of the coverage of the popula-
tion, is much less straightforward. Chapter IV describes the results of a community 
trial with annual ivermectin treatment in the OCP area (section IV.I) and how the 
data from this trial have been utilized to estimate key parameters for the effects of 
treatment on the parasite. The most important applications of ONCHOSIM in aiding 
decision making in OCP are presented in Chapter V. Section V.I reports predictions 
of the risk and dynamics of recrudescence after stopping vector control. Based on 
these predictions it is possible to derive a guideline for the required duration of 
vector control in the original OCP area (Le. the area where no ivermectin has been 
used). Assessing the required duration of strategies based on a combination of 
vector control and ivermectin treatment (the strategy employed in Ole extension 
areas of OCP) is more complicated. A search for effective strategies of this type is 
described in section V.2. 
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ONCHOSIM 

II.l ONCHOSIM: a model and computer simulation 
program for the transmission and control of 
onchocerciasis 
A.P. Plaisier, OJ. van Oortmarssell, J.D.F. Habbema, J. Remme, 
RS. Alley 
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Introduction 
Onchocerciasis - or river blindness - is a parasitic disease which is endemic in large 
parts of Western Africa and in some countries of Central and SouOlern America 
(WHO, 1987a). Important foci of the disease can be found close to fast-flowing 
rivers, where transmission is highest. Prolonged and intensive exposure to the 
parasite can lead to visual decline and even complete blindness, sometimes in more 
Olan 10% of the population of a village (Prost and Prescott, 1984). This makes Ole 
disease to a major obstacle to socio-economic development of fertile river basin 
areas, which justifies the broad attention for both the nature of transmission, and the 
possibilities of control of onchocerciasis (WHO. 1987a). 
River blindness is caused by the filarial worm Onchocerca volvulus. which is 
transmitted from man to man by flies of the genus Simulium (in Western Africa 
especially Simulium datl//lOSUIII s.I.). A schematic representation of this transmission 
and the life cycle of O. volvulus is given in Fig. 2. 
Adult inseminated female parasites produce millions of microfilariae (Mf, 
embryos) which migrate to the skin. where they can cause skin lesions, and into the 
eyes. where they ultimately may provoke blindness. A biting and blood-sucking 
SimuliulII fly can ingest Mf from the skin. A fraction of Olese Mf avoids to be 
digested and becomes an Ll-stage larva soon after the blood meal. These Ll-stage 
larvae migrate to the thorax of the fly and develop into the infective stage (L3 
larvae) which eventually enter the head capsule. 
During a subsequent bloodmeal. infective larvae can be transmitted to man. Only 
a small fraction of the infective larvae inoculated into a person succeeds in becom-
ing a mature male or female worm. Between inoculation and maturation there is a 
time lag. which is called the prepatent period. Mature female parasites usually live 
in nodules where they mate and produce Mf. Male worms are mobile and capable 
of mating with females in several nodules (Schulz-Key and Karam. 1986). Microfi-
larial lifespan is estimated between 6 months and 3 years (Duke. 1968). For Mf 
3 Modifications of ONCHOSIM since this publication will be indicated with footnotes. 
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engorged in a fly it takes about 6-9 days to develop into the infective L3 stage 
(philippon, 1977). Following inoculation into man, the parasite is prepatent for 
about 1-1.5 years (Prost, 1980). The total lifespan of the worm has been estimated 
to be about 10-12 years on average (Remme et al., 1986; Karam et al., 1987). 
Until very recently, tlle only means of onchocerciasis control was regular spray-
ing of tile breeding places of SillluliulII with chemicals which eliminate the fly 
larvae, and interrupt the transmission cycle of O. volvulus. The World Health 
Organization (WHO)-coordinated Onchocerciasis Control Programme in West 
Africa (OCP), which started its activities in 1975, has proven that tllis method can 
be very successful. After 12 years of larviciding, it had achieved tile control of the 
disease in 90% of the original Programme area (WHO, 1987b). Recently, also 
chemotherapy has become available. Clinical trials have demonstrated that the drug 
ivermectin is an effective and safe microfilaricide (i.e. it kills microfilariae) 
(Awadzi et al., 1986), and conmlUnity trials have shown that it is sufficiently safe to 
be used in mass treatment (De Sole et al., 1989a). Until now no significant long-
term effect on the viability of the mature parasite has been observed4. Regular 
administration of ivermectin should prevent visual decline and mass treatment has 
shown to lower the level of transmission (Remme et al., 1989b). 
Extensive entomological and epidemiological evaluation data have been collected 
in the OCP, and it became obvious that a bio-mathematical model was needed to 
facilitate the integrated analysis of these data and their optimal utilization in the 
planning of future control. After a start with a simple model for epidemiological 
trends in controlled areas of the OCP (Remme et al., 1986), modelling has evolved 
in close association with analysis and applied research, and has culminated in the 
present, complete model for onchocerciasis transmission and control. Application of 
the model will involve in the first place the identification of proper assumptions on 
the various parameters, including a thorough analysis of a range of possible alterna-
tives. Subsequently, the model will be used to analyze the consistency between 
different evaluation data. The fmal application of the model will involve the predic-
tion of future epidemiological trends under different assumptions on transmission 
and interventions in order to provide a framework for the prospective evaluation and 
monitoring of alternative strategies for the control of onchocerciasis, which is the 
ultimate aim of the model. 
The model can be regarded as a hybrid of two more or less distinct SUb-models. 
One sub-model deals with the human population and calculates the life history of the 
parasite in the human host. This is a stochastic sub-model. The other part is a 
deterministic sub-model which calculates the fly dynamics and the fate of the para-
4 But see Chapter IV, section 2. 
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site in the fly. In order to carry out simulations with the model, the computer 
program ONCHOSIM has been developed. 
The model 
The model describes the transmission and control of onchocerciasis in an endemic 
focus. In Fig. 4 the structure of the model is presented schematically, with reference 
to the life cycle of O. vo/vulus. The most important parameters of the model are 
sununarized in Table I. 
The process of illfection 
During a bloodmeal of a Simulium fly a person can become infected Witll the para-
site Ollchocerca volvulus. This is indicated in Fig. 4 as 'new infections'. Infection is 
defined as the inoculation in man of an O. volvulus larva (L3 larva) that succeeds in 
developing into an adult male or female worm. 
In the human population there is considerable variation in the degree to which 
individuals are exposed to the bites of the fly, and hence in the risk of becoming 
infected. Partially, this degree of exposure is related to the sex and age of a person. 
In general, exposure is higher for males than for females, while for bodl sexes the 
highest values are reached at the puberal and adult ages (Remme et al., 1986; Renz 
et al., 1987). 
Beside these systematic differences, there are numerous other factors which 
determine exposure, such as attractiveness to the flies and behavioral factors that are 
independent of age and sex (e.g. fishermen will be highly exposed due to their 
activities near the breeding places of the Simulium flies). Therefore, the exposure 
(Ex) is defined as the product of an age- and sex-dependent relative exposure (Exa) 
and an exposure index (Ext), which is assumed to be a personal characteristic during 
lifetime, and which reflects the remaining differences in exposure between individ-
uals. For an individual i with age ai and sex si: 
(I) 
The random variable Exi is governed by a continuous probability distribution (see 
Table I). 
Microfilarial production 
In the model, the duration of the development of the immature parasite, the 
prepatent period Tp, and the total longevity TI of the worm are both random vari-
ables governed by a continuous probability distribution. After the prepatent period a 
Table 1 Input parameters for the ONCHOSIM model 
Parameter Model specification 
Denwgraphy 
Initial population size 
Human life table 
Human fertility 
Exposure 
Age- and sex-specific relative exposure (Exa(a,s) 
Exposure index 
Number of men and women by age 
Survival probability as a function of age 
Number of offsprings per year as a function of age 
Average exposure for an individual of age a and sex s 
p.d.f.a of individual exposure (Ea) 
Life history and productivity of the parasiIe in the human host 
Worm longevity P.d.f. of the total lifespan ('IT) of the parasite human host 
Prepatent period 
Age-dependent potential microfilaria production 
Longevity of microfilariae 
Worm's contribution to the skin load 
Skin snip variability 
Dispersal factor 
Mating cycle 
Mating factor 
Parasite and vector 
Fly survival 
Gonotrophic cycle 
Fly fecundity 
P.d.f. of the duration of the prepatent period (Tp) 
Potential relative microfllarial productivity of a parasite by age 
Lifespan of a microfilaria (Tm) 
Factor (cw) between skin load (st) and effective load (el) 
P.d.f. of the number of microfilariae per skin snip (mean is sf) 
P.d.f. for a worm's contribution to the skin snip count (d) 
Interval (months) between two mating events 
Male worm:female worm ratio required to guarantee 100% mating 
Fraction of flies surviving during 1 day 
P .d.f. of the time between two blood meals 
Number of nulliparous flies resulting from a single brood of a Simulium fly 
Parameter 
Fly larval period 
Zoophily 
Maximum biting rate 
Fly immigration 
Microfilarial uptake (lu) 
Larval development 
Larval survival (LI- > L3) 
Larval survival (L3) 
Larval release 
Infection as a function of L3 release 
Disease 
Blindness threshold 
Excess mortality 
Ivermectin 
Coverage 
Age- and sex~specific compliance 
Instantaneous effect 
Cumulative effect 
Larvidding 
Inter-application period 
Coverage 
a P .d.f. = probability distribution function. 
Model specification 
Duration of the larval stage of Simulium flies 
Fraction of bites of Simulium flies which are not taken on humans 
Monthly biting rate (mbr) under undisturbed circumstances (for each calender month) 
Monthly biting rate caused by immigrating flies (for each calender month) 
Average number of Ll-larvae per blood meal as a function of the skin load (sf) of the human host 
P.d.f. of the time to reach the L3-stage after engorgement 
Fraction of the Ll-Iarvae that survives to the L3-stage 
Fraction of the L3-larvae that survives one gonotrophic cycle 
Fraction of the L3-larvae that is released during a human blood meal 
Average proportion of released L3-larvae that develop into mature parasites (Sf) 
P.d.f. of the critical value for blindness of the accumulated effective load 
P.d.f. of the reduction factor for the residual life expectancy of blind persons 
Average percentage of the census population treated with iverm.ectin 
Relative probability of compliance with treatment by age and sex 
P.d.f. for the reduction in microfilarial load due to treatment 
Reduction in potential productivity as a function of the number of treatments 
Number of days between two larvicide applications 
Percentage of the Simulium larvae killed per treatment 
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Figure 4 Schematic representation of the structure of the model. 
female worm can start producing Mf if there are also mature male worms. Female 
worms need to mate regularly (Schulz-Key and Karam, 1986). The longevity of the 
microfilariae Till is given a fixed value, as variability in Till is of minor importance 
in comparison WiOI variability in T/ and Tp. 
A single female worm can produce millions of Mf during her life. Since the exact 
number of Mf originating from one female is unknown, we introduce the relative 
microfilarial offspring 1110. This 1110 reflects the contribution of a female worm to the 
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total Mf load in the human body. It is a relative measure with a maximum value of 
1. 
Following the onset of Mf production, 1110 will build up to an equilibrium value. 
As Mf longevity is fixed, this build-up phase requires a period equal to Till. The 
equilibrium level of 1110 depends on the rate at which Mf are produced. This rate is 
represented by /', the relative productivity, which is dependent on the age of the 
female worm; /'= 1 at maximum productivity. 
For a female worm of age a, the microfilarial offspring 1110 can be described as 
follows: 
Tho 
1I10(a) = !_I-r(a-x)dx 
o Till 
(2) 
It is clear that this relationship is only valid if no microfilaricide is given, as this 
causes an instantaneous reduction of the Mf load (see paragraph on intervention by 
mass treatment). Beside the age of the worm, the value of I' is also dependent on the 
probability of mating. If mating does not occur I' reduces to zero. The probability of 
mating is a function of the parasite sex-ratio weighted by a factor for the mating 
capability of a male worm. 
The microfilarial offspring 1110 of all worms together determines the Mf load of a 
person. This Mf load is denoted with the effective parasite load el, which is calcu-
lated as: 
for all worms j = 1, " ,II; in person i. 
Blil/dlless 
n, 
el,= Lillo) )., (3) 
Dependent on the Mf load a number of Mf will penetrate the tissues of the skin and 
the eye. Immunological response to dead Mf in the eye may result in the develop-
ment of eye lesions and ultimately blindness. This is reflected in the observed 
incidence of eye lesions and blindness, which is closely related to the Mf load 
(Dadzie el al., 1986), and in the prevalence of blindness which is highest among old 
persons. In the model, the risk of going blind is a function of the Mf load (denoted 
by ef) accumulated over time. 
In agreement with reported excess mortality among persons with eye lesions 
(Prost and Vaugelade, 1981; Kirkwood el al., 1983), in the model a reduction 
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factor is applied to the residual life-expectancy of blind individuals. 
Skill-load and infection of flies 
The density of Mf in the skin is related to the number of Mf in the body, which is 
quantified by the effective parasite load el. The average skin Mf load is defined as 
the expected number of Mf that can be counted in a skin-biopsy (skin snip, see 
below) and is denoted as sl. It is a linear function of el: 
sl=cwxel (4) 
where cw is the mean number of Mf contributed by one fully productive female 
worm (with r equal to 1). 
Mf in the skin can be engorged by biting and blood sucking SimllliulII flies. 
Following uptake in the flies, only a fraction of the Mf succeeds in developing to 
Ll-stage larvae. Since this fraction is usually very small, we use a shortcut and 
consider an Ll-'uptake' (III), which is a direct function of the skin Mf load (sf). 
Recent fly feeding and transmission experiments, which were undertaken in the 
OCP, have enabled the estimation of this function which shows a saturation type of 
relation between Ll-uptake and skin-load (unpublished data5, see also Philippon, 
1977 and Renune et al., 1986). 
The probability that a fly will bite a certain individual depends on his exposure 
(Ex, see equation 1) and the following relationship is used to calculate the average 
Ll-uptake of a fly: 
for all individuals i=l, .. ,III. 
Development ill the fly 
m 
L Ex,xlll, 
111-","",'---
m 
(5) 
The vectorial (vector = the intermediate host, the SimllliulII fly) part of the trans-
mission is modelled deterministically, and involves the calculation of the monthly 
biting rate mbr and the probability for an engorged Ll-larva to develop into an 
infective L3-larva and to be released during one of the subsequent bites of a fly. 
This probability, denoted by v, is determined by combining data on the life history 
5 See Appendix of Section V.I. 
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of the fly (including daily survival and a distribution of the intervals between blood 
meals), the fraction of bites on non-human objects, the distribution of the duration 
of development from the Ll-stage to the infective L3-stage, and the survival of the 
larvae during and after development. For a given Ll-uptake, averaged over all flies 
(iii), this results in an average release of infective larvae per bite (If); so in sum-
mary: 
ir=vxiu (6) 
In combination with a given monthly biting rate (mbr, see paragraph on fly 
dynamics) the monthly transmission potential (mlp) can be calculated as follows: 
mlp=irxmbr (7) 
Given the average fraction of inoculated L3-larvae that succeeds in developing into 
a patent infection (sr), the ultimate result is a force of infection (foi, see Remme et 
al., 1986) which is here defmed as the expected number of new infections per 
person per month: 
foi =srxllllp (8) 
For each person i, it follows ulat 
(9) 
The person i is assumed to become infected according to a Poisson process with rate 
foi; (Law and Kelton, 1982). 
Fly dYllamics alld illler1'elllioll by larvicide applicalion 
The monthly biting rate (/IIbr) is calculated as Ule sum of the daily biting rates (dbr) 
per person in a given month. This dbr follows from the dynamics and the biting 
behaviour of Ule fly population. The level of the mbr is dependent on the season 
(calendar month) and accumulates into the annual biting rate, ABR (Walsh el al., 
1978). 
The size of the fly population can be reduced by spraying larvicides on their 
breeding sites. Reducing the fly population results in a reduction of mbr, and hence 
larviciding will have a strong limiting effect on the transmission. In order to model 
the effect of larviciding properly, the fly population is divided into daily age classes. 
Beside nulliparous and parous flies (flies before and after their first bloodmeal 
respectively), there are egg, larval and pupal stages. Larvicides will only kill the 
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larval stage, and hence following the application of larvicides, it will take some 
days before the size of the fly population decreases. If the larviciding frequency is 
too low - i.e. with an inter application period longer than the duration of the larval 
stage - eggs will develop into nulliparous flies, and the population can build up 
again at a speed which is dependent on the fecundity of the flies. 
In the model, a larviciding strategy is governed by three factors: 
(1) the duration of the strategy (months) 
(2) Ole period (days) between applications 
(3) Ole fraction of fly larvae killed at each application.6 
Even following complete eradication, a local fly population can build up again by 
immigrating flies. Additional assumptions can be made on the infectivity of these 
immigrant flies. 
lnlervenlion by mass Irealmenl wilh a micro filaricide (ivermeclin) 
A microfilaricidal drug, such as ivermectin, can be administrated to the population 
of a village. It will cause a substantial reduction of the effective parasite load eI by 
killing a large fraction of the Mf. It does however not kill the mature worms, and 
therefore lila and el will increase again after treatment, so Olat transmission by 
SimuliulIl is still possible. Treatment is especially effective as a means to reduce 
blindness as Ole accumulation of Mf load over time will slow down. 
In the model, Ole percentage of the population that will be treated during mass 
treatment is dependent on both the age and the sex of the individuals. In the case of 
ivermectin, children below the age of 5 and pregnant and lactating women are 
excluded from treatment (De Sole el al., 1989a). 
Participation in mass treatment is not only dependent on age and sex but also on 
the compliance of a person. In the model, this is characterized by a personal com-
pliance index, following a uniform distribution on [0,1). Some chronic diseases 
(e.g. epilepsy) may also be a reason for non-treatment. For this reason, a fraction of 
the modelled population is systematically excluded from treatment. 
From recent community trials with ivermectin, it became clear that the drug-
induced instantaneous reduction in individual Mf load varied from 100% reduction 
to no reduction at all (Remme el al., 1989b). Therefore, this Mf reduction is treated 
as a random variable, the value of which is determined for each participating person 
at each treatment. 
In addition, there is a possibility that ivermectin treatment might cause a perma-
nent reduction of a female worm's reproductive capacity. In the model Olis is incor-
6 In later versions factors (2) and (3) are directly translated into a reduction of the monthly 
biting rate (see Section 11.2). 
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porated by the option to specify a percentage reduction of the relative productivity 
(r) as a function of the number of treatments a worm underwent. 7 
Measurillg ollchocerciasis 
Epidemiological measures. In routine epidemiological surveys, skin snips are taken 
from each person and the number of viable Mf per snip are counted during micro-
scopic examination of the snip. At least two factors may cause a difference between 
the average skin Mf load (sf) and the number of Mf coullted in the skin snip (ss): 
(1) the worms are dispersed in the body. Thus, ss cannot be derived from sl 
directly. Instead, in the model tlle microfilarial offspring (mo) of each individ-
ual female worm is weighted with a dispersal factor (d) which follows a con-
tinuous distribution with mean 1. 
(2) the skin snip examination and counting procedure is subject to variation and is 
considered as a process following a Poisson distribution. 
Hence, the skin snip count ss of person i, harbouring 11; worms, is a random vari-
able having the following distribution: 
ss,- POisso(cwx:E mojxdJ) 
'1 J~l (10) 
An important characteristic of the epidemiology in a population is the distribution of 
the skin snip count, represented by a geometric series of categories for ss (0, 0.5, I, 
2-, 4-, etc.) using the mean of two snips. 
For the human population, the skin snip counts of all individuals are usually 
summarized into the geometric mean skin snip count (gs), modified to allow for 
ss;=O. For a population with //I individuals, gs is defined as: 
gs=(rn ir (ss, + 1))-1 
1,,1 
(11) 
The CMFL (Conllllunity Microfilarial Load, Remme et al., 1986) has the same 
definition, but is restricted to individuals older than 20 years. Further, the preva-
lence of persons with a positive skin snip (ss 21) is recorded (See Appendix). 
An important measure for the burden of onchocercal disease in the population is 
the prevalence of blindness, which has its model equivalent in the proportion of 
7 Extensions and modifications of the sub-model on ivermectin treatment, based on longer 
patient follow-up, are presented in Section IV.2. 
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persons in whom the accumulated effective parasite load exceeds a given threshold 
level (see paragraph on blindness). 
Infectivity of the vector. The common index for the intensity of transmission is the 
estimated annual transmission potential (ATP), which is the product of the estimated 
annual biting rate (ABR) and the average number of L3-larvae found in the head 
capsule of dissected flies. Furthermore, the number of inhabitant larvae of all 
developmental stages (Ll, L2 and L3) is counted and recorded for each fly. From 
these detailed counts, the infection and infectivity of the vector, as well as the 
distribution of the number of larvae, can be derived. 
In the model, the most important indices of transmission are the monthly trans-
mission potential (mtp) and the average number of Ll-larvae and L3-larvae in biting 
flies. 
The program 
The computer program ONCHOSIM, which is used to perform simulations with the 
model described in the previous section, can be considered as a hybrid of two 
different simulation techniques: 
(1) vectorial part: the development of the parasites in the flies and the dynamics of 
the biting fly population, including the effect of larviciding, is calculated in a 
deterministic sub-program. 
(2) epidemiological part: the largest portion of the program comprises the 
stochastic microsimulation of the life histories of the human individuals, their 
inhabitant male and female parasites, and the effect of chemotherapy. 
Vectorial part 
The vectorial sub-program consists of an initialisation part in which v (the trans-
mission probability of an Ll-larva, see paragraph on development of larvae in the 
fly) is calculated. The value of v is used throughout the simulation. The dynamics of 
the fly population is calculated by applying appropriate transition probabilities to a 
state variable that is represented by an array. The elements of this array are the 
daily fly stages (see paragraph on fly dynamics). Each day, dependent on the biting 
history, a number of flies (equal to dbr) will have a blood-meal. The dbr values are 
accumulated into mbr. The growth of the fly population is limited to the maximum 
mbr specified in the input. 
The variables mb,., v and Iii are the entry points to the epidemiological part of the 
program (next paragraph). 
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Epidemiological parI 
Data-structure: The backbone of the epidemiological part is a branched linked list of 
structures. These structures represent individuals of the human population. The 
branches, that are attached to these human structures, are linked lists themselves, 
and represent the inhabitant male and female parasites. Of course these branch lists 
may be empty in the case of uninfected individuals. In addition, especially in lowly 
infected people, it is possible that only one of the sexes is present (e.g. only female 
worms). 
Each human and worm structure consists of a number of characteristics, that fully 
describe the state of the human-parasite complex. A human structure is character-
ized by: 
(1) c 
c/v (2) 
(3) c 
(4) c 
(5) c 
(6) v 
(7) v 
(8) v 
(9) v 
(10) v 
the time of birth; 
the age of death; 
the sex; 
the exposure index (Ex!); 
the compliance with drug treatment (compliance index); 
the accumulated effective parasite load (see paragraph on blindness); 
the time since the last ivermectin treatment; 
the instantaneous reduction in Mf load at the last ivermectin treatment;8 
the number of inl13bitant female worms; 
the number of inbabitant male worms. 
In this list 'c' means that the characteristic is constant for the entire life, while 'v' 
denotes a characteristic that will change during program execution. The age of death 
will only change when the person goes blind. 
The characteristics of a female worm structure are: 
(1) c the time of maturation; 
(2) c the age of death; 9 
(3) v the time since the last mating; 
(4) v the number of ivermectin treatments the worm experienced during her 
life; 10 
8 In later versions a variable characteristic of a human is the age-structured microfilarial 
load. Reductions of this load as a result of treatment are then modelled explicitly and character-
istic (8) is no longer needed. 
9 At present, it is possible to simulate the effects of a hypothetical macrofilaricidal drug. 
Treatment with such a drug will, of course, alter the age of death of a Worm. 
10 Replaced by a variable which keeps track of the cumulative effect of the drug on the 
fecundity of worms; see section IV.2. 
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For male worms only the first two characteristics are needed. 
Sill/ulalion procedure 
Processing the data structure: The program starts by creating an initial population, 
i.e. a human list with a specified size and age distribution. As soon as a human is 
added to the list, the human characteristics are determined by random selection from 
the appropriate distributions. Initially, the worm lists are empty. If desired, also a 
worm burden can be initialized by assuming a given force of infection during a 
fixed period before the actual simulation starts. Generally, to reach an 
epidemiological equilibrium situation and a stable age structure of the population, a 
simulation must cover a period of many decades. 
Each month I, the infectivity of the population is calculated by examining the 
characteristics and worm lists of each human structure in the human list. This 
renders li/, which in combination with v, II/br and sr results infoi (see paragraph on 
larval development in the fly). 
As a next step in month I, the human list is updated by removing structures of 
persons that have died and by adding structures for newborns. Each person's worm 
lists are updated too: as a result of the force of infection foi, weighted for the 
exposure of the person, a number of worms is added, and dead worms are removed. 
The time step of 1 month is sufficiently short since the prepatent period (Tp) will 
certainly be longer than ! month. Thus new infections acquired in month I will not 
contribute to the force of infection in the same month. 
Events: In ONCHOSIM two stochastic events are generated from constant hazard 
rates: the acquisition of a new infection in a human (where the rate is given by foi;) 
and the birth of new humans. 
is: 
Generally, if we have a hazard rate <T, then the time interval between events (a1) 
aT= -!nil 
a 
(12) 
with u being a random number with a uniform distribution on the unit interval, and 
with the assumption that <T does not change during aT. An event (new infection, 
birth) only occurs if aT,,;,! month. If this is the case, then further events may 
occur, until the sum of aT exceeds 1 month. 
If we follow tIle fate of a single worm in a given human, then the events that will 
occur after infection are: maturation (after Tp years), regular mating (if both sexes 
are available) and death of the worm Tl years after infection. 
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Events that may occur in the human: 
(1) the human may become infected with new parasites; 
(2) the human may go blind, which has consequences fol' the residual life expect-
ancy; 
(3) a skin snip can be taken during an epidemiological monitoring; 
(4) the human may be treated with a microfilaricide; 
(5) the human may die. 
An event that may affect the fly population is the application of larvicides, which 
has consequences for the rate at which new infections are acquired (reduced force of 
infection). 
Program Olltpllt and program application 
The output of the program can be presented with several degrees of detail. In its 
most detailed form, epidemiological information is tabulated for each sex and age 
group separately. Vector-related results are tabulated for each month. In the Appen-
dix an example is given of detailed epidemiological output. The format of the tables 
closely corresponds with the standard tabulation in the OCP, which facilitates direct 
comparison. 
The choice of the degree of detail largely depends on the purpose of the simula-
tion. A lot of detail is required when the model is fitted to field data. In simulations 
where the effects of control strategies are predicted, it is more useful to produce 
alliual output in the form of aggregated indices such as the community microfilarial 
load CMFL, prevalence of blindness and the ATP. 
Roughly, in the utilization of the program, three phases can be distinguished: 
model quantification, integrated data analysis, and prospective evaluation. 
The quantification phase comprises a systematic search for sets of parameter 
values which result in program output corresponding to field observations of several 
endemic situations. During this phase the distribution of Mf per skin snip is SinlU-
lated for a number of villages in the OCP area that have been monitored at several 
moments since the start of larviciding control. In Fig. 5 an example of such a 
simulation is compared with the situation in Folonzo (Burkina Faso) at the start of 
control (a) and after 10 years of control (b). 
The second phase involves the routine application of the model in the integrated 
analysis of the extensive entomological, epidemiological and applied research data 
of the OCP. 
The 'prospective evaluation' is the ultinlate goal of the development of the model. 
It includes all simulations in which the effect of control strategies with larviciding 
and ivermectin administration is evaluated. 
One of the steps in this evaluation phase is the use of ONCHOSIM to predict the 
34 Chapter II 
40 CMFL 
<a) observed: 30 
30 
simulated: 35 
20 
10 
t: 
0 
.c 0 0 0.5· 16· 8 2· 4· 8· 32· 64· 128· 256+ 
'l5 40 
<f'. 
(b) CMFL 
30 
observed: 3.7 
simulated: 3.2 
10 
o o 0.5- 2· 4· 8· 16· 32· 64· 128· 256+ 
nr. mfcrofilariae per skin snIp 
Figure 5 Example of the simulated distribution of micromariae per skin snip (black 
bars) compared with the observed distribution in Folonzo (Burkina Faso; 
hatched bars) at the start of the control <a) and after 10 years of larviciding 
control (b). Data apply to a cohort of persons that were older than 20 years 
at the start of the control. 
risk and dynamics of the recrudescence of Infection in villages where, after a period 
of larviciding control the SillluliulII fly returns and bites at the pre·control intensity. 
In Fig. 6 an example is given of the trend in the prevalence of positive skin snips, 
the CMFL, and the prevalence of blindness when (100% effective) larvicidlng 
control ceases prematurely after 8 years. 
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Figure 6 Example of simulated decline in the prevalence of positive skin snips (solid 
line), the CMFL (dashed line) and the prevalence of blindness (dot-dashed 
line) during 8 years of larviciding control, and of the recrudescence after 
stopping control too early. 
Dlscllssion 
The development of the ONCHOSIM program is not the first attempt to formalize 
the processes involved in the dynamics of onchocerciasis. In 1969 Mills reported a 
quantitative approach to the epidemiology of onchocerciasis io West Africa. Para-
meters related to the human population. the Simulium population and the parasite are 
integrated into a statement of transmission in different bio-climatic zones. However, 
it was soon pointed out that this work was based on several incorrect and misleading 
assumptions (Duke, 1970). Partial models have been developed for certain aspects 
of the transmission, such as the fly-dynamics (Birley et 01., 1983) and the develop-
ment and migration of parasite larvae in the fly (Jerwood et 01., 1984). 
A mathematical description of onchocerciasis transmission has been provided by 
Dietz (1982) (see also the discllssion in Anderson and May, 1985). Dietz developed 
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relationships for the dynamics of the number of parasites in both the human popula-
tion and the fly-population, using several assumptions on Ole mechanisms of density 
dependent regulation, which are required to arrive at an equilibrium situation. Based 
on these relationships and few field observations, Dietz estimates Ote basic repro-
ductive rate of the parasite and provides dynamic projections of the effects of vector 
control. Subsequent evaluations in the OCP have shown that Olese projections were 
not correct, mainly because of the assumption of an age-independent survival dis-
tribution of the parasite, an assumption which also Dietz had recognised to be a 
major limitation of the model. 
On the basis of a force-of-infection model for onchocerciasis, Remme el al. 
(1986) made predictions of age-specific epidemiological trends and compared these 
predictions with the results of 8 years of larviciding control in the OCP. This 
model, which includes a realistic modelling of the life-history of the parasite in the 
human host, appeared to give reasonable predictions of both the average intensity 
and the prevalence of infection. However, it was still only a partial deterministic 
model which did not address the dynamics of transmission. 
ONCHOSIM is, to our knowledge, the only existing stochastic model for the 
transmission and control of onchocerciasisll . A distinguishing feature is its close 
comlection with the actual control of the disease (in the OCP) and its development 
in close collaboration with scientists from all disciplines involved. The model is 
highly flexible and new research fmdings can be easily incorporated. Control strat-
egies can be specified in a detailed and realistic way, while almost no restriction 
needs to be made on the life-history of the parasite (e.g. the longevity of the para-
site in the human can take any distribution). Its flexible design and its availability on 
micro-computer configurations should make ONCHOSIM a valuable tool for 
research workers and decision makers in the field of onchocerciasis control. 
11 Later, Davies (1993) developed a stochastic model for the forest form of onchocerciasis. 
1. The ONCHOSIM model alld compllter program 37 
Appendix 
Example of detailed epidemiological program output 
An example of the epidemiological part of the detailed form of output of the 
ONCHOSIM program is given below. It concerns output of a simulation of the core 
villages in the hyperendemic focus of Asubende in Ghana (Remme et al., 1989). In 
these tables 'MFS' means microfilariae in skin snips. 
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11.2 Formal description 
Allllex12 from: 
Habbema JDF, Vall Oortmarssell GJ, Plaisier AP. The ONCHOSIM model 
alld its use ill decisioll support for river blindlless cOlltrol 
III: Isham V; Medley G [Eds.]. Models for Illfectious Humall Diseases - Their 
structure alld relatioll to data. Cambridge, UK: Cambridge Ulliversity Press 
1996: pp. 369-380. 
This section gives a complete description of the ONCHOSIM model structure and 
parameter quantification. Except for the quantification of the effect of ivermectin 
treatment, the version of the model presented is the same as used in Habbema et 01. 
(1992). In other applications of the model, other quantifications may be used for 
situation specific parameter groups like demography, exposure, coverage of drug-
treatment, etc. Since the model structure and quantification is regularly updated, in 
future use of ONCHOSIM assumptions may differ from this description. Note that 
the ONCHOSIM computer program offers the opportunity to change parameter 
values, to choose other options regarding the type of probability distributions used, 
and to make structural changes in parts of the model. 
Demography 
The human population dynamics is governed by birth and death processes. We 
define F(a) as the probability to survive to age a (apart from excess mortality due to 
onchocerciasis related blindness). The values used are as follows: 
age (a) o 5 10 15 20 30 50 90 
F(a) 1.000 0.804 0.772 0.760 0.740 0.686 0.509 0.000 
Survival at intermediate ages is obtained by interpolation. 
The expected no. of births (per year) at a given moment t is given by: 
Rb(t)=L N/k,t)X1ik) (1) 
kool 
no. of women in age group k at time I. 
annual birth-giving rate of women in age-group k: 0.109 babies per year 
12 Written by A.P. Plaisier, GJ. Van Oortmarssen, and J.D.F. Habbema. 
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for women between 15 and 20 years; 0.300 between 20 and 30 years; 
0.II9 between 30 and 50 years; 0.0 for all other ages. 
" a no. of age-groups considered. 
Each month Rb(t) is adapted according to the number of women and their age-dis-
tribution. 
Exposure to blackflies 
The number of bites IIIbr;(III) a person i gets in month m is given by: 
mbr,(lII) =Mbr(m) xEx, (2) 
Mbr(m) no. bites in month m (m=Jan., Feb., .. ) for a person with relative expo-
sure I. 
The relative exposure Ex; is calculated as: 
EXi =Exa(a"s,) xExii (3) 
Exa(a,s) relative exposure of person with age a and sex s: Zero at birth, linear 
increase between age of 0 and 20 years to 1.0 for men and 0.7 for 
women, and constant from 20 years onwards. 
Exi;- Weibull(1.0,iY.e'i) 
13exposure index of person i. The exposure index of a person remains 
constant throughout lifetime. For selected OCP villages, estimated iY.Rt; 
values vary between 1.3 (nearly exponential) and 4.5 
Mbr(m) values are obtained from six representative years of fly collections near the 
village of Asubende (Ghana). There, monthly biting rates of on average 2570 bites 
per person, varying from 1500 in March to 3750 in November have been found. 
For the actual biting rates (Mbr(m) inside of this village we multiplied these figures 
with a factor (called the relative bitillg rate) of 0.95 (note: since we have no mea-
surements of biting rates actually experienced by villagers, we have - arbitrarily -
defined a relative bitil/g rate of 1.0 - i.e., mean Mbr=2570 - as the biting rate 
resulting in a geometric mean no. of Mf per skin-snip of 100 in hypothetical village 
with all persons being permanently characterized with a relative exposure of 1.0). 
13 i.e., Erij is a random variate described by a Weibull-distribution with mean = 1.0 and 
shape-parameter a = (XEti 
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Assuming the same seasonal pattern, for other villages relative biting rates have 
been estimated to vary from 0.4 to 0.9. 
Acquisition, development, longevity and productivity of parasites in the human 
ltost 
If during a blood meal of a fly in month III on average Ir infective larvae are 
released, the force-of-infection joii(lIl) - defmed as the expected number of new 
adult parasites per year - acting upon person i in month III is calculated as: 
joi,(lIl) = 12xmbr,(IIl) xlr(m) xsr (4) 
Sl' success ratio: fraction of injected L3-larvae succeeding in growing to 
adult male or female worms: sr=0.0031. An average male:female sex 
ratio of 1: 1 is assumed. 
The reproductive lifespan of male and female parasites is a random variable: 
TI- Weibull(Ti,cxn), with fl= 10 years and cxTl=3.8. The Mf productivity r(a,t) of a 
female worm of age a at time t is calculated as follows: 
r(a,t) = R(a)xlll(t) (5) 
R(a) potential Mf productivity of a female worm of age a (in years): R(a) = 0 
for 0";'a<1 (i.e., the in1lllature period of the worm is estimated at 1 
year); R(a) = 1 for 1";'a<6; R(a) = 1-((0-6)/15) for 6";'a<21; R(a) = 
o for a>21. 
met) mating factor at time t 
To continue Mf production, a female worm must be inseminated each rc months 
(I'c=reproductive cycle=3). If insemination took place less than I'C months ago, 
then lIl(t)=1. Otherwise, ule probability of (re-)insemination PillsCt) in month t is 
given by: 
P,,,,,(t) = Wm(t)/ Wf.t) 
=1 
if Wm<Uf 
oUlerwise 
W(I) no. of male (Will) or female (1Ij) parasites in the human at time I 
(6) 
If no insemination takes place then m(l) =0 and the female worm has a new oppor-
tunity in month t+1. If insemination occurs in month 'i then 111(1)=1 during 
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The skin Mf density at time I (sl(I)) is calculated by accumulating the Mf production 
of all female parasites over the past Till months: 
sl(t) =cIVxel(t) (7) 
(8) 
el(l) the effective parasite load at time t. This intermediate variable describes 
the female parasite load obtained by weighting each worm according to 
the Mf productivity during the past Till monO!s. 
CIV average contribution of an inseminated worm at peak fecundity (R= 1) to 
the skin Mf density: cw=7.6 Mf/worm. 
Tm (fixed) microfilarial lifespan: Tm=O.75 years. 
II; number of parasites alive during at least one of the months I-I, ... ,t-TIII. 
Skin-snip count 
The expected no. of Mf in a skin·snip is given by: 
(9) 
dispersal faclor of female parasite j. This is a random variable account-
ing for differences in the contribution of female worms to the Mf density 
at the site of the body where snips are taken. We assume an exponential 
distribution for describing these differences: dj-Expo(I.O). 
The actual number of Mf per skin-snip follows a Poisson distribution: 
ss(t) - Poissoll (s'S (I)). At each epidemiological survey 2 snips per person are taken. 
Uptal,e, development and release of larvae in the vector 
On the basis of fly-feeding experiments in OCP the following expression for the 
relation between Ll-uptake (III) and skin-microfilarial density (sl) has been derived 
2. Formal description of ONCHOSIM 43 
(note: since most of the Mf engorged during a bloodmeal are trapped in the fly, we 
consider Ll-'uptake' rather than Mf uptake): 
lll=a(l-e -bsl)(l +e -csl) (10) 
with a=1.2, b=O.0213, and c=O.0861 (the initial slope of Olis relationship equals 
2ab). The mean Ll-uptake in the fly population in month III is now calculated as: 
N(m) N(m) 
lii(lIl) = L (Exlxllll)I L EXI (11) 
1",1 i=1 
N(IIl) No. of persons in month Ill. 
It is assumed that a fixed proportion of the Ll-Iarvae develops to the L3-stage and 
will be released at one of the subsequent bites: 
lr(lIl) =VXIIl(IIl) (12) 
tr(lIl) mean L3-release per bite in month Ill. 
v transmission probability: average probability that an Ll-Iarva is released 
as an infective L3-larva. 
The calculation of the transmission probability v is complicated. In calculating v we 
take into account the life-history of the fly starting from her first bloodmeal. We 
assume that bloodmeals are taken at fixed hours during daytime, so that we can use 
1 day timesteps. Though we take into account differences in the length of the gono-
trophic cycle between flies, in the model we assume that a particular fly has always 
the same cycle length (which equals the time between two successive bloodmeals). 
We further explicitly account for variation in the duration of development from Ll 
to L3. The basic assumption underlying the use of a fixed proportion v is that at any 
moment the fly-population has a stable age-distribution and that the no. of bites per 
person is large enough to reflect this stable age distribution. 
Calculation of the transmission probability v 
Assume that a fly engorges 1 (one) Ll-Iarva at her 1Ilt/, bloodmeal, then the prob-
ability to release an L3-larva II bloodmeals later is given by: 
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(13) 
Pre/(n I i,j,lII) 
The probability to release one L3 larva at the (m+nyti' bloodmeal if one 
Ll larva has been engorged at the lII'h bloodmeal, given that: 
• a gonotrophic cycle takes j days 
• between bloodmeal 111 and 111+11 there have been i potentially infec-
tive bloodmeals (Le., bloodmeals at which the Ll-larva had already 
developed to the L3-stage) 
The probability that an Ll-larva develops to the L3-stage, given sur-
vival of the fly: PLl4L3=0.85. 
The probability that an L3-larva which is not released at a given blood-
meal survives to a next bloodmeal, given survival of the fly: 
PL34L3=0.90. 
The probability that an L3-larva is released at a bloodmeal: PL34=0.65. 
The probability that a fly survives for I days since bloodmeallll. 
In order to arrive at a general solution for all possible values of i, we use the 
probability distribution of the number of potentially infective bloodmeals since the 
intake-meal and before the release meal: 
n-t 
P",(II ~,III) = L [p",(lIlij,III)XP'b(i IIIJ)] 
i=O 
(14) 
(15) 
Pib(i 11I,j) 
The probability that before the ,,'h bloodmeal since intake, i bloodmeals 
have been potentially infective (Ll has become L3), given a cycle length 
ofj days. 
FdLl4Lil) Probability that the duration of development of Ll to L3 is equal to or 
less than I days (FdLl4L3(I)=0.0 for 1,;;,5; 0.07 for 1=6; 0.86 for 1=7; 
1.0 for 1';?8 days). 
A general solution for all possible values of 111 can be obtained by incorporating the 
probability that a fly takes her lII'h bloodmeal: 
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m= 
P",(II[/)= L [P,i"li,m)xPb(m[f)] (16) 
m""l 
Pb(m li)=L(i(m-I»/ L L(i(m-I» (17) 
m .. l 
Pb(m I j) Probability that a feeding fly takes her IIi" bloodmeal at a cycle length of 
j days. 
L(I) Probability that a fly lives for at least I days. At present we assume an 
age-independent daily survival of 0.78. 
Generalizing for j can be achieved by summation, weighted for the probability 
distribution for the duration of the gonotrophic cycle: 
J= 
P,i") = L [P,i"li)xPgc(f)] (18) 
N"", 
Pgc(j) Probability that a gonotrophic cycle takes j days (i.e., j days between 
successive bloodmeals; Pgc(j)=O.O for j,;,2; 0.2 for j=3; 0.6 for j=4; 
0.2 forj=5; 0.0 forj;,,6 days). 
Using the following equality 
S(m,lIx}) =L(i(m +11-1»/ L(i(III-I» (19) 
the average probability that an Ll-larva taken from a human will develop to the L3-
stage and released to another human is given by: 
(20) 
In equation (16), (17) and (18): 
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111 =l(= + l )j max j (21) 
alll"t Maximum attainable age of the fly (i.e., age at which L(t) approaches 
zero). (L ... J denotes truncation to integer). 
The transmission probability v is now given by: 
(22) 
z Fraction of fly-bites on non-human objects (zoophily; z=0.04). 
Using the indicated quantifications, we have calculated a v of 0.073 released larvae 
per Ll-larva resulting from a given Mf uptake. Note that formula (20) reduces to a 
much more simple form if we assume that each day a fraction S of the flies survive, 
that the gonotrophic cycle has a fixed duration of dgc days, and that the number of 
bloodmeals needed to complete tlle development of L1 to L3 is fixed to 111->3: 
(23) 
Blindness and excess mortality 
The probability of a person going blind at age a (months) depends on the acculIlu-
lated parasite load (elc) of a person: 
a 
elc(a)=L; el(x) '(24) 
X"'O 
Each person has a threshold level of elc (denoted as Elc) at which a person goes 
blind. Elc follows a probability distribution: Elc- Weibull(Elc'<XE{J, with 
Elc= 10,000 and <XE{c=2.0. Person i goes blind at age a when: 
(25) 
At that moment the remaining lifespan at age a is reduced by a factor rl which 
follows a uniform distribution on [0,1] (hence on average 1'1=0.5). 
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Ivermectin: mass treatment coverage and compliance 
The primary characteristic of a certain ivermectin mass treatment IV is the coverage 
CIY (fraction of the population treated; typically 0.65). However, a difficulty in 
calculating individual chances of participation is that there are sveral exclusion 
criteria for the drug. Moreover, compliance to treatment differs from person to 
person. Exclusion criteria can be either permanent (chronic illness) or transient 
(children below 5 and pregnant or breast-feeding women). We derme the eligible 
population as the total popUlation lIIi1lllS a fractionfc (=0.05) which is permanently 
excluded from treatment (in the model from birth to death). The coverage among 
the eligible population is now given by: 
(26) 
The transient contra-indications and other age- and sex-related factors are taken into 
account in the age- and sex-specific relative compliance c,(k,s) for each age-group k 
and sex s. Based on OCP data we use: 
age-group 0-4 5-9 10-14 15-19 20-29 30-49 50+ 
(k) 
c,(k, 00) 0.00 0.75 0.80 0.80 0.70 0.75 0.80 
cr(k, \? \?) 0.00 0.75 0.70 0.74 0.65 0.70 0.75 
Note that in cr(k,s) only the ratio between the values for tile different groups is 
relevant. The coverage c(k,s, IV) in each of the age- and sex-groups at treatment 
round IV is calculated as: 
c(k,s,IV) c/k,s)xN(IV) . ---'..:...c~-'-'--xCw 
I:;_II:;:IC,(k,s)xN(k,s,IV) 
(27) 
N(k,s, IV) Number of individuals eligible to treatment in age-group k and sex s at 
treatment round IV. 
N(w) Total number of eligible individuals at treatment round IV. 
Finally, the probability to participate in treatment round IV for an eligible person i of 
age-group k and sex s is given by: 
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l-c(k,s,w) 
PI - '(k~.w) 'I,w-CO; 
(28) 
COi Personal compliance index. This is considered as a lifelong property and 
is generated from a uniform distribution on [0.1]. 
Note that for all k and s the average value of Plri.1V equals c(k,s,w). 
Ivermectin: the parasitological effect of treatment 
In the model we assume that an effective treatment with the drug causes elimination 
of 100% of the microfilariae from the skin-tissues. The impact of the drug on the 
subsequent productivity r of a female parasite j in person i is given by: 
I 
r· ·(1) j,t 
,0 .. (1) j,t 
Vi 
d 
Tr 
rj,(I)= rj~(t)x(1-V,d)x(-t-)' 
.' v,Tr 
= 0 
Time (months) since treatment. 
if II/V,JlI ; v,d<1 and t~Tr 
otherwise 
(29) 
Mf productivity of female worm j at I months after treatment with iver-
mectin of person i (see eqn. (5» 
The Mf productivity of tllis worm j had person i not been treated at the 
last round. 
Relative effectivity of treatment in person i. 
Average permanent (unrecoverable) reduction in Mf productivity result-
ing from treatment (d=0.35). 
Average duration of the period of recovery. i.e., the period during which 
the Mf productivity of the female worm increases from 0 to the new 
eqUilibrium (Tr= 11 months). 
Shape parameter of the recovery function (s= 1.5). 
Random number on [0,1] generated for each female wormj. 
Average fraction of female worms killed as a result of treatment (at 
present: 111=0). 
The relative effectivity Vi is a random variable generated a probability distribution: 
vi- Weibull(l.O,Ci,J, with Civ=2.0. In the model we explicitly consider persons (5% 
of the treated population) which do not at all react on the drug at a certain round 
(malabsorption, e.g., due to vomiting). 
2. Formal description of ONCHOSIM 49 
Vector control 
Vector control is modelled as the fraction reduction of the monthly biting rates 
during a given period of time (efJ). A period of vector control is specified as the 
year + month + day of the beginning of the strategy and the year + month + day 
of the end of a strategy. If in a certain month during a period of d days larvicides 
have been applied, then the reduction in Mbr(m) in that month equals (dxeff!30) x 
100 %. 
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The reproductive lifespan of 
Onchocerca volvulus in West African savanna 
A.P. Plaisier, GJ. van Oortmarssen, J. Remme, J.D.F. Habbema 
Acta Tropica 1991;48:271-284. 
Introduction 
The productive lifespan of Onchocerca volvlIlus is the major determinant of the 
required duration of onchocerciasis control operations which aim at interruption of 
transmission and the subsequent elimination of the local parasite reservoir (Roberts 
et al., 1967; Remme et al., 1986; Karam et al., 1987). Thus far, estimates for the 
average lifespan of the parasite and the variability around this average have been 
based on experimental infections in monkeys (Duke, 1980) and on cross-sectional 
nodulectomy surveys and skin-snip surveys in areas with different periods of vector 
control (Roberts et al.,1967; Karam et al., 1987). Based on extensive longitudinal 
skin-snip data, Rennne et al. (1990a) provide a model based estimate of the average 
longevity of onchocerciasis infection and its variability by fitting observed trends in 
prevalence and intensity of infection during vector control. However, these authors 
note that their estimate represents only one possible quantification and that a 
detailed sensitivity analysis is required to determine the complete range of parameter 
values which are consistent with observations. 
The present paper provides such a detailed analysis. The comprehensive 
stochastic model for onchocerciasis transmission and control, ONCHOSIM (Plaisier 
et al., 1990), is used to systematically test different parameter quantifications of the 
worm lifespan distribution, using longitudinal skin-snip data collected in selected 
reference villages during 13-14 years of vector control operations in the area of the 
Onchocerciasis Control Progranmle in West Africa (OCP). The changes in micro-
filarial load are not only determined by the parasite lifespan. Therefore, other 
aspects are explicitly taken into account, including the pre-control endemicity level 
and infection heterogeneity among the inhabitants of the reference villages. 
The aim of the analysis reported here is to arrive at a plausible range of values 
for the average reproductive lifespan of the West African savanna strain of the O. 
volvulus parasite, and for the age at which the large majority of the worms have 
reached the end of their reproductive period. Especially the latter, which we will 
characterize by the age at which 95 % of the adult worms have ceased reproduction, 
is an important determinant of the period during which vector control must be 
continued to minimize the risk of recrudescence of onchocerciasis. 
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Materials and Methods 
Epidemiological slIrveys alld reJerellce villages 
Epidemiological surveys have been undertaken at regular intervals of 3-4 years in a 
large number of villages in tile OCP in order to monitor the epidemiological impact 
of vector control (WHO, 1987a). In all surveys two skin-snips were taken from 
each person. These snips were incubated in distilled water for 30 minutes, examined 
by microscope for tile presence and density of O. volvllllls microfilariae (Mf), and 
the number of Mf per snip was recorded for each individual at each survey (Prost 
and Prod'hon, 1978). From this extensive epidemiological data-set, four villages 
have been selected as reference for the analysis. Table 2 lists some demographic 
and epidemiological characteristics of these villages, which are all located in Bur-
kina Faso in the core area of the OCP and which have been under vector control for 
at least 13 years. The selection of the villages was such that they fitted into the 
general pattern for the epidemiological trends observed during the vector control 
period (see Remme el al., 1990a). All 4 villages were hyperendemic (prevalence of 
Mf >60%, Prost el al., 1979) but they were chosen to cover a fairly wide range 
for the intensity of infection as measured by the Community Microfilarial Load 
(CMFL), i.e., the geometric mean Mf/snip for all individuals older than 20 years 
(Remme et al., 1986). At least four surveys were done in each of the villages. 
The model 
Simulations have been carried out with the stochastic computer simulation model 
ONCHOSIM (Plaisier el al., 1990). An important characteristic of ONCHOSIM is 
the use of the technique of microsimulation. The life-histories of individual persons 
and their individual inhabitant male and female worms are sinlUlated. Together, the 
persons constitute a simulated village population. In the model, the reproductive 
lifespan is defined as the period between inoculation of the infective larva and the 
end of the fecundity period of the adult worm. This includes the pre-mature period 
in which the worm cannot yet reproduce. The end of fecundity may be due to 
factors such as disease or death of the worm. The requirement of regular mating is 
explicitly considered in the model and a temporarily cessation of Mf production 
when no mating takes place is not considered as the end of fecundity. The average 
reproductive lifespan is taken equal for male and female worms. In the remainder of 
the analysis, all causes leading to the end of the fecund period are simply referred 
to as 'death', while 'reproductive lifespan' is abbreviated to 'lifespan'. The variabil-
ity in the lifespan is considered to be solely the result of the worm's genetic vari-
ability and does not depend on intrinsic host factors. The lifespan is described by a 
probability distribution of the Weibull type. Weibull distributions are widely used in 
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reliability models for lifetime of devices and for survival analyses (see Kalbfleisch 
and Prentice, 1980). The Weibull distribution is a generalization of the exponential 
distribution which is often used for describing lifetinles in infectious disease models. 
However, the exponential dislribution has been shown to be inappropriate for des-
cribing the lifespan of O. volvlIllIS (Renmle et al., 1990a). In addition to the mean, 
a second 'shape' parameter is used in the Weibull to manipulate the variability of 
the lifespan (independent from the mean). In this paper, the 'shape' parameter is 
represented by the 95th percentile, i.e., the age at which 95 % of the parasites have 
died (see appendix for further details). 
Apart from the lifespan, the model enables a detailed description of a number of 
other aspects of the worm life-history. Fecundity starts after a pre-mature period of 
one year on average (Duke, 1980; Prost, 1980). Following tlus period, Mf produc-
tion only takes place when worms mate (Schulz-Key and Karam, 1986). In accord-
ance with several observations, the Mf output of fertilized female parasites is 
modelled to decrease with age after a few years of optimal productivity (A1biez, 
1985; Karam et al., 1987). The appendix gives details about modelling worm 
mating and fecundity. Newly produced Mf are assumed to live for 1.5 years. In the 
current quantification of the model one ferlilized female worm at peak fecundity 
corresponds with an average of 5 Mf/snip (this value is arrived at in an analysis 
which will be reported elsewhere). 
The model takes account of the fact that the exposure to (new) infections in the 
pre-control situation is unequally distributed in the human population. This exposure 
heterogeneity, which acts as a major determinant of differences in skin-snip counts 
between persons, results from differences between sexes (females are on average 
20% less exposed than males), differences between ages (beyond the age of 20 
years the maximum exposure is reached), and individual variation which is a.o. 
related to attractiveness to the flies and behavioral factors. Systematic simulations 
using various model assumptions pointed out that a considerable degree of age- and 
sex-independent variation between individuals must be stipulated in order to obtain a 
good fit with skin-snip distributions. This variation can take different values for 
different village populations. 
A detailed description of the model and of the parameter quantifications is pro-
vided in section II. 2. 
Estimation procedllre 
The validity of different quantifications of the model parameters are tested by 
determining the goodness-of-fit of simulated skin-snip data to the observed skin-snip 
results. For this purpose, both the observed and simulated skin-snip counts are 
summarized in a frequency distribution with geometric class boundaries: 0, 0.5, 1, 
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2, ... , 256 Mf/snip. The analysis is restricted to cohorts of persons who have been 
snipped at each survey and who were older than 20 years at the first survey. The 
restriction to adults follows previous arguments that it is only for this age group that 
one may expect a stable age-structure of the initial parasite population and, there-
fore, regular epidemiological trends during tile control period (Remme el at., 1986). 
Furti!ennore, only the first survey and the surveys after 10 years of control are used 
for the sensitivity analysis because in particular the differences between early and 
late surveys are sensitive to variations in the quantification of the parasite lifespan 
parameters. 
The goodness-of-fit is characterized by the P value ofax2 test. Each comparison 
of a simulated and observed skin-snip distribution renders one P value. Since we are 
interested in the goodness-of-fit with all relevant surveys, the results for separate 
surveys for a given reference village can be combined into one overall P value. 
Finally, P values for different villages can be combined into an overall measure for 
the goodness-of-fit. The procedure for combining P values is described in the 
appendix. 
Because of the difficulties involved in assessing the correct number of degrees of 
freedom in a model in which a number of parameters are estimated simultaneously 
from data from different sources, the P value resulting from the X2 test should not 
be used as a formal criterion for accepting or rejecting assumptions on the lifespan. 
Instead, it will be used to identify regions with good and poor fitting parameter 
values. Therefore, we will use the term 'score' instead of P value in the remainder. 
Goodness-of-fit scores have been determined for many combinations of values for 
the mean lifespan (between 7 and 12 years, with steps of 1 year) and for the 95th 
percentile (between 9 and 20 years). 
Table 2 strongly suggests that the pre-control endemicity of the villages (as 
measured by the CMFL of the first survey) is different and, hence, that the average 
vector biting density before the start of control must have been different. However, 
average biting rates are unknown. Therefore, each quantification of the lifespan 
parameters is tested for a range of values for the pre-control biting rate such that the 
observed endemicity levels fall within the range of simulated endemicity levels. As 
mentioned before, the reference villages also differ in their degree of exposure 
heterogeneity. Testing of lifespan quantifications for a village is therefore always 
done for the village specific best fitting values of the biting rate and exposure 
heterogeneity . 
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Results 
Lifespan parameters 
Fig. 7 shows for each of the villages the goodness-of-fit score as a function of the 
two lifespan parameters. The 95th percentile is plotted on the horizontal axis and the 
values for the mean lifespan are represented by different lines. The scores are 
plotted on tile verlical axis using a reversed log-scale, which implies that values in 
the upper part of the graph represent poor fitting model quantifications, whereas 
values close to the horizontal axis represent good fitting, plausible quantifications. 
For each village, the four values for the mean lifespan are shown which give the 
best fit. 
A straightforward conclusion from Fig. 7 is that only a limited range for the 
mean lifespan and the 95th percentile gives a good fit with the trends observed in the 
villages. At both sides of an optimal range for the two lifespan parameters, tile 
goodness-of-fit gets worse. The only exception is the mean lifespan of 12 years 
fitted to data of Sarba-Baforo, which shows a good score even when tilere is very 
little variation (95th percentile of 12.3). Both the width and the position of the 
optimal range is not identical for the four villages, as should be the case, if only 
because of random sampling fluctuations. The data for Folonzo and Sarba-Baforo 
allow for a fairly wide range for the 95th percentile while a more limited range is 
obtained from Tiercoura and Loaba. Except for Loaba,_ at least three values for the 
mean lifespan give rise to very high scores (close to the horizontal axis). In Loaba, 
only one value for the mean lifespan (8 years) gives a reasonable fit with the data. 
In this village there is also a preference for low values of the 95th percentile. In 
contrast, Folonzo shows a preference for higher values of the 95th percentile. 
A more regular picture, with a more restricted range for the 95th percentile is 
obtained when the results of the villages are combined. This is shown in Fig. 8. 
Loaba is not included in this combination. It is so different from the other villages, 
that no acceptable over-all fit could be obtained for all 4 villages combined. 
A sunnnary of the results in Table 3, together with Figs. 7 and 8, shows that the 
best fit is obtained for a mean lifespan of 9 to 11 years and a 95th percentile of 13 
to 15 years. 
Example of simulated Mf distributions 
In addition to the goodness-of-fit test, it is important to have a visual check of the 
appropriateness of tile estimates for the description of a given data set. As an 
example, in Fig. 9 for Folonzo the observed Mf distributions from three surveys are 
shown together with simulated distributions. In this simulation, the mean lifespan is 
10 years and the 95th percentile 13.7 years (which is a plausible quantification given 
Table 2 Characteristics of the four villages that are used for testing the assumptions on the parasite lifespan. 
Village River basin 
Tiercoura Leraba 
Folonzo Comoe 
Sarba·Baforo 
Loaba 
Bougouriba 
White Volta 
Initial census 
population 
160 
285 
600 
270 
Size of study CMFL at Timing of surveys (yrs. since start of 
cohort first survey control) 
(Mf/snip) 
31 53 0.8,5.0,7.0, 10.0, 12.0, 14.0 
48 30 0.8,4.9,7.0, 10.0, 12.0, 14.0 
76 17 1.4, 8.9, 11.0, 13.3 
19 41 1.8,5.1, 10.1, 13.1 
Table 3 Ranges for the mean lifespan and the 95th percentile with a goodness-of-fit score > .1 for the reference villages and for 
the combination of Folonzo, Sarba-Baforo, and Tiercoura. 
Village Mean lifespan 95th percentile 
Tiercoura 8-11 11-14.5 
Folonzo 7-l1 12.5-16 
Sarba-Baforo 8-12 12.5-16 
Loaba 8 11-13 
Combination (excl. Loaba) 9-11 12.5-15 
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centile for the combined test results of Folonzo, Sarba-Baforo, and Tier-
coura. See also Fig. 7 (For explanation of symbols see Fig. 7). 
the results of Figs. 7 and 8). Fig. 9 shows that the change in the Mf distribution is 
simulated quite well. 
Simulated trellds ill prevalence of Mf and in CMFL 
Skin-snip distributions are usually summarized to Mf-prevalence and CMFL, the 
level of onchocerciasis infection. Parameter quantifications with a good fit appear to 
provide also a close agreement between observed and simulated trends in these 
indices, see Fig. 10. The exception is again the Loaba data, which can only be 
fitted with a lower value for both the mean lifespan and the 95th percentile. This is 
clear from the overestimation of the infection prevalence. 
Discussion 
Reliable estimates of the parasite reproductive lifespan are not only important for 
the quantitative understanding of endemic onchocerciasis, but also for the prediction 
of the epidemiological impact of vector control and the determination of the 
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Figure 9 Folonzo: Simulated (hatched bars) and observed (hlack bars) trend in skin-
snip count distribution. In the simulation the mean lifespan is 10 years and 
the 95th percentile is 13.7 years. 
required duration of vector controi (see a.o. Remme et al., 1986, 1990a; Habbema 
et al., 1990). Several previous attempts at estimation of the lifespan have been 
made, though often on the basis of limited data. 
Roberts el al. (1967) reported on onchocerciasis infection levels after elimination 
of the vector from several isolated foci in Kenya. Cross-sectional surveys showed 
still life adult worms present in nodules and alive Mf in the skin 11 years after 
interruption of transmission, but no more Mf in the skin 18 years after vector 
elimination. These authors postulated, therefore, that O. volvulus loses its reproduc-
tive potential after a lifespan of 16 years or possibly earlier. Though this study did 
not explicitly address the question of variability, it is fair to assume that their 
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Figure 10 Simulated and observed trends in CMFL and Mf-prevalence In the four 
reference villages. The simulations use a mean lifespan of 10 years and a 
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postulate refers to an upper limit for the reproductive lifespan. 
A direct estimate of the duration of onchocerciasis infection is provided by Duke 
(1980) who recorded the intervals between inoculation of infective larvae in chim-
panzees, the appearance of Mf in the skin, and the final disappearance of skin Mf. 
Based on an experiment in a single chimpanzee, he found for the savanna strain of 
O. volvlIllIs an interval of less than 6 years between the last inoculation and the 
complete disappearance of Mf from the skin. Though it cannot be excluded that the 
last inoculum was ineffective, this duration (which includes both the adult parasite 
lifespan and the microfilarial lifespan) is extremely short and does not correspond 
with other estimates and with the trends observed in the OCP. 
Karam et al. (1987) present an analysis of epidemiological data obtained during 
the first 7 to 8 years of the OCP. Based on longitudinal changes in skin Mf loads 
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and in differences in the adult worm composition as compared to non-controlled 
areas, they postulate a breakdown of the worm populatiou 11 to 12 years after the 
begiuning of control. Furthermore, they demonstrate that the Mf productivity was 
significantly reduced in aged worms. 
The question of variability in the reproductive lifespan was first addressed in the 
study by Remme el al. (1990a). Following the introduction of a simple 
force-of-infection model, which led to a preliminary estimate of 11 years for the 
average duration of infection (Remme el al., 1986), they developed a more sophisti-
cated host-parasite model which actually was a predecessor of ONCHOSIM. The 
host-parasite model was quantified using longitudinal skin-snip data for the first 8-9 
years of vector control in the OCP and this resulted in an estimate for the mean 
longevity of infection (including Mf-survival) of 10.4 years and a variability which 
was such that 95% of the longevities were less than 15 years. The model allowed 
the prediction of trends in the prevalence of skin Mf and in the CMFL for different 
levels of endemicity and it was shown that the predicted trends gave a good descrip-
tion of those observed in 55 villages during 12-14 years of control. However, no 
formal estimation procedures were followed in this study and no attempts were 
made to investigate other quantifications. 
The distinguishing feature of the present analysis is the systematic search for 
plausible quantifications of the major parameters which determine the reproductive 
life-history of O. volvulus. The model used, ONCHOSIM, takes account of all 
aspects that ultimately determine the mean duration of onchocerciasis infection and 
its variability. Several model simplifications have been considered in order to arrive 
at a more simple and tractable estimation procedure. A first simplification would be 
to assume a (single-parameter) exponential distribution for the lifespan (see, among 
others, Anderson and May, 1985). However, this assumption is not compatible with 
the trends and is especially in conflict with the accelerated decline in Mf-prevalence 
during the late years of control (10 to 14 years, see Fig. 10). Also the restricted 
range of the 95th percentile of the lifespan distribution, which can be concluded 
from Figs. 7 and 8, demonstrates the inappropriateness of the exponential distribu-
tion which has still a 95th percentile of 21 years at the very low mean of 7 years. 
By systematically varying model assumptions it appeared that only with a con-
siderable degree of age- and sex-independent exposure variation between individuals 
a good fit is obtained between simulated and observed skin-snip distributions. A 
simple model which disregards this personal variation, could be fitted to trends in 
aggregated measures like CMFL and Mf prevalence, but is not suitable for describ-
ing the more detailed data that we have available. 
Two rather detailed assumptions that are not necessary for obtaining a fit of the 
skin-snip data are the age-dependent fecundity and the requirement of regular mat-
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ing for the female worms. The assumption of a constant fecundity level - though 
conflicting with nodulectomy results (see Karam el al., 1987) - will lower the 
estimates of the lifespan. When female worms can produce Mf even in the absence 
of male worms, the residual worm population in the final years of control will be 
much more productive and this must also be compensated by a shorter lifespan. The 
inclusion of these refinements which cannot be tested against skin-snip data is 
justified because of the (biological) face validity of the model. This is inlportant in 
view of the role of ONCHOSIM in prospective evaluation of control measures. 
Other parameters that influence the mean duration of infection include the Mf 
production per worm and the lifespan of Mf. Variations in these parameters are 
expected to influence the estimate of the worm lifespan. Alternative quantifications 
of the Mf production level have been tested by using the same goodness-of-fit 
procedure as reported in this paper. Lower values for the lifespan (especially the 
95th percentile) result when a lower Mf production per worm, and thus a higher 
worm load, is assumed. The opposite applies to a high per-worm productivity. 
However, these alternative quantifications for the Mf-production will affect the 
lifespan estimates with at most 0.5 year. 
Another parameter which may still alter our estimates is the microfilarial lifespan, 
which we have taken equal to 1.5 years. We tested the influence of other values 
between 0.5 and 2 years, which is the widest range compatible with the observations 
of Duke (1968). Intuitively, one would expect that a change in the lifespan of the 
microfilariae will be compensated by exactly the opposite change in the lifespan of 
the macrofilariae. Thus, a Mf lifespan of 0.5 years instead of 1.5 years would add 1 
year to the worm lifespan. However, because of a reduced Mf-production of old 
worms, this mechanism does not apply exactly. It was found that values of 0.5 or 2 
years for the Mf-lifespan will not change our estimates of the worm reproductive 
lifespan with more than 0.5 year. 
Different alternative values for the length of the prepatent period have been 
tested. This revealed that, in the range of 0.5 to 1.5 years, these alternative values 
do not influence the estimate of the lifespan. 
The goodness-of-fit results suggest some systematic differences between the 
lifespan estimates which were obtained with the longitudinal data for each of the 
four Villages. Some of these differences may reflect discrepancies between actual 
transmission patterns and the model assumptions of a stable pre-control transmission 
level and complete interruption of transmission during the vector control period. 
Circumstantial evidence suggests that the actual transmission pattern around the start 
of control may have been different in at least three villages and we will therefore 
discuss each village in some detail. 
The lowest estimate for the lifespan was obtained with the data for the village of 
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Loaba. This village is located along the White Volta River, much more to the east 
than the other three villages. It has been noted previously that the decline in infec-
tion levels was much faster in the north-east of the original OCP area. This has 
been attributed to a major reduction or even interruption of transmission during the 
last years of the pre-control period when there was hardly any local vector breeding 
because of severe drought and when there was no more vector invasion from the 
south-west where vector control started one to two years earlier than in the east 
(Karam ef aI., 1987; Remme ef al., 1990a). If local transmission was indeed absent 
for one or two years before the start of control, then our mean lifespan estimate of 
8 years for Loaba, is an underestimate. 
The highest estimates for the mean lifespan were obtained WiOl the data for 
Sarba-Baforo. This village is located along tile River Bougouriba, which was during 
the first few years of vector control subject to reinvasion by infective flies from 
outside the Programme area (Garms et al., 1979). This initial reinvasion may have 
been responsible for a significant incidence of (super)infection and this has been 
given as the explanation for the different epidemiological trends in the flrst line 
villages along this river, where the CMFL started to show the predicted linear 
decline only after a delay of a few years (WHO, 1987b). Sarba-Baforo is not a flrst 
line village and no signiflcant delay in the decline of the CMFL has been observed 
previously. However, it is possible tllat the detailed analysis presented here has 
detected some minor impact of the reinvasion phenomenon. 
Extensive entomological evaluation data are available for a fly catching point near 
the village of Folonzo where vector control resulted in an immediate reduction in fly 
biting rates. Nevertheless, the Annual Transmission Potential, an entomological 
index of O. volvulus transmission (Walsh et al., 1978), was during the flrst three 
years of control equal to 274, 50 and 107 infective larvae per year respectively 
before falling to levels close to zero during subsequent years. Annual Transmission 
Potentials in the range of 100 to 200 infective larvae per year are usually taken as 
evidence of a low level of active transmission (Thylefors et al., 1978), but it should 
be noted that the fly population during the first t1rree years of control at Folonzo 
consisted nearly exclusively of reinvading flies which stay close to tile riverine 
vegetation and have less chance of man-fly contact (Garms et al., 1979). One may 
speculate, therefore, that there have been occasional new infections during the flrst 
tlrree years of control which explain the higher estimate for the 95th percentile but 
which were too few to affect the estimate for the mean lifespan. 
At the fourth village of Tiercoura there has never been a catching point, but 
available evidence from the two nearest catching points at a distance of 8 and 17 
kilometres respectively suggest that complete control of the vector popUlation has 
been achieved since the start of the larviciding operations. 
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Combining the results of our analysis, the above background information about 
the four reference villages, and the results of previous studies, we conclude that the 
mean reproductive lifespan of the savanna strain of O. volvulus lies between 9 and 
II years, and that 95% of the parasites reach the end of reproduction before the age 
of 13 to 14 years. 
Appendix 
WOrtll mating and age dependent fecundity ill the model 
According to Schulz-Key and Karam (1986) and Schulz-Key (1990), a reproductive 
cycle of a female O. volvulus worm takes about 3 months, and hence for ongoing 
microfilarial production, insemination must take place at 3 monthly intervals. The 
mating probability is taken to be equal to the ratio of male to female worms, with a 
value of 1.0 when there are more male than female worms. By means of random 
number generation, on the basis of this probability, it is determined for each female 
worm that needs insemination - i.e., for which the last insemination took place at 
least 3 months ago - whether (re-)insemination takes place indeed. If not, then Mf 
production ceases immediately. Each manU!, all uninseminated female worms have a 
new chance to mate. It is obvious that in the case of low (residual) worm loads, the 
worm mating probabilities in the human host will be reduced and will vary con-
siderably from host to has!. 
Apart from mating, the Mf output is also dependent on the age of the worms. We 
tested several models for the age-specific fecundity. In the simulations of the present 
analysis, female worms have their maximum fecundity during the first 5 years of 
patency. So, with an average pre-patent period of 1 year, this maximum level of 
fecundity ends at the age of 6 years. Thereafter, fecundity reduces linearly, and 
becomes zero at the (practically unattainable) patent age of 20 years. 
Finally, it is assumed that, due to genetic variability and due to the differential 
distance to the snipping site, inseminated female worms of the same age can make a 
different contribution to the skin-snip coun!. The latter variability is described by an 
exponential distribution function. 
Combining lest resulls 
Test results for several surveys or for several villages are combined as follows: 
1. The P value obtained from a goodness-of-fit test is under the null hypothesis 
uniformly distributed on [0,1]. Hence, -In(P) is exponentially distributed with 
a mean of 1. 
2. In combining the P values of n tests (PI' P2, ... , PIl)' we use the fact that the 
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sum of II independent exponentially distributed random variables follows an 
n-Erlang distribution. 
Thus, 
n 
x=I: -In(Pt) 
j-I 
follows the II-Erlang distribution: 
3. F(x) is the goodness-of-fit score for the combination of n tests. 
Lifespan distribution 
The lifespan is described by a Weibull distribution, using an offset of 4 years, 
which implies that no parasite will reach the end of the reproductive period before 
the age of 4 years. 
One of the plausible distributions is characterized by a mean lifespan of 10 years 
and a 95th percentile of 13.7 years. This distribution can be described as follows (to 
be read as the probability to be dead before the age of x): 
F(x) = { 
0 if O<x<4 
1 -e -«x-4)f~)" if x~4 
Other percentiles of this distribution: 80th = 11.9; 90th = 12.9; 99th = 15.2. 
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Parasitological effects of ivermectin 

IV.1 The impact of five years of annual ivermectin 
treatment on skin microfilarial loads in the 
onchocerciasis focus of Asubende, Ghana 
E.S. Alley, A.P. Plaisier, B.A. Boalin, K. Y. Dadzie, J. Remme, 
G. Zerbo, E.M. Samba 
Transactions of tile Royal Society of Tropical Medicine and Hygiene 
1994;88:581-584. 
Introductiou 
Ivermectin (Mectizan 0) is an effective and well tolerated microfilaricidal drug which 
is suited for large-scale treatment of onchocerciasis (Awadzi et al., 1985; Remme et 
al., 1989b; Whitworth et al., 1991; Collins et ai, 1992). The registratiou of the 
drug in 1987 was the starting point of a series of community trials conducted by the 
Onchocerciasis Control Programme in West Africa (OCP) and the UNDPIWorld 
BanklWHO Special Programme for Research and Training in Tropical Diseases. 
The main objectives were to determine the safety of the drug when used on a large 
scale and to assess its potential for morbidity and transmission control. In the OCP, 
as many as 8 trials were started, initially covering a total of more than 50,000 
persons (De Sale et al., 1989a). The largest trial, which had also the longest series 
of follow-up surveys, was carried out in the holoendemic focus of Asubende in 
Ghana. In that trial the impact of treatment on transmission was studied over a 
period of 3 years. It has been reported by Remme et at (1989b) that transmission 
was reduced with 65 to 85 % during the first 3 months after treatment. In the present 
paper we report the changes in skin-snip microfilarial counts during the first 5 years 
of amlUal treatment in this area. 
Materials and methods 
Study population. 
A detailed description of the study area has been provided by Remme et al (1989b). 
The results presented here concern the 3 holoendemic villages located in the core of 
the focus, close to the breeding sites of Silllulil/Ill in the river Pru (west of Lake 
Volta). The total census population at the beginning of the trial was 892 persons, 
796 of whom were present at the baseline survey in September 1987. Treatments 
were done in October 1987, October 1988, October 1989, November 1990, and 
November 1991. Tablets of ivermectin were given as a single oral dose of 150-200 
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JIg/kg body weight. Children below 5 years or with weights of less than 15 kg and 
breast-feeding and pregnant women were excluded from treatment. The coverage of 
treatment at each round is summarized in Table 4. Follow-up skin-snip surveys 
were conducted at 2, 4, and 12 months after the fIrst 3 treatments, 12 months after 
the 4th treatment, and 6 and 12 months after the 5th treatment. Skin-snips were 
taken according to the standard OCP method. Two snips were taken from the iliac 
crest using a Holtz corneo-scleral punch. The snips were incubated in distilled water 
and microfIlariae (MO were counted after 30 min (Prost and Prod'hon, 1978). The 
changes in skin-snip counts 2, 4, and 12 months after the initial treatment and 2 and 
4 months after the second round have been extensively reported (Remme el al., 
1989b, 1990b). Ophthalmological information was also collected at each of the 
surveys, except for the follow-up after 2 months. The changes in ocular 
onchocerciasis for the fIrst 2 rounds of treatments have been documented (Dadzie el 
al., 1990, 1991). The results for a longer treatment period will be published else-
where. 
Table 4 Coverage of ivel'mectin treatment for onchocerciasis 
Total population Population > 5 years old 
Date of treatment No. No. treated No. Percentage 
treated 
October 1987 892 572 (64%) 710 81 
October 1988 874 583 (67%) 696 84 
October 1989 838 521 (62%) 670 78 
November 1990 821 605 (74%) 681 89 
November 1991 830 588 (71 %) 687 86 
Vector collIrol 
In the Asubende focus, which is at the northern boundary of the southern extension 
of the original OCP area, vector control operations were started in January 1986. 
However, since an important aim of the trial was to assess the impact of large-scale 
treatment on the transmission of the parasite (Remme el al., 1989b), larviciding was 
interrupted several times to allow the vector population to establish itself and build 
up to an eqUilibrium level before ivermectin delivery. 
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Results 
For the interpretation of the results presented in this paper it is important to notice 
that treatment took place in a situation of reduced vector biting levels. To provide 
an idea of the joint effect of ivermectin treatment and vector control on trans-
mission, Fig. 11 shows the trend in the monthly transmission potential (MTP, i.e., 
the product of the monthly biting frequency and the average number of infective 
larvae per biting fly) for the period 1979 to 1992. The MTP's are given as 6-month-
Iy averages: January to June and July to December. From 1979 to 1985 the average 
value was 172.3. From January 1986 to the end of 1991 it was reduced to 56.2. 
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Figure 11 Six-monthly averages of the monthly tmnsmission potential for 
onchocerciasis, based on blackfly collections during 1979-1992. Vector 
control operations started in 1986, but were interrupted several times to 
enable assessment of the impact of treatment on transmission. The hOl'izon~ 
tal dashed lines show the average values before and during vector control; 
arrows indicate ivermectin treatment. 
Basic results for the study populatioll 
The observations made at each of the follow-up surveys are summarized in Table 5. 
Except for the follow-up 2 months after the first treatment round, a considerable 
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percentage of tile cernus population could be examined. The second survey was an 
exception since it was intended to select only tlwse who had been treated in the first 
round. In the other surveys, 80 to 91 % of the census population was monitored. 
Each treatment caused a marked reduction in microfilarial counts. However, 4 
months after treatment tile loads had increased considerably, and this increase was 
maintained until the subsequent round of treatment. Twelve (or 11) months after 
each treatment the relative reductions in Mf load compared to the observations just 
before each treatment were 46%, 32%, 12%, 52%, and 39%, respectively. The 
over-all reduction observed between September 1987 and October 1992 is 90%. 
During this period the population examined in October 1992 received slightly fewer 
than 3 treatments on average. The total reduction in the prevalence of infection was 
much less. Only 25% of the persons who were initially positive had become nega-
tive at the end of the total trial period. 
Results jar treatlllellt cohort 
As a result of the high coverage, especially among the eligible population (> 5 
years; see Table 4), it was possible to select a corniderable cohort of 268 persons 
who had received all 5 treatments. The basic observations on this cohort are shown 
in Fig. 12. Participation of this treatment cohort in the pre-treatment and follow-up 
surveys varied between 80 and 96%. Following the 4th treatment the earliest fol-
low-up survey was after 11 months. COimecting the outcome of this survey with the 
previous one would obscure the (most probable) actual trend. We have used dashed 
lines in Fig. 12, therefore, to indicate the direction of the expected trends had there 
been intermediate follow-up surveys comparable to those after the first 3 treatments. 
The trends for the treatment cohort generally followed the pattern of the total 
examined population (Table 5). However, in the treatment cohort, the initial 
increase after the fust 3 treatments is slower. This was most probably due to the 
fact that this cohort did not include (untreated) young children, who have a relative-
ly young parasite population and whose Mf levels therefore increase. Fig. 12 clearly 
shows the increase in Mf prevalence between the follow-ups at 2 and 4 months after 
the fust 3 treatments. Apparently, worm loads are so high that, even though the 
worms might (initially) have produced Mf at a lower rate, treatment did not result 
in long-standing clearance of all Mf. 
A detailed overview of the results with the treatment cohort is provided in Table 
6. Only those people who participated both in the first survey (September 1987) and 
the last (October 1992) have been included. As a result, the cohort size has been 
reduced to 222 persons. The Table shows the relation between the pre-treatment 
skin-snip count distribution (using 7 classes) and the distribution 11 months after the 
last treatment (using 3 classes). In addition, for each of the pre-treatment groups, 
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Table 5 Ol/chocerca VOIVllllls microfilarial counts and prevalence at each of the 
follow~up surveys and the average number of ivermectin treatments given 
to the population examined. 
Average 
No. of Mean Mf Prevalence no. of 
Survey description persons count" (%) treatments 
September 1987 796 72.1 79.9 
October 1987: 1st treatment 
December 1987 422b 3.73 55.0 0.93 
February 1988 679 20.0 69.7 0.66 
October 1988 747 39.2 79.3 0.65 
October 1988: 2nd treatment 
December 1988 611 6.61 34.2 1.31 
February 1989 756 16.2 62.7 1.26 
October 1989 762 26.6 74.1 1.24 
October 1989: 3rd treatment 
December 1989 894 2.60 24.7 1.70 
March 1990 750 12.7 62.4 1.83 
October 1990 728 23.5 72.4 1.80 
November 1990: 4th treatment 
October 1991 709 11.2 67.1 2.33 
November 1991: 5th treatment 
May 1992 661 3.44 50.7 2.98 
October 1992 698 6.86 60.6 2.91 
a Mean no. of microftlariae per skin snip. 
bAt tllis survey people treated in tlle fll'st round were actively selected. 
the reduction in the mean skin-snip count is given. About one-half of the subjects 
with pre-treatment counts < 32 Mf per skin-snip became totally amicrofilaridermic 
as a result of treatment. However, in the highest category (;0, 128 Mf/snip), less 
than 5 % became negative, although the percentage reduction in the mean load was 
highest for this category. A relatively small reduction in Mf count was shown by the 
lowest Mf density pre-treatment category. Moreover, a number of persons negative 
before treatment became positive notwithstanding 5 treatments. In part this effect 
Table 6 Distribution and reduction of Onchocerca volvulus microfIlarial counts 11 months after 5 rounds of ivermectin treatment 
in relation to the counts before the frrst round 
Percentage of pre-treannent group having 
microfilarial counts within the ranges shown 11 
months after their last treannenr> Arithmetic mean no. of microfilariae/skin-snip 
Pre-treatment No. of Before After Reduction (%) 
count" patients 0 0.5-7 ;;:,8 treatment treatment 
0 14 50.0 42.9 7.1 0 3.9 
0.5-7 18 44.4 50.0 5.6 4.0 2.7 33.0 
8-15 12 50.0 50.0 11.6 1.5 87.1 
16-31 13 46.2 46.2 7.7 23.8 2.8 88.2 
32-63 26 23.1 53.8 23.1 48.0 4.4 90.8 
64-127 76 18.4 57.9 23.7 91.1 6.2 93.2 
>128 63 4.8 57.1 38.1 182.5 9.9 94.6 
Total 222 22.5 54.5 23.0 91.0 6.2 93.2 
a No. of microfilariae per skin-snip 
b All values apply to persons who had been treated 5 times 
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Figure 12 Trends in prevalence of Ollchocerca volvulus microfLIaridermia (Mf preva N 
lence) (a) and arithmetic mean number of microfLIarfae per skin snip 
(mean Mf/s) (.) III persolls who were treated in all 5 rounds. Note that 
these persons did not necessarily participate in all followNup surveys. After 
the 4th round of treatment only an llNmonth followNup survey was done, so 
the expected outcome of an intermediate survey is shown. 
can be attributed to 'regression to the mean': due to variations in the skin-snip 
procedure, persons could have been classified as low-density while their actual 
density was higher; this would reduce the apparent effectiveness of treatment at 
subsequent surveys. However, since most of the low-density persons were children 
(,;; 5 years), it is also possible that at the pre-treatment survey they had a relatively 
high number of immature worms, which may have started Mf production during the 
trial thus giving rise to higher subsequent Mf loads despite the effect of 5 treat-
ments. The average reduction caused by 5 treatments - in combination with vector 
control - was 93 %. 
wng-term impact of a single treatment 
The available combinations of treatment and surveillance histories enabled us to 
select individuals with a considerable follow-up period after their first treatment. 
Most of them received their first treatment during the first round in 1987, but some 
people entered the trial subsequently. A combined summary of results after a single 
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(first) treatment is shown in Fig. 13. Because persons could have been examined in 
several of the indicated follow-up periods, the overall number of observations shown 
in this Figure is larger than the total patient population. During the first year, Mf 
counts increased rapidly to about 45% of the pre-treatment count (see also Fig. 12). 
During the second year, however, a clear levelling-off occurred. Microfilarial 
counts barely increased after 14-16 months and stabilized around 55% of the pre-
treatment counts 2-4 years after treatment. 
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Figure 13 Long-terlll effect of a single treatment on Onchocerca volvulus micl'ofilari-
dermia. The bars indicate microfilariae (M:f) count per skin snip as a pcr-
centage of the pre-treatment value (the pre-treatment value was not necess-
arily obtained before the first treatment round and some persons are 
included who received their first treatment latcr in the trial). The numbers 
above each bar arc the numbers of observations. 
Discussion 
Pre-treatment surveys during 1987 showed that Asubende is a highly endemic focus 
of the severe blinding form of onchocerciasis. The high endemicity was reflected in 
the high skin Mf loads and in the very high loads in the eye (Remme el al., 1989b; 
Dadzie el al., 1990). Since the risk of developing ocular lesions and blindness is 
directly related to the intensity of infection in the conununity (Thylefors and 
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Brinkmann, 1977; Renmle et al., 1989a), the area is particularly suited to study the 
beneficial effect of ivermectin treatment on both the intensity of infection and ocular 
lesions. The results presented here show the effect of repeated annual ivermectin 
treatment over a period of 5 years on the skin Mf load and hence on a major risk 
factor for blindness. 
The general pattern observed after each of the treatments (both in the total popu-
lation and in the cohort treated 5 tinles) was a marked reduction shortly after treat-
ment followed by a steady repopulation of the skin by Mf. The same pattern has 
been observed in most other trials (Lariviere et al., 1985; Taylor and Greene, 1989; 
Greene et al., 1991), although these trials mostly showed a slower and sometimes a 
very slow repopulation during the first year (Lariviere et al., 1985). Although in 
our study repopulation occurred after each treatment, the highest Mf level reached 
after one year was consistently reduced during the course of the trial. Among those 
who received the drug during each of the rounds, the overall reduction of Mf loads 
one year after the last treatment was 93 % compared to the pre-treatment survey in 
1987. For comparison, about 12 years of effective vector control alone are required 
to arrive at a sinlilar reduction (Remme et al., 1990a). 
Our study emphasizes that even a single treatment with ivermectin has a signifi-
cant medium term (2-4 years) inlpact on Mf loads (see Fig. 13), which suggests that 
the impact of the drug on Mf production by female parasites is fairly long-lasting. 
Evidence of a short-term cessation of Mf production by the females has been report-
ed by Schulz-Key and colleagues (1985). In addition to this, Schulz-Key et al (1992) 
and others (Chavasse et al., 1992; Duke et al., 1992) have provided evidence that 
the inIpact on adult parasites is more than temporary. The profound and long-lasting 
effect of treatment observed in our trial cannot be attributed to the effect of the 
large-scale ivermectin distribution alone. The vector control activities, which started 
in January 1986, must have had a major impact as well. The mean reduction in 
MTP for the whole period was 67% (see Fig. 11). 
Additional analysis and field work are required to answer the question whether 
ivermectin has macrofilaricidal effects, and if so what is the nature of these effects 
(killing or partially disabling worms). An important next step in the analysis of our 
results will be the utilization of an epidemiological simulation model (Plaisier et al., 
1990) to isolate the impact of ivermectin per se from the overall result of treatment 
and vector control, and to estimate basic parameters for the effect of the drug. 

IV.2 Irreversible effects of ivermectin on adult 
parasites in onchocerciasis patients in the 
Onchocerciasis Control Programme in West 
Africa 
A.P. Plaisier. E.S. Alley. B.A. Boatill. G.J. Vall Oortmarssell. J. Remme. 
S.J. De Vias. L. BOlllle/lX. J.D.F. Habbema 
The Journal of bifectious Diseases 1995;172:204-210 
Introductiou 
The registration of the anthelminthic drug ivermectin (Mectizan; Merck. Rahway. 
NJ) in 1987 was a landmark in the control of human onchocerciasis or river blind-
ness, a parasitic disease caused by Ole filarial nematode Ollchocerca volvllills. Oral 
administration in a standard dose of 150-200 I'g/kg body weight is followed by 
rapid elimination of micro filariae (Mf) from the skin and gradual reduction of ocular 
Mf levels (Awadzi et al., 1985). Side effects are generally mild. This makes iver-
mectin a better therapeutic option than diethylcarbamazine, which is often accom-
panied by severe Mazotti reactions and ocular damage. Ivermectin also produces a 
longer suppression of Mf repopulation of the skin (Greene et at., 1985; Lariviere et 
al., 1985). To explain this difference, which was obvious in all studies done so far, 
the effects of ivermectin on adult parasites were studied. 
Adult female parasites in treated persons show an interruption of the normal 
embryogenesis, but after a single treatment, this appears to be reversible for most of 
the worms (Schulz-Key et al., 1985; Duke et al., 1991a). Excess worm mortality 
was not observed after a single treatment (Awadzi et al., 1985; Greene et al., 
1985), although significant numbers of dead and moribund worms were reported 
after multiple treatments at intervals between 2 weeks and 6 months (Duke et al., 
1990b, 1991b, 1991c, 1992; ehavasse et al., 1992, 1993). Furthermore, after mul-
tiple treatments, the reproductive activity of the surviving worms was markedly 
reduced. The suppression of Mf production persisted 1.5 years after five 6-monthly 
doses (KIager et al., 1993), which suggests the existence of irreversible effects of 
the drug. 
An important question in view of the limited resources available to health services 
in developing countries is whether these findings for shorter treatment intervals are 
applicable to regimens with intervals of 1 year, the current practice in nearly all 
control programmes (WHO, 1995). In this study we addressed this question by 
analyzing data from a large community-based study of annual treatment in a region 
with hyperendemic onchocerciasis (Asubende, Ghana), organized by the 
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Onchocerciasis Control Programme in West Africa (OCP) (Remme et al., 1989b; 
De Sole el 01., 1989b; Dadzie et al., 1991; Alley el al., 1994). 
The available data consist of Mf counts in skin snips from persons who were 
repeatedly surveyed over - 5 years during treatment. We investigated whether the 
observed changes in Mf counts could be explained if ivermectin had only transient 
effects on adult worms, or whether long-term irreversible effects on the fecundity of 
adult worms were required to explain the data. In addition to the direct effect in 
individual patients, community treatment with ivermectin also reduces the level of 
transmission in the area (indirect effect; see Remme et 01., 1989b; Alley el al., 
1994). To take both effects into account, we did the investigation with the aid of an 
epidemiologic model of onchocerciasis transmission. 
Material and Methods 
Study populalion 
The Asubende region is along the lower reaches of the Pro river, just west of Lake 
Volta. OCP initiated a programme to control the vector of O. volvulus, the blackfly 
SilllUliulll dal1l1l0SUIII, in this river basin in January 1986. Flies have been collected 
since 1979 to assess the vector biting rate and the vector infectivity. A clinical 
survey was done in September 1987 among 796 persons living in a cluster of three 
villages in the middle of the area. Botll entomological and clinical findings revealed 
that the savanna form of O. volvulus is hyperendemic in this area. Skin Mf densities 
were among the highest encountered in the OCP area (Remme el 01., 1989b). The 
community trial of annual ivermectin treatment was started in October 1987. 
In the present analysis we use data consisting of counts of Mf in skin snips that 
were collected during the period covered by the first five treatments (1987-1991). 
The organization of the trial, the trends in the skin Mf densities, and the joint effect 
of vector control and ivermectin treatment on the transmission potential of the flies 
have been described elsewhere (Remme el 01., 1989b; Alley el 01., 1994). Treat-
ment dosage varied between 130 and 200 I'g/kg. 
From the 796 persons examined at the baseline survey in 1987, we selected 2 
cohorts that comprised a total of 114 adults. Cohort I is 78 persons who were 
treated in all five rounds and were examined in all eight follow-up surveys. These 
surveys were done at 4 and 12 months after the first two treatments, 5 and 12 
months after the third, II months after the fourth, and 6 months after the fifth 
treatment. Cohort 2 is 36 persons who were treated in the first but not in the second 
round and who were examined 24 months after the first treatment. We restricted the 
study to adults to exclude the confounding effect of ageing; only for older ages do 
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we expect a constant infection level (Rennne el al., 1986). 
Model and hypolheses 
We tested two hypotheses: The fIrst (HI) assumes that treatment has only a transient 
effect on the Mf production of female worms; the second (H2) assumes that iver-
mectin's effect is partially irreversible, manifested by a permanently reduced fec-
undity of the worms in a treated patient. Hypotheses were tested with the stochastic 
microsimulation model ONCHOSIM. This model simulates the life histories of 
hypothetical individuals (birth, acquisition of parasites, death) and individual para-
sites (maturation, mating, production of Mf, death) and can be used to describe and 
test effects of ivennectin on a patient level. ONCHOSIM further allows for a 
detailed simulation of control strategies. The model simulates ivermectin treatments 
and surveys at the same tinles as in the fIeld. It also mimics the vector control 
activities in the Asubende area, which strongly affected the transmission potential of 
the flies both before and during the trial (Alley el al., 1994). The microsimulation 
method makes it possible to select persons from the simulated popUlation who 
satisfy the same criteria used for selecting the cohorts and whose Mf counts before 
the fIrst treatment are the same as those of the cohorts. 
A full description of ONCHOSIM and the validation of the model is given else-
where (plaisier el al., 1990, 1991; Habbema el al., 1992, 1996). Here we will 
present only those relationships and parameters that are directly relevant to the 
effects of ivermectin. 
Modellillg Ihe e./fecls of ivermeclin 
An assumption used throughout the analysis is that a treatment with ivermectin 
instantly elinlinates all Mf in a person, except in 3 % of treatments which totally fail 
as a result of malabsorption (e.g., diarrhea, vomiting; see De Sole el al., 1989a). 
Under the fIrst hypothesis (HI)' each treatment further causes a transient interrup-
tion of the normal release of Mf by adult female parasites. During a recovery 
period, the rate of Mf production increases from zero to the pre-treatment level. We 
explicitly test whether this increase is linear or not. 
The same assumption regarding the initial effect of treatment is made under the 
alternative hypothesis (H2)' However, in this case, we assume that worms do not 
recover to their full capacity to release Mf, but that this capacity is irreversibly 
reduced with a fraction called produclivity reduclioll. This productivity reduction 
affects all worms in a patient. 
Since the available data do not reveal much about tile exact mechanism of a 
(possible) irreversible effect, we also tested an alternative form of the hypothesis 
(H'2), in which a certain fraction of worms loses their fecundity totally, while the 
84 Chapter IV 
others recover completely. This fraction is calledfeculldity loss. 
Between-treatment (and within-patient) variation in recovery period, productivity 
reduction, and fecundity loss is governed by effect variability, defined as the vari-
ation coefficient (Le., the quotient of SD and mean) of treatment effects. The time 
between treatment and the stabilization of the Mf density in the skin is determined 
not only by the effect of ivermectin on adult worms but also by the lifespan of Mf. 
This Mf lifespan is estimated when the hypotheses are tested. A mathematical 
description of the sub-model for the effect of ivermectin treatment is given in the 
Appendix. A graphic representation of the hypotheses and role of the model para-
meters are provided in Fig. 14. 
Hypothesis testing 
To test hypotheses and quantify model parameters, both observed and calculated 
survey results were represented as frequency distributions of Mf counts, using the 
classes shown in Fig. 15. The agreement between observations and predictions was 
determined by calculating a total X2 for all follow-up surveys of cohorts 1 and 2. 
Some adjacent skin snip count classes were combined so that the number of individ-
uals is at least 5 per class. Estimating parameters for a specific hypothesis was 
achieved by minimizing X2 using a downhill-simplex method (NeIder and Mead, 
1965). The goodness-of-fit implied by the minimum X2 was quantified by the P 
value of the x2-distribution with 16 df (only transient effects) or 15 df (also irrevers-
ible effects). Generally, P < .05 indicates a poor fit and suggests rejection of the 
underlying hypothesis. 
After model parameters were estinmted a 95 % confidence interval (CI) of a 
particular estimate was determined by searching around the original estimate for 
values resulting in x2 =3.84 units (0.95 point of x2-distribution with 1 df) higher 
than the minimum. For each of the values tried, the other ivermectin-related para-
meters were reestinmted by minimizing X2. 
Resnlts 
For the baseline and follow-up surveys, the number of Mf per skin snip observed in 
the 2 cohorts are shown in the frequency distributions in Fig. 15. Considering the 
data from cohort 1, both short-term and longer-lasting effects of treatment were 
apparent. At 4-6 months after each treatment, the distribution was consistently 
skewed towards low Mf counts. Although after 11-12 months the distributions again 
tended to the pre-treatment shape, it is clear that, as the number of treatments 
increased, the peak of the distributions shifted to lower counts: - 32-64 Mf/snip 1 
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Figure 14 Schematic representation of hypotheses tested. Each graph shows rate of 
microfilaria production (r) of parasite as function of time (I) after single 
treatment. Moment of treatment is indicated with vertical arrow below x 
axis. In hypothesis HI' no irreversible effect is assumed; treatment only 
results in recovery period of length Tr. According to hypothesis H2• the 
productivity after recovery period is permanently reduced (factor d); with 
H'2' fraction //I of worms totally loses fecundity. Sec Appendix for further 
explanation of symbols. 
year after the first treatment to 4-16 Mf/snip 1 year after the fourth round. A long-
term effect was also observed in the data from cohort 2 (Fig. 15b); before treat-
ment, - 30% of the population had > 128 Mf/skin snip. Two years after a single 
treatment this was only slightly> 15%. 
We tested two hypotheses for explaining the data (see Fig. 14). The results are 
shown in Table 7. For each hypothesis, estimates of relevant parameters and good-
ness-of-fit (P values) are given. HI' which assumed no irreversible effects of iver-
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mectin, fits poorly (P = .0013) and must be rejected. By contrast, a good fit was 
obtained when an irreversible productivity reduction for all worms was considered 
(H2:P = .68). This productivity reduction was -35% per treatment (95% CI, 26%-
40%). Assuming another mechanism for the irreversible effect of treatment (H'2) 
did not lead to significantly different conclusions. Total fecundity loss was - 28 % 
per treatment, wlnle the other parameter estimates were about the same for H2 and 
H'2' A model that combines both types of irreversible effect (not shown) did not 
produce a significantly better fit to the data. In such a model, the combined loss of 
Mfproduction in a patient was -32% per treatment (95% CI, 22% - 40%). 
Table 7 Parameter estimates and goodness-of-fit for the different hypotheses about 
the effect of Ivermectin on the microfilaria (M!) production of adult para· 
sites. 
Hypothesis3 
Parameter Ht H2 
Productivity reduction -b 35%. (26%-40%)C 
Total fecundity loss 
Recovery period (months) 19.0 10.4 (7·16) 
Effect-variability (coefficient 0.87 0.54 (0.4·0.7) 
of variation) 
Mf lifespan (monUls) 14 9 (4·12) 
Goodness-of-fit (P[x2]) .0013 [39] .68 [11.9] 
a See legend of Figure 14 for a description of Ule hypoUleses. 
b _, this parameter is not considered and thus has the value O. 
C Nos. in parentheses are 95% confidence intervals. 
H'2 
28% (22%-35%) 
10.7 
0.52 
10 
.42 [15.5] 
The irreversibly reduced level of Mf production was preceded by a recovery 
period of - 10 months during which the production rate accelerated (see the non-
linear trends in Fig. 14; s = 1.5, Appendix). Both the recovery period and the Mf 
lifespan are inversely related to the speed of the Mf repopulation of the skin after 
treatment. Therefore, apparently to compensate for the lack of irreversible effect, 
under the first hypothesis both parameters were estinmted at significantly higher 
values. 
The effect of treatment varies considerably between treatments. The value of 0.54 
estimated for effect variability (H2) means that one-fourth of treatments resulted in a 
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recovery period of <6 monlhs and a productivity reduction of <20%. By conlrasl, 
for anolher one-fourth Ihese numbers were> 14 monlhs and >47%, respectively. 
Half of Irealmenls had an inlermediale efficacy. 
Model resulls, assuming irreversible effecls, were compared wilh Ole observa-
lions (Fig. 15, open bars). There were no syslematic differences between prediction 
and observalions for cohort 1 (Fig. 15a). The lowesl and highest Mf counl cat-
egories of Ihe follow-up survey of cohort 2 were underestimaled (Fig. 15b), sug-
gesting more Irealment variability in Ihis cohorl. For cohort 1, model prediclions 
under bolh hYPolheses are shown in Fig. 16. Here, predictions and observations are 
represenled as Ihe geomelric mean Mf counl. Only the pre-Irealment and follow-up 
surveys at 11-12 months are shown (Le., just before anolher treatment). Under both 
hypotheses, Ole geomelric mean Mf counls decline sharply after the fIrst treatment 
and more gradually thereafter. However, the slope of Ihe line connecting the follow-
up surveys is much sleeper if irreversible changes are considered (H2). Under HI' 
the Mf counls after repealed Ireatment decline only because the transmission 
dynamics of Ihe infeclion are disturbed by Ihe combination of treatment and vector 
conlrol. This decline is 100 slow to fIt Ihe observalions. 
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Figure 16 Observed (+) and predicted geometric mean microfilaria (MI) counts Oog 
scale) for pre-treatment and 11-12 follow-up surveys of cohort 1. Solid line 
= prediction based on hypothesis H2 (using parameter estimates of Table 
7); dashed line = prediction based on hypothesis HI' 
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Discussiou 
Our analysis of the results of five consecutive annual treatments provides strong 
evidence that apart from killing Mf, ivermectin reduces the viability of adult female 
parasites. The trend in Mf counts was explained by the hypothesis that after each 
treatment, Mf production gradually increases over to months (transient effect) and 
then reaches a plateau that remains 32% lower than before treatment (irreversible 
effect; combining H2 and H'2)' 
The transient effect agrees with the results from earlier studies, which showed 
that in most parasites the normal release of Mf was interrupted after treatment, but 
to to 12 months later, Mf production had largely been restored (Schulz-Key el al., 
1985; Duke el al., 1991a; Albiez el al., 1988a). Although none of these studies 
revealed excess mortality of worms from a single treatment, after 1 year a consider-
able fraction (40%, see Duke el al., 1991a) was not (yet) releasing Mf, which 
explains the considerable delay in repopUlation of the skin by Mf (Awadzi el al., 
1985, 1986; Lariviere el al., 1985; Taylor el al., 1986; Diallo el al., 1986). In 
some studies, even 2 years after treatment, Mf density was markedly reduced 
(Greene el al., 1987; Schulz-Key el al., 1992), although most persons had become 
Mf-positive again. Indeed, in cohort 2 (treated only once), the mean Mf density 
after 2 years was still less than half the pre-treatment level, suggesting a lasting 
effect. 
On the other hand, as Fig. 16 makes clear, one must be careful in drawing con-
clusions from decreasing Mf trends. Also, without irreversible drug effects, the 
model predicts a decrease (albeit insufficient) in Mf count at the follow-up surveys 
at 11-12 months. This decrease is exclusively due to the reduced transmission of the 
parasite as a consequence of ivermectin treatment and (partial) vector control (Alley 
el al., 1994). This effect on the transmission was taken into account under the 
assumption that the parasite larvae in flies originate from inhabitants of Asubende 
and will again be transmitted to them. Such an assumption would not be valid in 
areas with migration of flies, but Asubende is an isolated focus with a local trans-
mission (Remme el al., 1989b). 
So far, irreversible effects of ivermectin have been observed only after multiple 
treatments at intervals of ;5;6 months. In patients who received 4-12 doses at inter-
vals of 2 weeks to 6 months, more dead or moribund female parasites are found 
than in controls who receive no or only 1 treatment (Duke el al., 1990b, 1991a,b, 
1992; Chavasse el al., 1992). Excess worm mortality of 25%-33% is observed after 
8-11 doses at 3-month intervals (Duke el al., 1992). Though these are significant 
percentages, they are about equal to the irreversible effect we found for each round 
of treatment. This suggests that killing of worms is not the most important compo-
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nent of the irreversible effect: 25 % excess mortality after 8 treatments implies 
(only) -3.5% excess mortality per treatment. Furthermore, 6 months after the last 
dose (the longest follow-up in most studies), most female worms had not yet 
resumed normal embryogenesis and viability was markedly reduced. Recent investi-
gations suggest that recovery to full productivity after this short follow-up period is 
unlikely or will at least take >2 years (Kliiger el al., 1993). 
The available data on Mf counts do not allow us to draw inferences on the biol-
ogic mechanisms responsible for the irreversible treatment effect. The data are 
equally well fit by two quite different mechanisms: an average productivity reduc-
tion of 35 % for all worms in a patient or the total loss of fecundity by an average of 
28 % of the worms. The difference between these estimates is caused by the differ-
ent impact of the two mechanisms on the Mf counts in persons with low worm 
loads. If each treatment eliminates a certain fraction of productive worms, then in 
such persons frequently no productive worm is left (especially after repeated treat-
ment) and, as a consequence, the skin snip is negative (no MI). In the simulated 
population this leads to more skin snip-negative persons than with an equal percen-
tage of productivity reduction. This explains the (slightly) lower estimate for fecund-
ity loss. 
Other mechanisms also could cause both transient and irreversible changes. For 
example, some studies demonstrate a significant reduction of the number of male 
worms (Duke el al., 1990b, 1992). Although these lower counts may be the result 
of the ability of male worms to leave nodules (Schulz-Key and Karam, 1986), it 
may at least temporarily lead to reduced mating chances and a lower Mf output of 
female worms. Hence, we cannot exclude that part of the effect estimated for 
female worms should be attributed to males. It is important to stress that the results 
of our analysis are based on data collected during annual treatment using a dose of 
130-200 I'g/kg. Changes in treatment frequency or dose may lead to other effects 
per treatment. 
In all model calculations, we have assumed that variability in treatment etrect is 
exclusively between-treatment variability. Two extensions which have been tested 
explicitly are effect-variability between the worms in one patient and between-
patient variation of treatment effect (some patients systematically respond well, 
others poorly). Neither extension affects our conclusion or produced a better fit. 
The absence of between-patient variability justifies the use of the X2 statistic for 
calculating the goodness-of-fit (P) and determining CIs, the X2 assuming indepen-
dence between successive observations on the same persons. 
Our conclusions have important implications for the public health impact of 
strategies based on annual ivermectin treatment, which is the currently recommen-
ded regimen. In earlier studies, we emphasized the potential of the drug for reduc-
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ing the burden of blindness (Habbema el 01., 1992; Remme el 01., 1990b). How-
ever, lack of sufficient follow-up data at that time meant that an irreversible effect 
of treatment on adult worms could not be demonstrated. This was the main cause of 
doubt about the potential of ivermectin for transmission control and thus for our 
cautiousness in designating it as the successor of vector control. 
Now, this point of view merits reconsideration. If each treatment leads to an 
irreversible reduction of fecundity by -30%, after five treatments the loss will be 
> 80% (not counting reinfections). These results should stimulate the assessment of 
the impact of higher doses on the viability of adult parasites. Extrapolating to a 
longer period of annual treatment is less straightforward; not everybody will be 
treated (a coverage of 65%-70% would be excellent in routine health care), and 
transmission will continue (albeit on a lower level), causing new infections. Prelimi-
nary computer simulation studies indicate that, although the impact of long-term 
ivermectin regimens is more pronounced than previously expected, the parasite is 
unlikely to be eradicated within a period of 15 years of annual treatment in an area 
where it is endemic. 
Appendix 
Here we describe the model tllat combines hypotheses H2 and H'2' By making tile 
appropriate simplifications, the models for HI' H2 and H'2 are obtained. 
If 111 denotes the mean fraction total fecundity loss and vij is the effectiveness of 
treatment round i (i = 1, .. ,5) in personj, then fraction Vijlll of the worms in person 
j will permanently cease Mf production immediately after treatment i. vij is a ran-
dom variable, which for each treatment i and each person j is generated from a 
gamma probability distribution with mean = 1.0 and a variation coefficient equival-
ent to the effect variability. For female worms in person j that do not lose fecundity 
after treatment i (a fraction 1 - Vijlll) , the rate of Mf production rijk of each worm k 
at time I after treatment is described by the following: 
In this expression, ,.0 ijk is the rate of Mf production of worm k without treatment. 
This basic Mf production depends on the age and the mating history of the worm. 
Parameter d is the mean irreversible productivity reduction, Tr is the mean duration 
of the recovery period, and s is the shape of the recovery. If s > 1, then the 
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increase in the Mf production is initially slow and accelerates by the end of the 
recovery period. If s = 1, then this increase is linear. 
In case the random variable vij would take such high values that Vijlll or vii (or 
both) is > I, the products are truncated to I. However, given the estimates of the 
effect variability (-0.5; Table 7), these situations are highly unlikely. 
In case of repeated treatment (i > 1), the model does not allow that an ineffec-
tive treatment (which implies a short recovery period) accelerates the recovery of a 
previous (effective) treatment. In case of total treatment failure (3% of treatments), 
Vij = 0 and no Mf are killed. It is assumed that Mf will in principle be detectable in 
die skin inuuediately after their release from the worm. No provision is made for a 
delay due to dispersal in the body and penetration of skin tissues. Mf are assumed 
to have a fixed lifespan (Tm). In this simple concept, if the Mf production rate of 
the worms in a person stabilizes at time I, then the Mf density in the skin stabilizes 
at time 1 + Tm. 
Chapter V 
Control of infection and prevention of 
recrudescence in the OCP 

V.l The risk and dynamics of onchocerciasis 
recrudescence after cessation of vector control 
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Bulletill of the World Health Orgallizatioll 1991;69:169-178 
Introduction 
The objective of the Onchocerciasis Control Programme in West Africa (OCP) is to 
control onchocerciasis as a disease of public health and socio-economic importance 
and to ensure that there will be no recrudescence of the disease thereafter (WHO, 
1987a). The strategy has been to interrupt transmission by vector control through 
larviciding and this has been very successful. After 8-10 years of control operations, 
onchocerciasis was no longer a public health problem in more than 90% of the 
original OCP area (WHO, 1987b), and after 12-14 years the prevalence of infection 
had fallen to very low levels or zero in most of this area (De Sole et al., 1990a; 
Remme et al., 1990a). Because of the major decline in the parasite reservoir and the 
high costs of the aerial larviciding, it was important to determine how many years 
of successful vector control were needed before the operations could be discon-
tinued, and the vector allowed to return, without running an unacceptable risk of 
onchocerciasis recrudescence thereafter. 
The risk of recrudescence depends on tile interaction between many factors. This 
made it necessary to use an epidemiological model to study the required duration of 
vector control. The computer simulation model ONCHOSIM (plaisier et al., 1990), 
which has been developed especially to analyze epidemiological trends and to 
evaluate prospectively alternative control strategies, simulates the transmission of 
onchocerciasis and the effects of vector control and chemotherapy (Habbema et al., 
1990; Remme et al., 1990b). Using this model, we have investigated the risk and 
dynamics of recrudescence after different periods of vector control in an 
onchocerciasis focus. Reported is the impact of the major confounding model para-
meters on recrudescence and on the recommendations about the required duration of 
vector control. 
Materials and methods 
Simulatioll of recrudescellce 
The ONCHOSIM model uses the technique of microsimulation; this involves the 
simultaneous simulation of life-histories of individual persons and of individual 
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female and male parasites in the human host (plaisier el al., 1990). Collectively, the 
simulated persons constitute the population of a hypothetical endemic focus. One of 
the most important outputs of the simulation is the microfilarial (Mf) load in skin-
snips for each member of the population. In order to facilitate detailed comparison 
with observed data, the results of tl\e simulation are presented in the same statistical 
format as used in the epidemiological evaluation of vector control in tl\e OCP. 
Fig. 17 illustrates the results obtained with ONCHOSIM for the simulation of a 
period of vector control and recrudescence thereafter. Soon after the start of con-
trol, the Community Microfilarial Load (CMFL), i.e., the geometric mean number 
of Mf per skin-snip (Mf/s) in adults (Remme el al., 1986), starts to decrease, 
followed by the Mf prevalence. When vector control is interrupted after 11 years, 
new inoculated worms become productive after a delay of several years, and the 
trends reverse; the Mf prevalence starts rising first, followed by the CMFL much 
later. 
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Figure 17 Simulation of the recrudescence of onchocerciasis after 11 years of full-scale 
vector control (1975-86). The trends in microftlarial (MI) prevalence and 
Community Microftlarial Load (CMFL) are shown as percentages of the 
values at the start of vector control. Indicated are the years when the 
CMFL reaches 25% and 75% of the pre-control value. 
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Confounding model parameters 
The transmission and control of onchocerciasis are governed by many parameters, 
most of which also influence the risk and dynamics of recrudescence. The following 
parameters are very important in this respect: the pre- and post-control level of 
exposure to the bites of SimuliulII spp. and tile exposure variation in a community; 
the lifespan of the Onchocerca volvulus worm and possible variations in this; and 
the infection level of biting flies as a function of tile human skin Mf density. Esti-
mates for these important confounding parameters are discussed below. They are 
based on epidemiological data collected by the OCP, especially the frequency 
distributions of skin-snip counts obtained at various intervals since the start of 
control, and on experimental results. 
Exposure level (relative biting rate) and exposure heterogeneity 
After a given period of vector control, communities with a high pre-control 
endemicity level, and hence a high biting rate per person, have a higher risk of 
recrudescence than communities in less endemic areas. Analysis of the risk and 
dynamics of recrudescence for different endemic situations is, however, difficult 
because the real average biting rate per person in a village is not known. Reported 
values of the Annual Biting Rate (ABR) apply to passive collection of flies close to 
the breeding sites (Walsh et al., 1978). Although the ABRs are valuable for assess-
ing the potential endemicity of an area and for monitoring the effects of vector 
control, the actual ABR experienced by village members may be quite different. In 
the OCP area it has therefore not been possible to establish a direct relation between 
the average skin-snip count of a village and the pre-control ABR. 
We have therefore defined a scale parameter (the relative biting rate, rbr) to 
assess the biting rate relative to the skin-snip counts. A value of I'bl'= 1.0 corre-
sponds to a biting rate in a village where the individuals are equally exposed and the 
mean Mfls is 100. 
The risk of recrudescence is also influenced by the heterogeneity of exposure 
among members of a community. When the heterogeneity is high, infection will be 
concentrated in a few extremely highly exposed individuals, who will act as fre-
quently bitten, highly infective sources of transmission. Exposure heterogeneity is 
quantified by the variation coefficient of the biting rate. 
Estimates for the I'br and exposure variation coefficients for a village are based 
on goodness-of-fit between observed and simulated skin-snip distributions. The 
estimates are not unique; using the estimation procedure reported by Plaisier et al. 
(1991a), a good fit (with X20.05 as the critical point) call be obtained for a range of 
values of I'bl' and the coefficient of variation. Here, we analyze the recrudescence 
for two different quantifications of I'br and the variation coefficient in each of the 
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villages of Tiercoura and Folonzo, Burkina Faso. The standard quantification for 
both villages are shown in Table 8 as models I and 3, respectively. Models 2 and 4 
represent quantifications that are among the most unfavourable from the point of 
view of recrudescence risk, but are nevertheless still compatible with the observed 
data for the two villages. Table 9 shows the observed pre-control CMFL and the 
pre-control Mfls distribution in the villages. Also, the simulated Mfls distributions 
for models 1-4 are shown. It should be noted that, although in Tiercoura the 
observed CMFL (a geometric mean) is 71 Mfls, a large number of persons has a 
skin-snip count of > 128 Mf/s; this is reflected in a relative biting rate of 1.10 in 
the standard quantification for Tiercoura. 
Table 8 Model quantifications used for the determination of the risk and dynamIcs 
of recrudescence in the villages of Tiercoura and Folonzo, Burkina Faso. 
Model number and designation Relative biting 95th percentile Ll-uptake curve 
rate lifespan (years) 
1 (standard Tiercoura) 1.10 (0.36)' 13.7 I 
2 (high-risk Tiercoura) 1.16 (0.52) 13.7 
3 (standard Folonzo) 0.61 (0.52) 13.7 I 
4 (high-risk Folonzo) 0.67 (0.68) 13.7 I 
5 (low-risk lifespan) 1.10 (0.36) 12.8 I 
6 (high-risk lifespan) 1.10 (0.36) 14.8 
7 (high-risk Ll-uptake) 1.10 (0.36) 13.7 II 
a Figures in parentheses are the coefficients of variation. 
Parasile lifespall 
The estimation of the parasite's reproductive lifespan has been reported in detail by 
Plaisier el al. (1991a). In the West African savanna, O. volvulus is estimated to live 
9-11 years on average, while the variability is such that 95 % of the parasites die 
before the age of 13-14 years. Especially the extreme longevity, as measured by the 
95th percentile of the lifespan distribution, is important for recrudescence. For a 
mean lifespan of 10 years, the best fit for the 95th percentile is 13.7 years, and this 
value is used here as a standard quantification. The 95 % confidence interval is 
estimated to be 12.8-14.8 years, and the risk and dynamics of recrudescence are 
analyzed for the boundaries of this interval (models 5 and 6, respectively, in Table 
8). 
Table 9 Characteristics of the reference villages of Tiercoura and Folonzo (for comparison, the simulated skin-snip count 
distributions of models 1-4 are shown). 
Initial % of adults with an initial skin-snip count (Mf/s) of:b 
1975 census CMFL 
Village River basin populationa (Mf/s)b 0 « 0.5 «2 «8 «32 « 128 
Tiercoura Leraba 160 (66) 71 3.0 0 3.0 6.1 57.6 30.3 
Modell 
0 0.2 0.9 4.3 59.0 35.6 
Model 2 
0.7 0.7 1.3 9.1 49.8 38.4 
Folonzo Como" 285 (123) 30 2.4 2.4 7.3 27.7 56.9 3.3 
Model 3 
2.5 1.4 5.3 29.3 58.5 3.0 
Model 4 
3.5 1.8 5.5 27.3 53.6 8.2 
a The first figure shown is the total popUlation, while the figure in parentheses is the number of adults. 
b Mfls = microfilariae per skin-snip. 
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Skill microfilarial density, microfilarial uptake, and larval load of blackjlies 
The relatiornhip between skin microfilarial density and the microfilarial uptake by 
biting flies is an important factor in the transmission of onchocerciasis. A number of 
studies have reported that the uptake increases with Mf dernity. but that saturation 
occurs at high dernities (Duke. 1962). hlfection levels of blackflies from the West 
African savanna suggest that, probably also because of the excess mortality of flies 
with very high larval loads. this saturation level is about 1.2 larvae per biting fly. 
and 2-3 larvae per infective fly. since. in general. the proportion of flies that 
engorge microfilariae does not exceed 50% (OCP. 1989). and most first-stage (Ll) 
larvae survive to the infective stage (Philippon, 1977). However. if the parasite 
reservoir has been reduced by a long period of vector control. then in view of 
recrudescence. the capability of flies to engorge Mf at low skin densities rather than 
the saturation level. is important. This capability determines the degree of danger of 
the residual parasite reservoir for renewed transmission. Recently ,in the OCP area. 
a series of experinlents has been conducted to determine the relatiornhip between fly 
infection and skin Mf density (OCP. 1989). Volunteers with a known skin-snip 
count were exposed to blackflies. and the Mf load in the flies was then determined. 
Especially inlportant are Mf that avoid encapsulation py tile fly's peritrophic mem-
brane and which can be considered to be the potentially infective larvae. 
For the model. the relatiornhip between the Mf density in human skin and the 
resulting number of Ll larvae in biting flies needs to be quantified (resulting in the 
Ll-uptake curve). Based on the experimental results, and llsing the procedure 
outlined in the appendix, a maximum likelihood estimate (MLE) was obtained for 
this relationship. The MLE determined for the saturation level of the larval load was 
1.8 Ll larvae per fly (3.6 per infective fly). However. since the flies were dissected 
shortly after the bloodmeal. excess mortality as a result of high larval loads could 
not be taken account of. Therefore. for the standard relationship in the simulations 
we set the saturation level at 1.2 Ll larvae per fly. Imposition of this restriction 
upon the relationship gives an MLE shown as curve I in Fig. 18. In the analysis, we 
tested also the impact of a relationship with the same initial slope as curve I. but 
with a saturation level of 0.8 Ll larvae per fly (1.6 larvae per infective fly. shown 
as curve II in Fig. 18; see also Table 8, model 7). 
Assessment of the risk and dynamics of recrudescence 
The analysis reports the risks and dynamics of recrudescence for the model quantifi-
cations shown in Table 8. For each of these models the recrudescence is analyzed 
for several periods of vector control, ranging from 9 to 15 years. To determine the 
risk for a given model and a given duration of control, we carried out 50 simula-
tions. Because of the stochastic microsimulation approach. the outcomes for these 
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Figure 18 The two curves used in the study for the relationship between skin microfi-
larial density (skin-snip count) and the resulting number of LI larvae in 
biting flies (Ll-uptake). 
50 simulations are different, reflecting the chance character of the underlying pro-
cesses. If 50 years after cessation of control the simulated CMFL is still lower than 
10 Mf/s, the given simulation is termed a 'nou-recrudescence' case. The risk of 
recrudescence was taken to be the fraction of the 50 simulations that lead to recru-
descence. Logistic regression was used to smooth the risk as a function of the 
duration of control and to estimate the required duration of control needed to arrive 
at risk values of 50%, 5%, and 1 % (see Fig. 19). 
The dynamics of recrudescence is characterized by the time to reach a given level 
of the CMFL after stopping control measures. Especially the time needed to estab-
!ish a CMFL of 10 Mfls is considered, since at this load onchocercal blindness 
starts to become an important public health problem in a stable endemic situation 
(Remme el ai., 1989a). This period of time is denoted the 'recrudescence time'. For 
comparison, we also examined the times needed to produce CMFLs that correspond 
to 25 % and 75 %, respectively, of the pre-control value. 
Basic assumptions and starting points 
The following underlying assumptions were made for all the simulations: 
- the force of infection during the years preceding control is stable; 
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the larviciding-based vector control effectively interrupts transmission; 
there is no migration of infected persons into the area; and 
there is no invasion by infected flies and only a slight invasion by uninfected 
flies. 
Because of this invasion, the flies can repopulate the breeding sites, and the 
pre-control biting rate will be reached in a few months after the end of larviciding 
(Davies et al., 1981; Remme el al., 1989b). In the simulations, the pre-control 
village consisted of about 200 individuals and the annual rate of population increase 
was about 2.5 %. 
Results 
Biting rale and exposure heterogeneity 
Fig. 19 shows the probability of recrudescence for different durations of vector 
control for models 1-4, which differ in the values of biting rate and exposure 
heterogeneity, and which represent the standard and high risk models for Tiercoura 
and Folonzo (see Table 8). From Fig. 19 it can be inferred that the specific circum-
stances in a village markedly influence the recrudescence risk. Although both 
villages are hyperendemic, the duration of vector control required to reduce the risk 
to acceptable levels in Folonzo is shorter than that in Tiercoura. If for both villages 
the model is used that gives the best fit with the observed skin-snip data (standard 
Tiercoura and standard Folonzo), the risk of recrudescence in Tiercoura is 1 % if 
vector control is continued for about 13.5 years. In Folonzo vector control needs to 
be carried out 11.5 years (i.e., 2 years less) to achieve the same risk of recrudes-
cence. 
In Folonzo, to arrive at a risk of 1 %, the high risk model predicts a vector 
control period of 13 years, i.e., 1.5 years more than the standard model. Similarly, 
in Tiercoura the high-risk model predicts 14 years, i.e., only 0.5 year longer than 
the standard model. The most plausible explanation for the different behaviour of 
the two high-risk models is that in a holoendemic village such as Tiercoura, the risk 
of recrudescence is mainly determined by the lifespan of O. volvulus, so that increas-
ing the fly biting rate only causes a minimal increase in the risk. In Folonzo, how-
ever, because of the lower pre- and post-control infection loads of the human hosts, 
the risk of recrudescence is also determined by the mating chances and subsequent 
production of Mf by the few remaining parasites. Here, a slight increase in biting 
rate (which causes the over-all worm load to increase) and exposure heterogeneity 
(which favours clustering of the worms, and hence increases the mating chances) 
has more impact on the risk of recrudescence. 
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Figure 19 Probability of recrudescence as a function of the duration of vector control 
determined using foul' different model quantifications. Bars show the 95% 
confidence intervals. The vertical dashed lines indicate the vector control 
period after which the risk of recrudescence is reduced to 50%, 5%, and 
1%. 
Fig. 20 shows the recrudescence time, i.e., the period after cessation of vector 
control for the CMFL to reach 10 Mfls. With all four models, the recrudescence 
time increases with the duration of vector control. Extending the duration of control 
therefore not only reduces the risk of recrudescence, but also reduces the rate at 
which the epidemiological indices increase. Furthermore, Fig. 20 indicates that for a 
given period of control the recrudescence time becomes shorter as the biting rate 
and exposure heterogeneity increase. Also the difference between the recrudescence 
times for the standard and high-risk models for Folonzo is greater than that for these 
models in Tiercoura. In the high-risk Folonzo model the clustering of worms result-
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ing in increased chances of mating and production of Mf had a greater impact than 
in the high-risk Tiercoura model. 
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Figure 20 Average pedod (including 95% confidence intervals) after cessation of 
vector control before a Connnunity Microfilarial Load (CMFL) of 10 Mfls 
is reached, as a fUllction of the duration of vector control in Tiercoura and 
Folonzo (models 1-4, Table 8). Results are shown only when at least 3 
sllllulations showed recrudescence. 
With the standard model for Folonzo (model 3), 9 years of vector control, 
although not sufficient to prevent recrudescence, guarantee that for more than 25 
years after the end of control activities the CMFL will still be below a dangerous 
level. For Tiercoura this recrudescence time is less than 10 years. For longer 
periods of control, the differences in recrudescence times between the various 
models remain virtually unchanged, notwithstanding the decreased recrudescence 
risks. 
The times after control which elapse until 25 % and 75 % of the pre-control 
CMFLs are reached are shown in Fig. 21 for the standard models for Tiercoura and 
Folonzo. The clear differences between the two models demonstrate that not only 
the absolute recrudescence rate, but also the rate relative to the pre-control situation, 
is higher for villages with a higher endemicity. Since for both villages the plots for 
tlle 25 % and 75 % levels have the same slope, it can be concluded that if recrudes-
cence exceeds 25 % of the pre-control CMFL (which for Folonzo is still less than 10 
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Figure 21 Average period after cessation of vector control before a COlllmunity 
MicrofIlarial Load (CMFL) of 25% or 75% of the pre-control value is 
reached, as a fUllction of the duration of vector contl"Ol for the standard 
models in Tiercoura and Folonzo (models 1 and 3, respectively, Table 8). 
Results are shown only when at least 3 simulations showed recrudescence. 
Mf/s) the rate of progression no longer depends on the duration of vector control. 
O.volvulus lifespan 
The effect of different values for the lifespan of O. volvllills on the results is shown 
in Table 10. As might be expected, the period of vector control needed to reduce 
the risk of recrudescence to acceptable levels increases with the value of the 95th 
percentile of the lifespan probability distribution. Using the most unfavourable 
assumption for the 95th percentile (5% of the worms reach an age of :2: 14.8 years), 
we estimate that in a village such as Tiercoura vector control operations have to be 
continued for 14 years and 14.5 years, respectively, to reduce the recrudescence 
risk to 5% and 1% .. 
Also, the recrudescence time is a function of the O. volvllills life expectancy. 
After 12 years of control, the time to reach a CMFL of 10 Mfls increases from 16 
to 34 years when the 95th percentile of the lifespan decreases from 14.8 years to 
12.8 years. 
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Table 10 Duration of vector control to reduce the risk of recrudescence to 50%, 5%, 
and 1%, and the recrudescence time after 12 years of vector control, for 
three different assumptions about the 95th percentile of the lifespan dis-
tribution of the adult worm, and two Ll-uptake curves. 
Model Duration of vector controi (years) Recrudescence 
number at a risk of recrudescence of: time (years) 
50% 5% i% 
95th percelltile lifespall (years) 
i2.8 5 i2.2 i2.5 12.7 34.0 (28.7-39.3)' 
13.7 12.4 13.0 13.4 25.9 (23.8-27.9) 
14.8 6 13.3 14.0 14.5 16.2 (15.7-16.8) 
Ll-uptake curve 
I 12.4 13.0 13.4 25.9 (23.8-27.9) 
II 7 12.8 13.4 13.8 20.8 (19.4-22.2) 
a Figures in parentheses are 95 % confidence intervals. 
Ll-uptake 
Table 10 also shows the impact of two different assumptions about the Ll-uptake of 
SimuliulII spp. as a function of the skin Mf density. For the curve with a low satura-
tion level at high skin densities (curve II, Fig. 18), the risk of recrudescence is 
greater than that with the standard curve (curve I): about 6 months of additional 
vector control are required to produce recrudescence risks comparable with those 
obtained with the standard Tiercoura model. To reduce tllC risk to about 1 %, 
approximately 14 years of vector control are required with the Ll-uptake curve II. 
The high-risk characteristic of curve II arises because, to maintain a given pre-
control endemicity level, the low saturation level must be balanced by higher values 
for other transmission parameters (e.g., the probability that infective larvae trans-
mitted by biting flies become a mature parasite). After vector control, before satura-
tion has occurred, these higher values increase the recrudescence risk. 
If vector control is stopped after 12 years (risk of recrudescence about 100%), 
approximately 20 years are required to arrive at a CMFL of 10 Mfls; this is 5 years 
less than with the standard uptake curve I. 
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Discussion 
The decision to stop vector control after many years of interruption of 
onchocerciasis transmission in the well-protected central OCP area is a difficult one 
to make. Premature interruption of vector control, when tile residual parasite reser-
voir is still too large, may jeopardize all the achievements obtained so far and result 
in the recrudescence of onchocerciasis as a public health problem. On the other 
hand, aerial larviciding operations are very costly and any mmecessary continuation 
of them would prevent the use of funds where they are urgently needed, e.g., in the 
extension areas of the OCP where vector control has only recently been started. 
A further complication is that there are no precedents which can serve as 
guidelines. The decision-m~king process, therefore, has to rely exclusively on the 
optimal use of epidemiological information and on current understanding of the 
dynamics of onchocerciasis transmission, infection, and about the disease itself. 
Epidemiological modelling has been helpful in this respect. The ONCHOSIM 
computer simulation model has been used to carry out an integral assessment of the 
relevant information and to provide objective predictions of the risk and dynamics 
of recrudescence after different periods of vector control. 
Table II summarizes the recrudescence risks for the different models tested. The 
data indicate that in areas with the highest potential risk (such as Tiercoura) 14 
years of vector control are required to reduce the risk of recrudescence to < 1% 
(estimated using the most plausible quantifications of the confounding parameters). 
Predictions for other quantifications for the confounding parameters, which are also 
compatible with the epidemiological data for the OCP, show that in the worst case 
after 14 years the risk of recrudescence is still greater than 1 %, but less than 5%. 
The simulations show that the risk of recrudescence is dependent on the local 
endemicity level and the associated relative vector biting rate. Por the holoendemic 
village of Tiercoura the simulations indicate that the required duration of vector 
control is 14 years, while for the hyperendemic village of Polonza they indicate 1.5-
2 years less than this. The endemicity level of Polonzo (in terms of CMPL) was 
only half that in Tiercoura, where the pre-control CMPL of 70 Mf/s made it one of 
the most endemic onchocerciasis villages of the original OCP area. The dependency 
of recrudescence on the biting rate also has implications for the epidemiological 
surveillance system that will be set up during the post-Iarviciding period to detect as 
early as possible eventual recrudescence. The biting rate varies greatly between 
villages and it is essential that the surveillance will be carried out in villages where 
the vector biting rate per inhabitant is extremely high. 
It has long been recognized that the required duration of blackfly control depends 
largely on the lifespan of O. volvulus (Roberts et al., 1967; Remme et al., 1986). 
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Table 11 Risk of recrudescence for different durations of vector control and for the 
various model quantifications. 
Model number and designation Risk of recrudescence at a duration of 
vector control (years) of:' 
10 11 12 13 14 15 
1 (standard Tiercoura) + + + ± 
2 (high-risk Tiercoura) + + + + 
3 (standard Folonzo) + + 
4 (high-risk Folonzo) + + + 
5 (low-risk lifespan) + + + 
6 (high-risk lifespan) + + + + ± 
7 (high-risk Ll-uptake) + + + + 
, + = risk> 5%; ± = 1 % < risk < 5%; - = risk < 1 %. 
Our findings confirm this and show that the remaining uncertainty about the upper 
limits of the lifespan distribution, which was estimated from longitudinal 
epidemiological skin-snip data from the OCP, has a significant effect on the pre-
dicted risk of recrudescence. Using the linlits of a confidence interval for the age at 
which 95% of the worms have died, we calculated that Ule required duration of 
vector control was 12.7-14.5 years. In an earlier attempt to project the 
epidemiological trends after cessation of vector control, Dietz (Dietz, 1982) used a 
model in which he assumed an exponentially distributed lifespan for the worms with 
a mean of 8.3 years. From this assumption, which could not be verified against 
longitudinal data, it follows that 5% of the parasites lived for more than 25 years. 
Dietz's implausible assumption about the lifespan of O. volvllills therefore explains 
why he predicted recrudescence even after 20 years interruption of transmission. 
Different quantifications of the relationship between Ll-uptake and the skin Mf 
load of human hosts also affect the predicted risk and rate of recrudescence, 
although the effect was less than we expected. The Ll-uptake curve with an early 
saturation point, and hence a high ratio between the initial slope and the saturation 
level (curve II), resulted in the greatest risk and the shortest recrudescence time. In 
view of the available experimental data, curves with a lower saturation point and a 
greater initial slope seem unprobable (see appendix). However, it should be noted 
that in our simulations the levelling off of the Ll-uptake curves at higher Mf loads 
is the most important density-dependent regulating mechanism in the transmission of 
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onchocerciasis. Other regulation mechanisms may, however, exist (Dietz, 1988) and 
could increase the risk of recrudescence. It can, therefore, be argued that the real-
ism of curve II would increase when the L1-uptake curve in the our model took 
other possible regulating mechanisms into account. 
Our study has clarified several aspects of the dynamics of recrudescence. The 
recrudescence time, i.e., the time after cessation of control for the CMFL to reach 
10 Mfls, depends on the duration of the preceding period of vector control: the 
longer the period of control, the longer it takes for the prevalence and intensity of 
infection to climb again to significant levels. This recrudescence time increases 
exponentially as the period of vector control approaches 14 years, and in this 
respect the last few years of vector control are the most cost-effective. After 10 
years of vector control, recrudescence is relatively slow. Even in instances of 
recrudescence after 12-13 years of vector control, it would take more than 20 years 
for the CMFL to reach levels of public health importance. 
These predictions for recrudescence apply only to situations where no other 
intervention is undertaken after cessation of vector control. However, it is important 
to note that ivermectin, an effective and well-tolerated microfilaricide, has recently 
become available for the treatment of onchocerciasis, while research is continuing to 
develop a macrofilaricide (Brown el al., 1990). Although some studies suggest that 
the potential of ivermectin to control transmission in an endemic area is limited 
(Remme el al., 1989b, 1990b), it may play an important role in the control of 
onchocerciasis recrudescence. 
Our conclusions depend on some basic assumptions, i.e .. the existence of a stable 
endemic situation during the pre-control period, complete interruption of trans-
mission during the vector control period, no reinvasion by infective flies, and no 
immigration of infected humans. There are, however, many situations where these 
assumptions do not hold. Variations in epidemiological trends during blackfly 
control have been attributed to major variations in transmission during pre-control 
years (Remme el al., 1990a). Isolated foci have been identified where there has 
been a relapse in transmission (De Sole el al., 1990a), while the western and east-
ern flanks of the OCP area were reinvaded by infective flies (Philippon el al., 
1990). Immigration of infected individuals has not yet been proven to lead to prob-
lems (De Sole, 1990), but more extensive field studies are currently being carried 
out, and computer simulation studies are plalmed to investigate the effects of immi-
gration by infected persons and of reinvasion by infective flies. 
There will be other situations where not all the assumptions made in the current 
analysis will hold true. However, these do not invalidate the above analysis, which 
is intended to provide general guidelines as a reference for operational decision-
making on cessation of larviciding. For each situation the decision will have to be 
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based on a critical analysis of the relevant epidemiological and entomological infor-
mation using classical statistical methods, epidemiological modelling, and a large 
amount of common sense. 
Appendix 
To describe the mean Ll-uptake of 50 flies (y) as a function of the skin-snip count 
(x), we use tile following relationship: 
y"a(l-e -h')(1 +e -'') 
where a(l-ebx) describes a simple saturation curve with saturation level a and initial 
slope ab, and (1 +e-"') permits adjustment of the initial slope. At a given skin load, 
xi' the uptake follows a negative binomial distribution with mean, Yi' and parameter 
of aggregation, k. It is further assumed that k is independent of x. 
Using a downhill simplex method (press el al., 1988), this model is fitted to the 
experimental data by maximizing the likelihood function (Le., searching for the 
maximum likelihood estimate, MLE). The MLE gives values for a, b, c, and k of 
1.82, 0.0096, 0.0677, and 8.0, respectively. Restricting the saturation level to 1.2 
larvae per fly (2.4 per infective fly) in the above relationship, implies setting a = 
1.2. The MLE for this restricted relationship gives values for b, c, and k of 0.0213, 
0.0861, and 6.6, respectively. 
For curve II the values for a, b, and c were fixed to 0.8, 0.044, and 0.1686, 
respectively. With this relationship the MLE gives a value for k of 4.4. A likelillOod 
ratio test of curve II to curve I results in a P value of slightly more than 0.05, so 
that curve II falls within a 95 % confidence region of curve I. 
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Introduction 
When the Onchocerciasis Control Programme in West Africa (OCP) started its 
activities in 1975, the only reliable strategy for controlling river blindness was 
larviciding of the rivers where the vector Simulium damnosulII breeds. This tech-
nique would enable the interruption of transmission of the Onchocerca volvulus until 
the parasite reservoir in the human host was reduced to insignificant levels that will 
not lead to recrudescence after withdrawal of control and the return of the flies. On 
the basis of model calculations it was estimated that 14 years of complete vector 
control would be sufficient to achieve this objective, provided there was no import-
ation of new infections (through humans or flies) (plaisier et 01., 1991b). 
The registration of ivermectin for human use in 1987 was a breakthrough in the 
control of the disease. Treatment causes a drastic decline in microfilaria (MO 
densities and has a significant impact on die development of ocular padlOlogy 
(Dadzie et al., 1987, 1991; Abiose et 01., 1993). Furthermore, ivermectin has little 
side effects and is proven to be suitable for large scale application (De Sole et al., 
1989a, 1990b). The availability of ivermectin implied a reorientation of OCP and a 
review of its original plans. The anticipated primary role of the drug was the control 
of morbidity in the extension areas and in those parts of the original area where 
vector control was unsuccessful or where vector reinvasion was reported (WHO, 
1991). It was, however, of operational importance to determine to what extent 
ivermectin mass treatment, either on its own or in combination with vector control, 
could contribute to control of transmission. Conununity trials suggested a noticeable 
impact of treatment on transmission (Remme et al., 1989b; Cupp et al., 1992; 
Guillet et al., 1995), but the remaining level of transmission was too high to justify 
total substitution of vector control by mass chemotherapy. This was confirmed by 
tentative model predictions, showing that annual ivermectin treatment alone is not 
expected to eradicate the parasite from an endemic area within a period of 25 years 
(Remme et al., 1990b; Habbema et al., 1992). 
The subject of the present paper is to determine the required duration of a strat-
egy based on the combination of vector control and annual ivermectin treatment. 
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This strategy is currently applied in the extension areas of OCP. In these areas, 
vector control was instituted during the years 1988 to 1990, while routine iver-
mectin treatment started in 1990 (OCP, 1994a; Guillet et al., 1995). An important 
question is whether and to what extent the addition of ivermectin to larviciding 
allows a relaxation of the original guideline of 14 years as the minimum duration of 
vector control for the prevention of recrudescence (plaisier el al., 1991b; Remme et 
al., 1990a). A shortening of this duration would imply important savings in efforts 
and money. In addressing this question, we will utilize recent findings of the effects 
of ivermectin on the viability of adult worms (plaisier et al., 1995). Assessment of 
the potential effects of alternative strategies will be based on model predictions. 
Materials and methods 
In this study, the effectiveness of a strategy - a certain combination of vector control 
and annual ivermectin treatment - is summarized into the risk of recrudescence of 
infection after stopping control. Calculation of these risks is based on simulation of 
strategies with the stochastic microsinlUlation model ONCHOSIM and statistical 
analysis of simulation results. A complete description of the model and its validation 
has been reported elsewhere (plaisier et al., 1990, 1991a; Habbema el al., 1996). In 
this paper, the most important assumptions for the present study will be given and 
the procedure for performing simulations and calculation of recrudescence risks will 
be explained. 
Basic assumptions 
Vector control operations are assumed to be 100% effective, i.e., to reduce the 
biting rate to zero. In agreement with observations, flies immediately recolonize 
their former breeding sites after cessation of larviciding (Remme et al., 1989b). It 
is, therefore, assumed that the post-control biting rate is equal to the pre-control 
level. Based on the analysis of longitudinal data from a community trial of annual 
treatment in Asubende (Ghana) (Alley et al., 1994; Plaisier el al., 1995), the fol-
lowing assumptions are used with respect to the effect of an ivermectin treatment 
(given at a standard dose of approximately 150 I'g I kg body weight): (1) all micro· 
filariae are eliminated, (2) after a temporary loss of fecundity, the Mf production of 
female worms increases during 10 to 11 months and (3) reaches a new stable Mf 
production level which is 35 % lower than before treatment (irreversible effect; 
confidence interval (CI) 25%-40%). Both the period needed to recover and the 
irreversible impact of the drug vary between treatments (var. coeff. =0.54). The 
irreversible effect of the drug has a multiplying outcome, i.e., after II treatments an 
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average female worm produces at only 100 xO.65n percent of the level before the 
first treatment (e.g., 12 % after five treatments). We will also test the implications 
of a lower efficacy of the drug by assuming 25 % irreversible reduction of fecundity 
per treatment (the CI lower bound). It is further assumed that 3% of treatments 
totally fail as a result of malabsorption (diarrhea, vomiting) (De Sole et al., 1989a). 
The coverage of treatment (% of census population in a village getting the drug) is 
one of the variables in the present analysis. In the model we take account of age-
and sex-differences in the proportion treated (in part due to temporary exclusion 
criteria, see Alley et al., 1994), individual variation in Willingness to participate in a 
treatment round, and a proportion permanently excluded from treatment due to 
chronic illness. The explanation of how these individual-based factors and the mean 
population coverage are interrelated is provided in the appendix. 
Based on these assumptions ONCHOSIM has been used to simulate control 
strategies in human popUlations of around 300 persons (a representative village-
size). Two 'model-villages' are considered. One with an extremely high and the 
other with a medium high pre-control endemicity level. These endemicity levels are 
similar to that of Tiercoura and Polonzo (both in Burkina Paso) which we con-
sidered in previous work (plaisier et al., 1991a,b) and which had a pre-control 
CMPL (Conununity Microfilarial Load; i.e., the geometric mean Mf load in adults) 
of 70 and 30 Mf per skin-snip respectively. Por these villages, which we will denote 
as HIGH and MED respectively, observations of pre-control fly biting rates are 
lacking. Using observations in the Pru-river, close to ihe highly endemic Asubende 
region in Ghana (Renune et al., 1989b; Alley et al., 1994) we estimate the Annual 
Biting Rate (ABR) in the absence of vector control within Tiercoura (HIGH) at 
27,000 bites per person per year (for adult men) and within Polonzo (MED) at 
16,000. The maximum exposure to fly-bites is reached at the age of 15 years. 
Women are, on average, 30% less exposed than men. The variation coefficient of 
bites I person within a specific age and sex group is estimated at 0.39 for Tiercoura 
and 0.54 for Polonzo. Since we have previously found that the variation in biting 
rate within a village is a risk factor for recrudescence (plaisier et al., 1991b), we 
will also simulate a 'Tiercoura-like' village with a higher exposure variation coeffi-
cient of 0.58. 
Simulation of colllrol strategies 
A control strategy is described by the number of years vector control (v), the num-
ber of annual ivermectin treatments (0, and the treatment coverage (c) assuming that 
this will be constant for the whole period. A large number of combinations of v 
(range: 0 to 15 years), i (range: 0-25), and c (range: 45%-75%) are simulated. The 
result of each simulation run is sununarized as 'recrudescence' (1) or 'no recrudes-
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cence' (0). We conclude that 'recrudescence' occurs when 50 years after stopping 
control the CMFL is higher than 10 Mf/skin·snip (Mf/s) (Plaisier el 01., 1991b). 
Due to the stochastic nature of the model, the simulation of a certain control strat-
egy may one time result in recrudescence and another time not. It is assumed that 
there is no importation of the infection from elsewhere (by humans or flies). Thus, 
recrudescence is exclusively the result of local transmission. An example of a 
control strategy followed by recrudescence is shown in Fig. 22a. An example 
successful control is given in Figure 22b. Both are based on a single simulation, and 
the possibility of otller results from repeat simulations cannot be excluded. 
Statistical analysis of simulation results 
Because of the variability of simulation outcomes, statistical analysis is required to 
efficiently relate the recrudescence risk to the strategy characteristics. Since recru-
descence is a binary outcome variable (yes=I, no=O) risk estimates were obtained 
by means of logistic regression (using SPSS). In their most complete form, the 
regression equations comprise the dependent variables v and i x c, their square and 
cubic forms (e.g., ;, i x ?), as well as linear, square, and cubic combinations 
(e.g., \,3 X i2 X c). The strategy variables i and c always appear as a combination 
because i = 0 implies the absence of ivermectin treatment regardless the value of c, 
and vice versa. Estimation of regression coefficients is always started witl\ only the 
linear and square terms. Insignificant terms are removed from the equations (likeli-
hood-ratio test; P > .1), While possible significant cubic terms are added (P < 
.05). The Wald-criterion (Clayton and Hills, 1993) is used to select the terms 
eligible for inclusion or exclusion. Regression equations are derived for each of the 
model villages and for the alternative assumptions on drug efficacy. The resulting 
equations, each based on 3000 to 6000 simulations, enable a straightforward calcula-
tion of the risk of recrudescence for a given v, i, and c. The reverse (e.g., given i 
and c, how long must vector control be done to reduce the risk to .01) is done 
numerically. For several control strategies in different villages the goodness-of-fit of 
the equations has been tested by comparing the risks (indirectly) predicted by the 
regression model with those (directly) obtained by repeatedly simulating the same 
strategy (100x) and counting the number of occurrences of recrudescence. In all 
cases the indirect and direct estimate were in close agreement. 
Results 
Fig. 23 shows how the risk of recrudescence depends on combinations of annual 
ivermectin treatment and vector control in village HIGH. It is assumed that the 
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Figure 22 Simulated trend in Mf.prevalence, CMFL, and blindness prevalence during 
combined vector control and annual ivermectin treatment (coverage 65%) 
in a highly endemic area (model village IDGH). Program output (simulated 
surveys) is given at three month intervals. The upper graph (A) shows 
recrudescence after 8 years of combined control. The lower graph (B) gives 
an example of 11 years of control which appeared to be sufficient to pre-
vent recrudescence. In both simulations it is assumed that vector control 
and annual treatment start at the same time and have the same duration. 
average treatment coverage is 65 % and that both control methods start in the same 
year. The lines in the figure represent 'iso-risk' lines, connecting those strategies 
that result in equal recrudescence risks (.01, .1, .5, and .99). Below or left of each 
line (less vector control or less annual treatments respectively) the risk is higher 
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than indicated, otherwise it is lower. In the absence of ivermectin treatment (points 
on the Y-axis) approximately 13 years of vector control are required to reduce the 
recrudescence risk to .01. If larviciding is combined with annual ivermectin treat-
ment throughout the control period, then a total duration of 11 years of control is 
sufficient to achieve the same result (intersection point of solid and dashed line). 
The iso-risk lines shown in Fig. 23 diverge at increasing number of annual treat-
ments. In the absence of treatment, the risk of recrudescence changes from - 0 to 
-1 when the duration of vector control is shortened from 13 to 10.5 years. With 11 
ivermectin treatments, the same change in risk occurs over a much wider range of 
vector control durations: from 11 to 6 years. If treatment is continued for 25 years 
then even in the absence of vector control the recrudescence risk is reduced to .5. 
However, still 6 years of larviciding are required to reduce the risk further to below 
.01. The explanation for the divergence of iso-risk lines is that, compared to vector 
control, community treatment involves more chance factors, both with respect to the 
participation of persons (coverage, compliance) and the effect of treatment. As the 
number of treatments increase, so does the role of these chance factors, leading to 
more variability in the calculation of recrudescence risks. 
The effect of alternative treatment coverage-levels in HIGH is shown in Fig. 24a. 
In this figure only the .01 iso-risk lines are shown. Especially for longer periods of 
treatment the importance of the treatment coverage is considerable. High coverage 
levels allow more prominent reductions in tile duration of vector control. For 
example, if annual treatment continues for 10 years at a coverage of 45 %, then 
vector control can be shortened WWl only slightly more than one year as compared 
with the situation without treatment. WWl a coverage level of 75 %, a saving of 
almost two years can be achieved. Fig. 24b demonstrates that the effectiveness of 
control strategies is highly dependent on the pre-control endemicity of the area. In 
the village MED a period of 20 years of almual treatment with a coverage of 65 % is 
sufficient to eradicate the parasite without the help of vector control; in village 
HIGH a supplement of at least 8 years of vector control would be required to 
achieve the same. Shorter periods of treatment (10 - 15 years) allow considerably 
higher reductions in the duration of vector control in MED than in HIGH. 
Simulation results for a village with a pre-control endemicity level like HIGH, 
but with more individual variation in fly biting rates (more exposure heterogeneity) 
indicate tIlat in such heterogeneous villages the allowed reductions in larviciding 
('savings') are only little less than for more homogeneous HIGH Villages. For 
example, with 10 treatments (cov. = 65%) in the standard HIGH village the dur-
ation of vector control can be reduced by 22 months, while in a heterogeneous 
HIGH-village tIlis is 19 months. However, in these latter villages we have found 
that at least 14 years of vector control would be required if this were the only 
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Figure 23 Iso-risk lines, representing combinations of vector control and ivemlectin 
treatment (coverage = 65%) resulting in equal recrudescence risks. Predic-
tions are made for a village with an extremely high pre-control endemicity 
level (model village IDGH). It is assumed that both strategies start in the 
same year. The dashed line represents strategies in which treatment and 
larviciding also stop in the same year. 
means of control. In the standard HIGH tIus is 13 years. 
Considerably lower savings are calculated under the assumption that an iver-
mectin treatment is less efficacious than estimated (25 % reduction of female worm 
fecundity instead of 35 %). Now 10 years of treatment at a coverage of 65 % allow 
only 15 months reduction of vector control. Under all circumstances, there is more 
than a proportional increase in savings with the number of annual treatments. This 
is apparent from the concave shape of the lines in Figs. 23 and 24. For example, 10 
treatments (cov. = 65%) in HIGH result in a saving of 22 months. By adding 5 
treatments the saving increases with 16 months. Adding another 5 treatments 
increases the allowed reductions in vector control even with 20 montils. 
Table 12 gives savings under the assumption that vector control and annual iver-
mectin treatment are always done together (same starting moment, same duration; 
e.g., a 'duration' of 10.5 years of treatment means 11 treatments). From this table 
we could derive the general guideline that if annual treatment is given to on average 
65 % of the population then the total duration of control can be 1.5 to 2 years less 
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Figure 24 .01 iso-risk lines for combinations of annual treatment and vector control in 
the model villages IDGH (A) and MED (B), representing villages of extrem-
ely high and medium high pre-control endemicity. The different solid lines 
represent different levels of treatment coverage. The dashed line represents 
strategies in which treatment and larviciding stop in the same year. 
than in the absence of treatment. 
Discussion 
The model predictions shown in this paper reflect the anticipated effects of the 
current practice of OCP in its extension areas. The primary aim of adding iver-
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Table 12 Number of months by which the duration of vector control can be 
shortened as a result of annual ivermectin treatment in several circum-
stances (villages), assuming that both control methods start and stop at the 
same moment. Savings are such that the risk of recrudescence after stop-
ping control (larviciding and treatment) remains less than 1 %. 
Village Vector control Treatment coverage (%) 
(endemicity alone (years 
45 55 65 75 level) [months])' 
HIGH 12.8 [154] 16b 20 24 26 
MED 10.5 [126] 14 18 24 31 
HIGH' 13.5 [162] 15 20 23 25 
HIGHd 12.8 [154] 13 16 18 20 
a No. of years [months] of vector control required to reduce the recrudescence risk to 
below 1% 
b Interpretation: if vector control and annual treatment are combined throughout the 
control period and the treatment coverage is 45%, then the total duration of control can 
be 16 monUls shorter than a strategy which relies on vector control alone (Le. 138 
instead of 154 monUls). 
, Village HIGH with more exposure variability. 
d Assuming a lower efficacy of ivermectin (25% irreversible reduction of female worm 
fecundity per treatment; standard = 35%). 
mectin treatment to the usual larviciding activities was the prevention of morbidity 
during the early years of vector control, when the intensity of infection is still so 
high that new cases of blindness or severe ocular lesions cannot be excluded. 
Indeed, ivermectin has proven to be an efficacious drug for the treatment and 
prevention of ocular onchocerciasis (Dadzie et al., 1991; Abiose el al., 1993). 
However, as combined control continues, a question of major operational relevance 
is to what extent the reduction of the community Mf load as a consequence of 
repeated ivermectin treatment allows an earlier cessation of vector control. On the 
basis of statistical analysis of simulation resuIts obtained with the ONCHOSIM 
model, we conclude that in a situation where vector control is accompanied by 
annual ivermectin treatment, the required duration of control can be reduced with at 
least one year (in case of low coverage of -45%) up to two years (coverage 
- 65 %) when compared to strategies which rely on vector control alone (see Table 
12). Compared to the original guideline of 14 years of vector control (plaisier et 
al., 1991b), this implies that when at least 65% coverage can be assured and when 
there is no importation of infection from elsewhere, a duration of 12 years of 
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combined control would be sufficient to prevent recrudescence even in areas of very 
high endemicity like our model village HIGH. 
The strength of the combination strategies is highly dependent on the treatment 
coverage. The attainable coverage depends on a variety of factors. An important 
determinant is, of course, the efforts of the control programme to include as many 
persons as possible. There are, however, unmanageable factors which relate to a 
person's ability or willingness to participate. The original guidelines for treatment 
are that pregnant women, women during the first week of lactation, and children 
below 5 should be excluded from treatment (De Sole ef al., 1989a). These exclusion 
criteria are taken into account by considering an age/sex-specific compliance profile 
(see appendix). Though this limits the effectiveness of one particular treatment 
round, in the framework of a long term treatment programme the impact will be 
moderate: children below 5 years harbour low numbers of worms, while pregnant 
or breast-feeding women may receive the drug in subsequent rounds (nine months 
pregnancy plus one week lactation falls within the interval of one year). More 
important will be persons who are permanently excluded because of chronic diseases 
(mainly related to the nervous system, e.g., epilepsy) or who have a limited ability 
or willingness to participate. In terms of the model, this latter group has a low 
'compliance-index' (see appendix). Among those with a low compliance there will 
be persons with a considerable Mf load (even after a period of control), and they 
will have a relatively high contribution to transmission when vector control ceases. 
It is, therefore, advisable not only to attempt to reach a high coverage (65% - 75% 
seems to be attainable, even in situations of 'community self treatment'; OCP, 
1994b), but also to trace people who tend to miss treatments systematically. 
All results of this study are based on the assumption that larviciding and iver-
mectin treatment start in the same year. However, in some parts of the extension 
areas large scale treatment started with a delay of two years. Therefore, for the 
model village HIGH we have calculated recrudescence risks for several tinle-lags. 
We have found that up to a time lag of 4 years - which is more than in any of the 
areas - no observable difference with a synchronous start could be found in the 
sense that .01 iso-risk lines are virtually on top of each other. However, a time lag 
may result in a longer total duration of control. Applied to the guideline of 12 years 
of combined control, a time lag of two years implies an increase of the total dur-
ation to 14 years. 
Of course, the conclusions of our study are as sound as are the underlying 
assumptions. In a previous study (plaisier ef al., 1991b) we showed how uncertainty 
about model parameters is reflected in the outcome of the recrudescence analysis. 
The guideline of 14 years as a minimal duration of vector control in an area without 
inlportation of infection (through infective flies or infected migrants) is largely 
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based on 'unfavourable' assumptions on the parasitic life span, the efficiency of the 
SimuliuIn vector in transmitting the parasite at low skin Mf densities, and the 
heterogeneity of the exposure to fly bites. The present study is mainly concerned 
with potential savings in terms of reducing the vector control efforts by the addition 
of ivermectin treatment. Most of the uncertainty about the estimates of these savings 
is related to the efficacy of the drug. We have previously found that in a schedule of 
annual administration, each treatment causes an irreversible reduction of - 35 % of 
the fecundity of female parasites (plaisier el 01., 1995). However, the confidence 
interval for this estimate ranges from 25% to 40%. The impact of a lower efficacy 
of 25% has been explicitly tested. From Table 12 we learn that with this 
unfavourable assumption the savings are only 1.5 years when the treatment coverage 
is 65%. However, both this 1.5 years of saving and the 14 years of the original 
guideline are based on unfavourable assumptions on model parameters. When both 
are combined (14-1.5= 12.5) we end up with an extremely pessimistic view of the 
potential of mixed strategies, and therefore there is no need to revise the guideline 
of 12 years of combined control. 
The conclusions of our analysis are not only determined by assumptions on 
specific model-parameters, but also largely by assumptions on the effectiveness of 
vector control and the circumstances in the areas where control is carried out. We 
always assume that prior to control there is a stable endemic situation and that the 
pre- and post-larviciding fly biting rates are equal. It is imaginable that the observed 
pre-control endemicity (CMFL) is an underestimation' of tlle potential endemicity, 
for example because of the Sahelian droughts of 1968-1974, preceding the start of 
OCP (McMillan, 1995). Furthermore, we assume that there is no transmission 
tlrroughout the whole period of vector control and that there is no immigration of 
infected flies and infected persons. It is clear that in many places these strong 
conditions are not met. Reinvasion of (infected) flies has been reported frequently 
(Garms el al., 1979; Philippon el 01., 1990). Though importation of the infection by 
human migration is not (yet) an important problem (most migratory movements are 
from areas where river blindness was not endemic to the river-valleys where the 
disease is eliminated; see McMillan, 1995), explorative computer-simulations have 
demonstrated that a few infected migrants settling in a village of limited size con-
siderably raise the risk of recrudescence. It is clear from these considerations that 
the guidelines as presented in this paper may be applied only after critical review of 
the situation. A thorough study of the local circumstances and the history of control 
(especially control failures) should all be included in a rational decision making. 
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Appendix 
Calclliation of Ihe individual Ireatmelll probability 
The primary characteristic of a certain ivermectin mass treatment W is the coverage 
Cw (fraction of the population treated). However, a difficulty in calculating individ-
ual chances of participation is that there are several exclusion criteria for the drug. 
Moreover, compliance to treatment differs from person to person. Exclusion criteria 
can be either permanent (chronic illness) or transient (children below 5 and pregnant 
or breast-feeding women). We define the eligible population as the total popUlation 
minus a fraction fc (= .05) which is permanently excluded from treatment (in the 
model from birth to death). The coverage among the eligible population is now 
given by: 
C>Cj(l-fc) (1) 
The transient contra-indications and other age- and sex-related factors are taken 
into account in the age- and sex-specific relative compliance c,(k,s) for each age-
group k and sex s. Based on OCP data we use: 
age-group (k) 0-4 5-9 10-14 15-19 20-29 30-49 50+ 
c,(k,66) 0.00 0.75 0.80 0.80 0.70 0.75 0.80 
c,(k, '¥ '¥) 0.00 0.75 0.70 0.74 0.65 0.70 0.75 
Note that in c,(k,s) only the ralio between tile values for the different groups is 
relevant. 
Now, the coverage c(k,s,w) in each of the age- and sex-groups at treatment round 
W is calculated as: 
c(k,s,w) c,(k,s)xN(w) , -----'-------xC" 
,<,2 ,<,", 
'-',e I '-'ke I c,(k,s) xN(k,s, IV) 
(2) 
with: N(k,s, w) Number of individuals eligible to treatment in age-group k and 
with sex s at treatment round IV. 
N(w) Total number of eligible individuals at treatment round IV. 
Finally, the probability to participate in treatment round ]V for an eligible person i 
of age-group k and sex s is given by: 
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(3) 
with: eOj Personal compliance index. This is considered as a lifelong prop-
erty and is generated from a uniform distribution on [0,1]. 
Note that for all k and s the average value of Ptrj,1Y equals e(k,s,w). 
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This thesis describes the use of a model for onchocerciasis, or river blindness. 
The objectives were: (1) to develop, quantify and validate a model for the trans-
mission and control of onchocerciasis in West African savanna and (2) to use Utis 
model for aiding decision making in OCP. 
Though the second objective, the practical application of the model, is the most 
important justification of putting money and efforts in a research project like this, 
the first objective outweighs the second both in terms of time investments and 
number of pages in tltis thesis (Chapters II, III, and IV). Specific questions within 
Ule fIrst objective included the estimation of the reproductive lifespan of Onchocerca 
volvllills and the estimation of the effects of ivermectin when given at a standard 
dose. Answering these specifIc questions was essential for the fluitful application of 
the model in evaluating and prediction. 
Within the second objective (aiding decision making), specifIc questions were (a) 
how long should vector control be continued to reduce the risk of recrudescence to 
very low levels after ceasing operations, and (b) can Utis required duration of 
control be shortened in areas where larviciding is accompanied by annual ivermectin 
treatment. The guidelines derived from addressing these questions (see Chapter V) 
have had important implications for decision making within OCP (Samba, 1994; 
Aron and Silverman, 1994; Goodman, 1995; Molyneux, 1995; WHO, 1995). 
In this discussion, first the contributions computer simulations made to decision 
making in OCP will be summarized (section VI.1). These contributions not only 
comprise the results presented in Chapter V. ONCHOSIM has frequently been used 
to aid the understanding of epidentiological trends in areas or villages with a speci-
fIc history of control or control failures (Habbema et al., 1992). Furthermore, once 
the guidelines for the prevention of recrudescence were adopted, it was recognized 
that surveillance strategies need to developed for the early detection and control of 
recrudescence if it unfortunately occurs. Model simulations have helped in designing 
such strategies, and in section VI.I the, as yet unpublished, results will be intro-
duced. 
It is obvious that the quality of model predictions highly depends on the quality of 
the model and the suitability of the modelling technique. Section VI.2 considers the 
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extent to which the applied methodology - stochastic microsimulation - was crucial 
for the use of the model as an operational tool. Advantages and disadvantages of 
this technique will be discussed. A very important issue is the validity of the model 
with regard to both the overall structure and the parameter quantification. In section 
VI.3 first the different steps in the development of a model and of ONCHOSIM in 
particular will be presented. Next it will be discussed to what extent this develop-
ment resulted in a valid model. Though in Chapter III the quantification of the 
reproductive lifespan and related parameters are already discussed extensively, all 
model assumptions made thus far and the way alternative assumptions would most 
likely affect the predictions of the model will be reviewed. Finally, the current and 
future use of the model, both within and outside the OCP context, will be presented. 
VI.1 Contribution to policy making in the OCP 
The required duration of vector coutrol 
By focusing on the trend in the intensity of infection within a cohort of adults, 
Remme et al. (1986) demonstrated that 8 years after the start of OCP, vector con-
trol had a significant impact on the parasite population. The force-of-infection model 
used in this study predicted a gradual reduction in the intensity of infection to 
insignificant values after 11-12 years of control. By explicitly considering variability 
in the lifespan of O. volvulus predictions with a host-parasite model (a micro-
simulation model developed by the Dept. of Public HealUl, waich can be considered 
as a precursor of ONCHOSIM; see 1.4) suggested that both the prevalence and 
intensity of infection will have declined to very low values (Remme et al., 1990a) 
between 13 an 15 years of larviciding. Both model based analyses and predictions 
were highly relevant for the question of how long the costly control operations 
should be continued to prevent recrudescence of infection and disease after allowing 
blackflies to re-colonize their original breeding sites. Though by 1989-1990 the 
efficacy of Ivermectin was being studied in many clinical and community trials, 
there was too much uncertainty about its impact on transmission to rely on its 
possible use in controlling recrudescence. Hence, stopping vector control untimely 
could, in the long term, lead to complete re-establishment of an endemic sitnation. 
Section V.I extensively discusses the required duration of a control strategy 
based on larviciding alone, knowing that blackflies will immediately retnm to their 
former breeding sites and start to bite the human population as before control. 
Tlu'ough a large number of simulations with ONCHOSIM, covering both tile uncer-
tainty in important model parameters (like the reproductive lifespan of the parasite 
and the efficiency of blackflies to transmit infective stages at low human Mf levels) 
and the variability in endemic levels in the OCP communities, it was shown that 14 
years of vector control should be sufficient. TIllS 14 years has been adopted as a 
general guideline and has led to cessation of larviciding in those parts of OCP's 
original area - i.e., the area where control started in 1975 - where epidemiological 
trends were consistent with the predictions and where no problems with vector 
control (e.g., as a result of large-scale reinvasion) were reported in the past (EAC, 
1991). Noticing that, in view of the rather strong underlying assumptions (100% 
effective vector control), these guidelines may not be applied uncritically, in the 
OCP there is a continuous awareness of the potential occurrence of recrudescence in 
the central area. 
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Combining vector control with ivermectin treatment 
Since 1990 (between 0 to 2 years after the start of larviciding) in the southern and 
western extension of OCP Ivermectin is administered annually in most of the 
endemic communities with a CMFL 14 of above 10 Mfls (EAC, 1991), mainly to 
achieve a better control of morbidity. This addition of ivermectin distribution is a 
fortunate reason for reconsidering the guideline on the duration of vector control 
discussed above. Section V.2 addresses the question whether and to what extent this 
combination of ivermectin treatment and larviciding could be a reason to shorten the 
originally planned period of 14 years of control. This question became increasingly 
important since the results of the trial in Asubende suggested that Ivermectin is not 
a microfilaricide sellSu stricto (section N.l) and a model based analysis demon-
strated a considerable irreversible effect on the reproductive potential of female 
parasites (section lV.2). On the basis of a multitude of sinlUlations of these combi-
nation strategies in conmlUnities with a range of endemicity levels we conclude that, 
provided vector control had been and will continue to be highly effective and treat-
ment coverage-levels of around 65 % can be maintained, 12 years of control should 
be sufficient to prevent recrudescence even in the most afflicted conmlUnities. This 
fmding gives support to the conclusion that the present strategy of OCP should be 
continued until the year 2002 (Molyneux, 1995). However, also this guideline can 
never be a panacea and should be accompanied by intensive surveillance. A compli-
cation in this respect is that by suppressing Mf loads, Ivermectin treatment troubles 
the evaluation of the effects of vector control (EAC, 1995). This is especially a 
problem when the exact treatment time is not known or when a treatment round is 
spread over a longer period of time. 
Post-larviciding surveillance strategies 
In the OCP central area larviciding was only ceased in a river basin when after 
14 years (i) according to the entomological evaluation there had been no significant 
transmission during the control period, (ii) the epidemiological trends in all indicator 
villages in the river basin were consistent with the model predictions, and (iii) no 
children born since the start of control had become infected. It was, however, 
realized that in spite of this careful decision making, the threat of recrudescence 
remained. Hence, strategies had to be developed for the detection of recrudescence. 
14 Community Microfilarial Load; i.e. the geometric mean no. of Mf / skin-snip in adults 
(220 yrs.). 
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Such strategies should on the one hand be based on sound expectations of the 
dynamics of the infection during recrudescence, both in the human population 
(trends in intensity, prevalence, and incidence) and in the vector population 
(infectivity of flies). On the other hand they should be based on the anticipated 
possibilities to control tile recrudescence either by restarting larviciding or by 
starting ivermectin treatment. Using model predictions of the infection dynamics, a 
short-term and a long-term strategy for the detection and control of (potential) 
recrudescence was agreed upon. The short-term strategy is based on entomological 
data: should infectivity of the (returned) vector exceed an unacceptable value, then 
larviciding should be restarted. The long-term strategy is based on epidemiological 
data: should the Mf counts in the population exceed a certain threshold, or should 
the incidence of new Mf positive cases be too high, then large-scale treatment with 
ivermectin should be started to prevent further progress. 
Elltomological surveillallce 
In order to validate whether the decision to stop had been correct, special entomo-
logical studies were undertaken of vector infectivity levels during the first two years 
after cessation of vector control. A difficulty in these entomological studies was to 
determine which vector infectivity levels were to be considered as insignificant and 
which levels reflected an unacceptable risk of transmission. This question was 
studied in a number of ONCHOSIM sinmlations of epidemiological situations witl} a 
medium to very low risk of recrudescence. These simulations indicated tlmt, if the 
number of flies with L3 larvae in the head (F3h) was in the order or 0.9 to 1.3 per 
1000 parous flies, the risk of recrudescence was negligible. However, in simulations 
where vector infectivity reached 1.4 to 2.2 F3h per 1000 parous flies, there were 
several cases of recrudescence. These results provided a basis for the following 
operational guidelines: if the observed infectivity levels are significantly lower than 
1 F3h per 1000 parous flies, the entomological evaluation confirms the correctness 
of the decision to stop vector control, and no further entomological evaluation 
would be required at the site in question. If vector infectivity is significantly higher 
than 2 F3h per 1000 parous flies, the risk of recrudescence is unacceptable and 
vector control should be started again. In the range between 1 and 2 F3h per 1000 
parous flies it is difficult to take a decision on the basis of the model predictions 
alone, and additional information on the specific local situation should be taken into 
account. These guidelines were used to develop sequential decision charts for the 
entomological evaluation (Remme et al., 1995). 
Epidemiological surveillallce 
A definite indication of the occurrence of recrudescence can only be obtained from 
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epidemiological data (Mf counts in skin snips). The timing of post-control 
epidemiological surveillance is a complicated issue and it is important to know: (i) 
when should such post-control data be collected and (ii) when do such data indicate 
'recrudescence'. In section V.1 we showed that in general recrudescence is a rela-
tively slow process. Therefore, to distinguish a 'real' recrudescence from either an 
occasional new infection or previously undetected old infections, one should prefer-
ably postpone epidemiological surveys until significant Mf levels are to be expected. 
On the other hand, model simulations have indicated that, if recrudescence has 
proceeded too far, it is very difficult to control it by means of mass treatment with 
ivermectin. Simulations also indicated considerable variation in the dynamics of 
recrudescence: sometimes infection prevalence increases rapidly, sometimes it 
remains on the same level for quite a long time. These considerations have led to 
the conclusion that post-Iarviciding surveillance should be based on a longitudinal 
approach and consist of a series of surveys at regular intervals. The first surveys 
(plalUled shortly after cessation of larviciding) will detect cases of fast recrudescence 
at a moment that they can still be controlled by ivermectin. Slowly progressing 
cases of recrudescence can be detected by later surveys. Given this approach, two 
crucial questions emerge: what is a suitable interval between surveys and what 
should be used as an indicator of recrudescence. 
The way in which these questions are addressed is illustrated in Fig. 25. The 
basis of this example is 300 simulations of 12.5 years of vector control a highly 
endemic village (CMFL = 70 Mf/s) resulting in 110 casesl5 of recrudescence. 
Immediately after detection of recrudescence a campaign of 10 years of annual 
ivermectin treatment is started with a constant population coverage of 65 %. The 
detection is based on a series of surveys at three years intervals, the first being done 
at the moment of cessation of larviciding. Fig. 25a shows what happens if an annual 
incidence of Mf positive skin-snips among adults (;e 20 yrs.) of 1.5% is used as an 
indicator of recrudescence. Already at the 2nd survey 40 cases are detected and 
after 15 years (6 surveys) only a few remain undetected. The finding that only after 
30 years all cases are detected illustrates the variation in the dynamics of recrudes-
cence. For none of the recrudescence cases detection comes too late to be controlled 
by ivermectin treatment (all closed circles are on the X-axis). Though this is certain-
ly a safe strategy, it is probably not the most cost-effective one: in almost 40 situ-
ations ivermectin treatment is started without need. In these situations ('false 
alarms') the incidence exceeded 1.5% but no real recrudescence followed. The 
effect of increasing the threshold incidence from 1.5% to 2.5% is showed in Fig. 
15 'Case' is here used for a village (or conmlUnity, river basin) and not for an individual 
patient. 
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25b. Now the number of false alarms is negligible, but in one case the detection of 
recrudescence came too late to be controlled by ivermectin. This latter phenomenon 
becomes a considerable problem when the incidence-threshold is increased from 
2.5% to 3.5% (Fig. 25c) . 
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Figure 25 Detection of post-Iarviciding recrudescence with 3-yearly surveys. Thresh-
old fol' annual incidence of Mf in skin-snips among adults: (a) 1.5%, (b) 
2.5%, (c) 3.5%. See text fol' details. 
From this example, it becomes clear Ihat Ihe design of post-conlrol surveillance is 
based on Ihe balance between 100 lale delection and unnecessary conlrol. Safe 
slralegies comprise frequenl surveys and Ihe slarting of ivermeclin Irealment at low 
values of Ihe incidence (or prevalence) of infection. Such safe slralegies run Ihe risk 
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of many false alarms and unnecessary starting of a treatment strategy. By contrast, 
low-cost strategies comprise infrequent epidemiological surveys and high threshold 
values for indicators of potential recrudescence. As a consequence some cases of 
recrudescence may be missed or detected too late. Noticing that the possibility of 
recrudescence control relies on the strength of the treatment strategy that can be put 
into action, we have tried to find optimal strategies. As a criterion for an optimal 
strategy we concluded that there should be less than I % cases of too late detection 
and a minimum number of instances where treatment is started unnecessarily. By 
comparing optimal strategies for a number of realistic ivermectin treatment strat-
egies, the Expert Advisory Committee of the OCP recommended post-control 
surveys should be carried out at three years intervals and that a strategy of at least 
10 years of annual treatment should be started if the aIDlual incidence of Mf/s 
among adults exceeds 2% (EAC, 1991). 
VI.2 Methodological issues 
The constmction of a model - variables, parameters, and their interrelation - and 
the exploration of the characteristics of this model - such as the prediction of trends 
during interventions - are two different things. The development and validity of the 
ONCHOSIM model will be dealt with in section VI.3. Here we will discuss the 
modelling methodology used for the inlplementation of ONCHOSIM. The features 
of this methodology - microsimulatioll - are extensively presented in section 11.1 and 
in Habbema et al. (1996). Here we will give a justification for the choice of this 
technique and list a number of (potential) disadvantages. 
Why microsimuIatiou 
Choosing a modelling methodology is based on a number of considerations. A 
decisive factor is often the modelling tradition of the research group. For example, 
a group with a reputation in the use of analytical modelling will most likely start 
with employing this technique. Other factors include the availability of (powerful) 
computers and the time and resources allocated to the modelling effort. However, 
by far the most important factor is (or should be) the objective of modelling. Gen-
erally, when models serve to study the behaviour of a (biological) system and to 
determine the sensitivity of certain parameters, a tractable analytical approach is to 
be preferred. There are a lot of good examples of the use of analytical models for 
investigating the dynamics of infectious diseases. An' overview can be found in 
textbooks like Anderson and May (1991) and Scott and Smith (1994). When models 
are to be used for predicting the impact of a variety of interventions in specific 
endemic situations, it is mostly belter to use simulation techniques. In this section 
we will list a number of considerations which supported the decision to construct a 
sinlUlation model, or more precisely a microsimulatioll model, for analyzing the data 
of OCP and predicting the impact of control. We will also make clear that, after all, 
this was a good choice. 
1. Need for a detailed model 
In view of the envisaged use it was necessary to develop a model which reflects as 
good as possible the biologic, demographic, and epidemiologic situation in the 
onchocerciasis endemic areas covered by OCP. Noticing that the understanding of 
past trends and the prediction of future trends under the larviciding strategy was 
sharply determined by the life-history of the parasite (Rennne et al., 1986, 1990a), 
it was essential that the model was suitable to test a variety of assumptions on this 
life-history, including the mean and variation of the reproductive lifespan of O. vol-
vulus, the age-dependent production of microfilariae, the variability in this Mf 
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production, and mating of parasites. For a realistic model - both in view of the 
quality of the outcomes and in view of Ule acceptance by users within OCP - it was 
further essential to include known facts like the excess-mortality among blind per-
sons, the non-linear relation between human infection and vector infection, and 
variability in the exposure to fly-bites. Finally, to enable a detailed testing of the 
model, it should produce output with the same degree of detail as the results of 
epidemiological surveys, such as longitudinal output for cohorts of persons. Includ-
ing all these details into one model makes it extremely difficult, if not impossible, to 
use analytical techniques for evaluating such a model. 
2. Flexibility 
It was further essential that, once a basic model was developed and tested, it was 
relatively easy to extend it on the basis of new evidence or in view of new ques-
tions. An example of such an extension is the more detailed modelling of the life-
history of microfilariae (considering monthly age-classes). This extension was 
essential to enable a more realistic sinmlation of the short-term effect of ivermectin. 
In general, analytical approaches are too rigid to allow for major extensions and 
require a complete revision of the model. 
3. Estimation of recrudescel/ce risks 
By simulating discrete events (birth and death, acquisition and death of parasites) in 
a finite human population (e.g., a village of 300 persons) the stochastic nature both 
of infection and disease and of the impact of control is mimicked. This property of 
microsimulation has been utilized to calculate the risk of recrudescence of infection 
after stopping of control (Chapter V). When after a certain period of effective 
vector control the flies are allowed to return then it is a combination of stochastic 
elements which will determine whether recrudescence will occur or not: the remain-
ing worm load in the population, the distribution of the worms over the population 
and the associated mating chances, the distribution of individual biting rates, etc. 
Especially when the average worm load approaches critical values below which no 
endemic situation can be maintained, a certain simulated control period will some-
times be followed by recnidescence and sometimes not. Thus, by repeatedly simu-
lating a range of larviciding periods it is possible to relate the recrudescence risk to 
the duration of control. This type of risk-calculations are much more complicated 
when relying on analytical meUlOds. With analytical modelling it is at most possible 
to identify a breakpoint (worm load) below which no recrudescence will occur and 
associate this breakpoint with a certain duration of control: below this breakpoint it 
willI/ever occur, above the breakpoint it will always occur. 
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4. Prediction of effects of complicated strategies: 
A final reason in favour of microsimulation was the need to evaluate a large number 
of control strategies in a variety of endemic circumstances. These strategies include 
vector control, chemotherapy (ivermectin), and a combination of both. The endemic 
circumstances include different levels of infection and different levels of variation in 
individual biting rates. Furthermore, it was essential that the effects of specific 
complications could be studied such as the reinvasion of flies during the control 
period and the immigration of infected individuals during control or during the 
period after cessation of contro!. Microsimulation is particularly suited to mimic 
such highly specific events. 
It is the combillation of these considerations which was decisive. For example, 
for the isolated question of how long the parasite persists when transmission is 
interrupted, we explored a simplified model which gave similar results (Van Oort-
marssen, unpub!.). 
Disadvantages of microsimulation 
The most important drawbacks of microsimulation models are tlle 'black-box' nature 
of such models, the stochastic variability in model output and the related difficulties 
involved in fitting the model to data, and the efforts required for the development 
and management of the complex computer programs. 
1. Black box 
In the absence of restrictions imposed by calculus and algebra, (micro)simulation 
models like ONCHOSIM easily grow to levels of complexity which hamper under-
standing of the behaviour of the model, Le., the relation between model output and 
the assumptions made in the mode!. Understanding the behaviour of the model 
requires extensive and time consuming sensitivity analyses. In analytical approaches 
the relation between model calculations and model parameters is mostly much more 
transparent. 
2. Variable olltcome 
Though very useful for the calculation of recrudescence risks, the stochastic nature 
of the microsimulation model is also a disadvantage. A single simulation of a con-
trol strategy in a population of around 200-300 individuals represents only one 
possible outcome of that strategy and can never be used for far reaching conclusions 
about the effectiveness of that strategy. Variability in model outcomes is especially 
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cumbersome in attempts to fit the model to data in order to estimate parameters (see 
Chapter III and section IV.2). The goodness-of-fit of a set of assumptions can only 
be accurately determined by repeating simulations many times or, similarly, simulat-
ing large numbers of individuals. The consequence of simulating small populations 
is a considerable probability of either not rejecting a poorly fitting set of assump-
tions or rejecting good fitting assumptions. Related to this, standard optimization 
routines developed for deterministic models, such as the Downhill-Simplex method 
employed in section IV.2, cannot be applied without making adaptations for dealing 
with stochastic results. Finally, shnulation of limited populations (discrete numbers) 
considerably hampers the use of maximum likelihood procedures for fitting the 
model. This is especially a problem in attempts to fit the model to data on repeated 
measurements, like the repeated skin snip examination of the treatment cohort in 
section IV.2. Other modelling approaches are better suited for this task. An illustra-
tive example is the statistical model developed by De VIas et al. (1992, 1993) for 
describing variations in repeated egg counts in Schistosoma mansoni infections. This 
model links a (negative binomial) probability distribution of worm numbers with a 
distribution describing the variability of egg counts in a person with a certain worm 
load. For given values of these distribution parameters', the probability that a person 
exhibits a certain series of egg counts in repeated observations can be calculated. 
With a maximum likelihood procedure the model parameters can then be estimated 
by fitting the model to observations of repeated egg counts. In microsimulation the 
number of simulated individuals is generally too small to generalize their combina-
tion of features to likelihoods. For example, the individuals in treatment cohort 1 of 
section IV.2 were examined 9 tinles during the ivermectin trial. Even if we repre-
sent their skin-snip count at each survey by a frequency distribution with only three 
categories (e.g., 0-3, 4-15 and;" 16 Mf/s), then the total number of possible series 
of skin-snip outcomes equals 39= 19,683. Arriving at an esthnate of the likelihood 
to be in either of these states requires the simulation of a population of millions of 
individuals for each parameter quantification tested. This was the main reason for 
fitting the model to the marginal distributions: a total X' was derived as the sum of 
X's for the goodness-of-fit to the Mf count distribution of each of the surveys. This 
implies the assumption that successive observations are independent. Since observa-
tions were done on the same persons (cohort), this is - a-priori - not a tenable 
assumption. However, we have demonstrated that the explicit model assumption of 
dependency of observations (Le., persons systematically respond good or poor to 
ivermectin) did not result in a significantly better fit. This is - a-posteriori - a 
justification of this approach. 
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3. Complex computer programs 
A final disadvantage experienced with microsimulation is dIe complex computer 
programs that have to be developed and maintained. The total ONCHOSIM pack-
age, including dte simulation-core and programs for processing output, consists of 
more than 20 highly interlinked modules (flies with C-code) which together 
comprise around 10,000 lines of source code. Debugging of such a program is an 
arduous task and programming errors may sometimes remain undetected for quite 
some time. 
In conclusion, microsinlUlation has proven to be a very powerful modelling 
tecllllique, but before constructing a microsimulation model the following consider-
ations should be made: 
(i) to gain insight in the system under study (the transmission of an infectious 
disease in a popUlation) it is recommendable to start with constructing a more 
tractable analytical model or deterministic simulation model. Once the limits of 
these techniques are reached, one could consider the additional benefits of a com-
prehensive microsimulation approach. 
(ii) the construction of a stochastic model and its implementation in a micro-
simulation program is a time consuming enterprise which relies on dIe availability 
of a powerful computing equipment and progrannning skills. Though the availability 
of computers becomes a less important lintitation in developed countries it can still 
be pressing elsewhere. 
(iii) validation of a stochastic individual based model by fitting it to data is ham-
pered by the random output produced by the model and the difficulty in using 
maximum likelihood procedures. 
VI.3 State of the art of ONCHOSIM 
Evolution of the model 
In the development of a model, several evolutionary stages can be distinguished. A 
schematic overview of these stages is given in Fig. 26 (see also Habbema et 01., 
1995). As the arrows in this flow diagram suggest, one can be in several stages at 
the same time and certain loops may be passed several times. For the development 
of ONCHOSIM there were clear objectives (problem identification): for a balanced 
decision making, predictions had to made of the long-term impact of current and 
future control strategies of the OCP. Thanks to two previous modelling enterprises 
(Remme et 01., 1986; 1990a), the second phase - investigation of knowledge - could 
be focused on those aspects that were related to transmission (which was lacking in 
these models), especially the relation between human infection and the mean uptake 
and development of larvae by the vector, and the impact of control by ivermectin 
treatment (Chapter IV). The model design was entirely tailored to the anticipated 
use as an epidemiological model for long term predictions. For that reason, short-
cuts were made in the entomological part of the model. In the absence of vector 
control a fixed value is used for the biting rate in each calendar month. Hence we 
only consider seasonal variation and not, for example, year to year variation. Also 
the probability that an engorged Ll-stage larva will be released as an infective L3-
larva (the transmission parameter v, see section 11.2) is constant. On the contrary, a 
detailed description of the life-history of the parasite in the human host was included 
to enable a realistic calculation of epidemiological trends during vector control and 
chemotherapy. By far the largest investments were made in tile, highly interlinked, 
phases of model quantification (assigning values to parameters on the basis of 
available knowledge) and model validation (adapting parameter values in order to fit 
the model to observations); see Chapter III and section IV.2. Although in this 
respect many uncertainties remain (see below), the close agreement between pre-
dicted and observed trends in the OCP area stimulated extensive use of the model in 
prediction and optimization of future control; see Chapter V and section VI.I. 
Although no considerations were made about resource use, the results presented in 
these chapters can be considered as an attempt to optimize control: what is the 
minimal control effort to meet a certain goal (prevention or timely detection of 
recrudescence). By extensively discussing model predictions with OCP staff and by 
stressing the conditions under which predictions are valid or invalid, major 
contributions have been made to decision making (see above). Although depicted as 
a final phase, transfer of the simlilation program has been a continuous process. In 
fact the first complete version of the computer program (shortly after model design) 
was inunediately transferred to OCP headquarters in Ouagadougou and tested on 
General Discussion 141 
their equipment. Since then, numerous updates have been sent and experiences 
exchanged. Recently, triggered by many requests outside OCP, a user-friendly 
version of ONCHOSIM has been developed which can be used for research, teach-
ing and training. 
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Figure 26 Stages in the development of a model (see Habbema et al., 1995). 
The most important lesson learned from the development of ONCHOSIM and its 
application within OCP is that models can only become effective tools if tIlere is 
continuous feedback both from those who could benefit from model calculations (the 
decision makers) and from the experts in the epidemiology of the disease under 
study. In terms of the schedule of Fig. 26: wandering back to 'earlier stages' (e.g., 
from model validation to model design) is not only inescapable but, in fact, crucial. 
Flexibility and the willingness to revise initial ideas are essential ingredients for 
applied modelling. In section VI.2 we have shown that this was an important reason 
to choose microsinlUlation as modelling teelmique. 
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ONCHOSIM and curreut knowledge 
The flow diagram of Fig. 26 reveals that predictive models should be data-driven. A 
valid model not only incorporates as much as possible field or laboratory evidence 
on certain processes, but should also be able to reproduce observed trends in the 
area to which the model applies. For ONCHOSIM this area is the West African 
savalUla. Parameter estimates have been derived for the O. volvulus strain and 
S.dalllnosulII species typical for this area. For other areas, such as the African rain 
forest or Cental and Southern America, the same model structure can be used, but 
parameter estimates will be different, and additional research is required to apply 
the model there (see WHO, 1995 for a discussion of geographical differences). 
Here, we will briefly discuss the validity of the present structure and quan-
tification of the model (see Ch. II) in the light of current knowledge. We will 
especially highlight those aspects that are known to be crucial for the model predic-
tions presented in this thesis. 
Reprod/lctive lifespan 
As reported in Ch. III the reproductive lifespan of O. ~olv/ll/ls has been estimated on 
the basis of trend in skin-snip counts in three representative villages in the core area 
of OCP. It has been argued that this estimate depends on a number of other parame-
ters, such as the age-specific Mf production, mating of worms, and the lifespan of 
microfilariae. Together, these parameters constitute the effective duration of the 
infection. Confounding parameters for this effective duration and its variability are 
the between-person variation in exposure to fly-bites (resulting in variation in worm 
loads), the mean Mf production (in terms of the average contribution of a female 
worm to the Mf density in a skin-snip), the selected type of probability distribution 
for the lifespan (Weibull), the variability in Ole contribution to the Mf count bet-
ween parasites (e.g., because of the variable distance of parasites to the skin-snip 
site, or because of genetic differences in fecundity), and the assumption on skin-snip 
sampling variability (Poisson distribution). Two of these parameters (mating and 
fecundity-variation) have only been included in the model because Olere is over-
whelming evidence that they play a role in the production of Mf by O. volvulus 
(Schulz-Key and Karam, 1986; Karam et 01., 1987; Schulz-Key, 1990; Duke et 01., 
1990a). All other parameters appeared essential to arrive at a good fit to the longi-
tudinal series of Mf count distributions used in the analysis. We further found (see 
Chapter III) that, except for the age-trend in the fecundity, varying these parameters 
did not result in major changes in Ole estimate for the lifespan. Though this points 
to a reasonably robust estimate for this parameter, one possible problem could still 
be the tail of the probability distribution. It cannot be excluded that more parasites 
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survive to old ages than indicated by the Weibull model. These long survivors may 
be important risk factors for recrudescence after stopping vector control. 
Worm load versus Mf productioll 
A problem with a parasitic disease like onchocerciasis is that adult worms in the 
human host cannot be counted, at least not on a routine basis. Though nodulec-
tomies shed some light on potential worm loads (see. e.g., Duke, 1993), a certain 
Mf density can either be caused by a single or few highly productive worms, or by 
a large number of lowly productive worms. Though not the most sensitive variable 
in the model (it is the microfilariae which cause the trouble), especially ullderes-
timating the worm load (which is equivalent to underestimating the probability that 
an inoculated L3-larva succeeds in becoming an adult worm: the success-ratio, sr) 
may result in an underestimation of the risk and speed of recrudescence after with-
drawal of vector control: the lower the worm load, the lower the mating chances, 
the lower the Mf production. Using the follow-up data in the same three villages as 
mentioned in Chapter III, we have attempted to arrive at a 95 % confidence interval 
for both the success-ratio and the fecundity (represented by the parameter ClV, see 
section 11.2). Translated into a range of possible worm loads in a hyperendemic 
Village, we found that this could range from 10 to 27 female worms per person all 
average (Le., including persons with low or zero worm loads; unpubl. analysis). 
There is some evidence that this range is in accordance both with nodulectomy 
results and with calculations based on the ill vivo release of Mf. These latter calcula-
tions resulted in an estimate of 16 female worms per patient (geometric mean; 
Schulz-Key, 1990). Nodulectomy of patients from Liberia and Burkina Faso (Albiez 
et al., 1988b) revealed 20 to 40 female worms per person. Since, these observation 
only included nodule carriers (Le., a biased sample), this range is an overestimation 
of the mean worm burden in the population. In an attempt to link the level of 
transmission of infective larvae to the human parasite load, Duke (1993) - using 
data from various sources - estimated that the ratio between the Annual Number of 
Potentially Productive Female Worms (APPF) and the AlUmal Transmission Poten-
tial (ATP; no. of L3-larvae transmitted per year) is around 0.002. Given the defini-
tion of this ratio (only female worms), the value should be compared with 0.5 x our 
sr. Since we estimate sr at 0.0015, this model parameter is a bit lower than the 
findings of Duke, but given the totally different routes followed to arrive at the 
estimates, they are in fact remarkably well in agreement. 
Parasite dellsity regulation 
In the absence of any density regulating mechanism, parasite numbers will increase 
to infinity if one female worm is able to replace herself by more than one female 
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worm in a next generation (Le., if the so called basic reproductive number Ro 
exceeds unity; see Anderson and May, 1991). Density regulation of O.volvulus is 
observed to occur in the vector: at increasing numbers of engorged Mf, a decreasing 
proportion is developing to later larval stages (Basanez et ai., 1995). On the basis of 
a xenodiagnostic experiment with persons from Asubende (Ghana), a good estimate 
could be made of the relationship between human Mf density (measured by the 
mean of 3-4 skin-snips) and the number of fIrst stage larvae developing in engorged 
flies (Basaiiez et al., 1995; section V.I - appendix). The saturated relationship 
resulting from this experiment is by far the most important density regulating mech-
anism in the ONCHOSIM model. 
Another, much weaker, regulating mechanism is the excess-mortality of blind 
persons, Le., the early death of persons with a high accumulation of infection. In 
the model we assume that, at the moment a person goes blind, his life-expectancy is 
reduced with 50% on average (range 0-100%, uniformly distributed). This percen-
tage is in agreement with Prost & Prescott (1984) who estimate that, while the 
normal life-expectancy at the average age of the onset of blindness is approximately 
23 years, for blind persons this is only about 9 years. 
To our knowledge, there is no strong evidence for any otller density regulating 
mechanism within the human host, such as density dependent production of Mf or 
resistance to super-infection of infected persons. In a recent review of immunologi-
cal aspects of O. volvulus infection, Ottesen (1995) concludes that, while infection is 
accompanied by prominent antibody responses, the primary force driving the 
immune system is the need to prevent inflammatory reactions against the huge 
numbers of microfIlariae dying in the skin or elsewhere. The simple observation 
that in hyperendemic areas prevalence rates among adults are close to 100% pro-
vides quite some evidence that neither inunune-reactions against worms or Mf nor 
resistance to new infections play an important role in the regulation of parasite num-
bers. This lack of evidence, combined with the fact that the model could very well 
explain both the observed age related prevalence and density patterns as well as the 
frequency distributions of Mf counts, support the assumption that density regulation 
in the human host can be neglected. 
Should this assumption turn out to be wrong, then two consequences can be an-
ticipated. Firstly, if either the survival of L3 to adult worms or the fecundity of 
adult worms is reduced at a high parasite load, then in a situation of recrudescence 
(when worm loads are brought down through control) higher rates of acquisition of 
new parasites or a higher Mf output will occur than predicted by the model. Hence, 
in this case both the risk and the dynamics of recrudescence have been underesti-
mated. A second possibility is that in an uncontrolled situation high worm loads and 
high Mf densities are maintained because of a down-regulated immune system 
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(immunological tolerance). It cannot be excluded that after reducing the worm load 
to insignificant values, or in children born in a situation without transmission, strong 
innnune-responses against new infections occur. Such strong responses will than 
most likely result in a much more rapid development of morbidity in skin and eyes. 
At the same tinle they are likely to either reduce the establishment of parasites or 
limit the appearance of Mf in the skin. Hence, if this is true, both the risk and 
dynamics of recrudescence have been overestimated. 
Pre- alld post-collfrol fly bitillg rates 
Since the start of larviciding in the OCP in 1975, a sophisticated system of entomo-
logical monitoring was set up, with fly catching sites at all important rivers and 
tributaries and a weekly briefing of important variables such as the biting rate and 
the infectivity of the flies (Philippon et al., 1990). However, prior to OCP, no other 
programme could afford such an extensive evaluation, and sufficient comparative 
pre-control entomological data are not available for the whole area. Hence, it is not 
possible to link the pre-control epidemiological situation in most of the indicator 
villages to the prevailing biting rates in or around these villages. Such comparative 
data are only available for the Pru river and the village of Asubende and surround-
ing villages (Ghana). For this area six years of fly collections enabled us to esti-
mate, for each calendar month, the level of the Monthly Biting Rate (MBR). After 
linking these figures with the epidemiological situation in this area, the biting rate 
in other villages is derived by applying an appropriate multiplication factor (mostly 
< I) to these MBR-values (this multiplication factor is denoted the relative bitillg 
rate, rbr; see section 11.2). This is of course a very indirect estimate of the pre-
control biting rate and the quality of the estimates strongly rests upon the assump-
tion of the absence of parasite density regulation in the human host. A possibly 
more serious threat to the validity of this approach is the assumption that these 
estimated biting rates have been constant for a period sufficient to establish an 
eqUilibrium epidemiological situation in the Villages. Though one can only speculate 
about the implications for O. volvllllls transmission, during the decade prior to the 
start of OCP there have been several severe droughts in the Sahel region 
(McMillan, 1995). Especially along streams which normally do not flow during the 
dry season, this may have resulted in considerably lower biting rates. These sup-
pressed biting rates, in turn, may have caused a gradual reduction in the parasite 
density in the Villages. Hence, the observed pre-control endemicity level in these 
villages may be an underestimation of the potelltial endemicity and the biting rate 
estimated for these villages may be an underestimation of the potelltial biting rate. 
In such areas, the biting intensity after stopping control could be much higher than 
estimated, and this could result in higher risks of recrudescence than predicted by 
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the model. In anticipation of this problem we have derived the guideline for the 
required duration of vector control for the highest endemicity levels encountered in 
the OCP area. 
Morbidity 
In the model highly simplifying assumptions are made with respect to morbidity. 
The only sign of morbidity considered is complete blindness (operationally defmed 
as the inability to count fingers at a distance of three metres WiOl the better eye). No 
provision is made for ocular lesions or for skin disease. The restriction to blindness 
alone is mainly because (i) it is this aspect of morbidity which is the only reason for 
large scale control of the West African savanna type of onchocerciasis, and, 
consequently, reduction in blindness is the most important marker for the success of 
control; (ii) in West African savanna blindness is a much greater public health 
problem than skin disease; (iii) ocular pathology, leading to a variety of lesions of 
the (anterior and posterior segment of the) eye is complicated and not well under-
stood. In the model, blindness is assumed to the consequence of the accumulation of 
infection in a person. This implies that, on average, highly exposed and heavily 
infected persons go blind early in their lives, while modestly infected persons 
develop morbidity at older ages. Lightly infected persons will probably die from 
other causes before they reach their 'blindness' threshold. This concept is in agree-
ment with observations that both on an individual level (Anderson el 01., 1976) and 
on a community level (Remme el 01., 1989a; McMahon el 01., 1988) there is a high 
correlation between intensity of infection and (the risk of) blindness. Furthermore, 
with this simple assumption we were able to reproduce the age specific prevalence 
of blindness in most of the villages we considered. 
Relating the risk of blindness to the accumulation of infection16 is equivalent to 
assuming that there is ollly progression and 110 regression of ocular disease. Trials 
with ivermectin have demonstrated that this assumption deserves revision. After two 
treatments in the Asubende trial (see Chapter IV) a slight improvement of early 
anterior lesions was found (Dadzie el al., 1991). It is, therefore, possible that we 
underestimate the long term impact of repeated ivermectin treatment on the inci-
dence of blindness. 
The impaci of colllrol 
Both the estimation of the reproductive lifespan of O. volvllills (Ch. Ill) and the 
predictions of recrudescence risks (Chapter V) rely upon the assumption that larvici-
ding has resulted in a complete interruption of transmission. In Chapter III we have 
16 The area under the infection~intensity curve of an individual. 
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argued that this assumption is not unrealistic for the villages on which the estimates 
have been based. It is unlikely that the low levels of transmission, observed during 
the fIrst years of OCP operations in some of the breeding sites, may have a large 
impact on our estimates. However, we have stated several times that the estimated 
recrudescence risks are only applicable to those areas where transmission during 
control is negligible. In this respect, especially dangerous will be transmission 
during the later years of larviciding, since this results in relatively young parasites 
at the moment that cessation of operations is being considered. 
Chapter IV reports a detailed analysis of the impact of annual ivermectin treat-
ment on the Mf counts in a cohort of patients. This analysis convincingly shows that 
the observed trends are compatible with the assumption that treatment at a dose of 
150 I'g/kg eliminates all Mf and permanently. reduces the fecundity of female worms 
with 35% (95% confIdence interval 25%-40%). Given the thoroughness of this 
analysis (taking into account the indirect effect of treatment on transmission) and the 
agreement with the results of nodulectomies, we believe that these are robust esti-
mates. However, in section V.2 we have shown that tlle impact of a treatment 
strategy in a village or area not only depends on the effect of the drug in a patient, 
but also on the treatment coverage and compliance. The compliance pattern pres-
ented in the appendix of section V.2 reflects the observed pattern in the Asubende 
trial. The effectiveness of community treatment will decrease (considerably) if the 
proportion of persons which systematically escape treatment (passively or actively) 
increases. 
The above considerations make clear that, as a result of the investments made to 
bring the model in agreement with current knowledge and data, credible predictions 
could be made of the impact for the control strategies of OCP. However, model 
validity has biological, statistical, and public health aspects. Statisticians will, 
rightly, stress that a number of parameters are not identifIable if only skin-snip data 
are being used. We have already discussed that parameters governing the worm load 
are largely exchangeable with parameters governing the (cumulative) Mf output of 
worms, and that the effective duration of an infection comprises more parameters 
than the two (mean lifespan and lifespan variation) estimated on the basis of tlle 
observed trends. However, biologists (as well as clinicians and epidemiologists) will 
counter that even though ONCHOSIM is a complex model, it is still too simplistic 
in several aspects, especially with respect to the vector-parasite dynamics, and that 
much uncertainty remains about parameter values used in the predictions. One 
could, therefore, state that ONCHOSIM is much like a compromise between these 
viewpoints. Though not exhaustive, guidewe have attempted to statistically explore 
the uncertainty of several assumptions in the model. On the other hand, we have 
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included quite a number of parameters and variables in order to gain confidence in 
the model from experts in the field, and because they may be important in view of 
the use of the model for predictions. 
The final and most important criterion for validity is, however, the quality of the 
predictions of the (long term) epidemiological and public health impact of interven-
tions. Given the time-frame of these predictions, judging the quality of the model in 
this respect is too premature. In the majority of river basins where vector control 
has stopped in agreement with model based guidelines, no new infections have been 
encountered and old infections are dying out. However, recent surveys in the 
Bougouriba river basin (Burkina Paso) demonstrate that five years after stopping 
larviciding there was a significant increase in the prevalence of Mf. In this river 
basin epidemiological and entomological surveillance is now being intensified and 
research has been initiated to detect the source of this recrudescence. If the recru-
descence turns out to be purely local, then this is an important reason to put addi-
tional efforts in once more reViewing the model and the validity of assumptions. 
VIA The future of ONCHOSIM 
In this thesis we have only reported the use of ONCHOSIM in the context of the 
OCP. However, a start has been made to utilize the model for addressing problems 
with a wider perspective. One of these problems is the possible emergence of 
resistance of O. volvulus against ivermectin. Since it is likely that both within and 
outside OCP ivermectin will be administered on a large scale for many years, it is 
very important to gain insight into the likelihood of spread of resistance. This 
should be studied both on the level of the genetics of resistance and on the level of 
parasite population dynamics. Recently, ONCHOSIM has been extended with a sub-
model for the dynamics of resistance. Important parameters of tllis SUb-model are 
the initial resistance allele frequency (at the onset of treatment), the location of the 
resistance alleles (autosomal vs. X-linked), and tile phenotypic expression of resis-
tance alleles (dominant vs. recessive). The model is currently being used to investi-
gate whetller spread of resistance is likely and how this depends on the model 
parameters and the treatment strategy. 
A second application of the model concerns the prospects of a future mac/'ofllari-
cidal drug for tile local elimination of the infection. By using ONCHOSIM it is not 
only possible to compare such future drugs by varying tile efficacy in terms of tile 
fraction of parasites killed per treatment, but also to investigate the impact of sev-
eral patterns of compliance. Tentative simulation results suggest that even a very 
effective drug (75 % of the parasites killed per treatment) will fail to eliminate the 
infection if a small fraction (10%) of the popUlation systematically escapes treat-
ment. 
As mentioned before, ONCHOSIM has been developed and quantified for the 
savarma form of O. volvulus, which is most prominent in the OCP area and which is 
associated with severe blindness. However, over 50% of all infected persons live in 
areas where blindness is not common (e.g., over 4,5 million cases in Zaire; WHO, 
1995), but where onchocercal skin disease is the most important health problem 
(Remme, in press). A recent report of the Pan-African Study Group on Onchocercal 
Skin Disease (WHO-TDR, 1995) revealed that several kinds of skin lesions impose 
a burden of severe itching and other symptoms that have important psychosocial 
effects. This study is an important basis for the recently launched African Pro-
gramme for Onchocerciasis Control (APOC) which aims 'to establish, within a 
period of twelve years, effective and self-sustainable community based ivermectin 
treatment throughout the remaining endemic areas in Africa and to eliminate the 
disease by vector control in selected foci' (Remme, 1995). Undoubtedly, in tile 
framework of this initiative a number of operational questions will emerge related to 
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the time, efforts, and costs involved in elimination of disease both during and after 
the programme. To use ONCHOSIM for addressing tllese questions a thorough 
study is required both of the area specific parasite dynamics and of the natural 
history of the several forms of skin-disease. 
Apart from the current and future use of ONCHOSIM in the framework of 
(collaborative) research projects, recently a user-friendly version of the package has 
been prepared for the use by other researchers in the field of onchocerciasis control 
and for teaching and training. This user-friendly package comprises the 
ONCHOSIM computer program itself, a user-interface for parameter quantification 
and a user's manual17 . 
17 An order~form for the package can be obtained from the author. 
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Summary 
This thesis describes the development and application of a quantitative model for 
onchocerciasis. Onchocerciasis, or river blindness, is a parasitic disease caused by 
the filarial nematode Ollchocerca volvulus and is transmitted by llies of the genus 
Simuliulll (blackllies). Prolonged infection may lead to visual decline and complete 
blindness. Since 1975, the Onchocerciasis Control Programme in West Africa 
(OCP) aims to eliminate the disease in sub-saharan Africa by larviciding of 
Simuliulll breeding sites (vector control) and large scale chemotherapy with the drug 
ivermectin. 
The objectives of dIe work reported in this thesis were: (1) to develop, quantify, 
and validate a model for dIe transmission and control of the disease in West African 
savanna, and (2) to use this model for aiding decision making in OCP. 
Within OCP modelling had been used as a tool to interpret epidemiological trends 
observed during the first 8 years of vector control. This revealed that, while the 
prevalence of infection (% with microfilariae in the skin) is a very insensitive 
measure for evaluating the success of control, the observed trend in the intensity of 
infection (average density of microfilariae) was compatible with what one expects 
for a long lived parasite and indicated complete interruption of transmission in most 
of the evaluation areas. In collaboration with the Department of Public HeaWl, 
Erasmus University Rotterdam, a more sophisticated simulation model was devel-
oped which could take account of variability in the reproductive lifespan of the 
o. volvulus parasite. This latter model, which has been extensively used as a routine 
tool for predicting trends in areas with varying levels of endemicity, was the basis 
for the development of ONCHOSIM, which is the principal subject of this thesis. 
Opposite to its predecessors, ONCHOSIM describes dIe full transmission cycle of 
the parasite, including the role of blackllies as vector. 
The model, which is presented in chapter II, comprises a detailed description of 
the life-history of Ollchocerca volvulus and of its transmission by Simuliulll-llies. 
The effects of different control strategies, based on larvicide application and 
chemotherapy (ivermectin), on dIe transmission and on the disease symptoms can be 
evaluated and predicted. ONCHOSIM is a hybrid of two simulation techniques. The 
human and parasite parts of the transmission cycle, including the impact of iver-
mectin treatment, is based on stochastic microsimulation model, which means dlat 
chance and variation play an important role and that the individual is the basic unit. 
Apart from birth and death, events in the life of a simulated person are acquisition 
of (new) parasites, the onset of blindness, participation in popUlation treatment, etc. 
Together the simulated persons and inhabitant parasites constitute a hypothetical 
population of an endemic village. The part of the model describing dynamics of the 
Simuliulll-population and the development of dIe parasite in the llies is simulated 
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deterministically. Output of ONCHOSIM conforms to the format in which data 
collected by the OCP are reported. This enables detailed checking of model-specifi-
cations against empirical data. Output can also consist of summarizing key indices 
for the intensity of onchocerciasis infection, which is especially useful for compar-
ing the effectivity of control strategies. Section II.1 describes the first version of the 
model and computer program; section 11.2 provides a complete formal description of 
the model as it evolved during its application in OCP, including quantification of the 
model parameters. 
ONCHOSIM is a comprehensive model with many parameters. For a number of 
crucial parameters no or very limited information was available, and their estimates 
should rely on indirect observations. In view of the ain, of OCP to eliminate the 
infection from an area through interruption of transmission by controlling the vector 
(initially, the only means of control), a very important model-parameter is the 
reproductive lifespan of the parasite in the human host. Therefore, the first step in 
model quantification comprised the estimation of this reproductive lifespan and 
related parameters. The procedure and results are described in chapter III. Model 
predictions based on different lifespan quantifications were compared with the 
results of longitudinal surveys in 4 villages where control lasted for 13 to 14 years. 
At each of these surveys skin-snips (piece of skin in which Mf can be observed) 
were collected from the popUlation. Good fits between predicted and observed 
trends in microfilarial loads could be obtained for all villages. By combining the 
estimates for three of these villages, it is concluded that the mean reproductive 
lifespan of the savanna strain of O.volvullls is in the range 9-11 years, and that 95% 
of the parasites reach the end of reproduction before U,e age of 13-14 years. 
Other model parameters which are crucial for making credible predictions of the 
effectiveness of interventions are related to the control strategies themselves. The 
effects of vector control are simply described by a certain reduction in the fly biting 
rate. In agreement with entomological evaluation data, a reduction to zero is 
assumed in most of the predictions for the central OCP area. The effect of iver-
mectin treatment is much more complicated. The drug is known to be very effica-
cious against the microfilariae, but the result of clinical trials suggested that there 
might also be an effect on the adult parasites. Furthermore, patients were known to 
differ in their response to the drug. Testing hypotheses about the effects of the drug 
should preferably be based on data from community trials (covering a lot of 
patients) with repeated treatments to look for the existence of cumulative effects. 
Such a data-set and its use in validating the sub-model for the effects of treatment 
on the parasite is reported in chapter IV. The first section (IV.l) describes a 
community trial of five annual treatments in the holo-endemic focus of Asubende 
(Ghana). The general observed pattern was a marked reduction of microfilarial loads 
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shortly after each treatment followed by a steady repopulation of the skin until a 
subsequent round. The overall reduction of microfilarial loads observed between the 
baseline survey and one year after the last treatment was 90% for the whole 
examined population and over 93 % for a cohort which received the drug at all five 
treatment rounds. The study further highlights that already a single treatment with 
ivermectin has a significant medium term impact on microfilarial loads. Microfil-
arial counts hardly increased after 14-16 months of treatment and stabilized around 
55 % of pretreatment counts 2 to 4 years after a single treatment. 
The observation that post-treatment Mf levels remain lower than before treatment 
gave support to the hypothesis that ivermectin is not a micro filaricide sellsu stricto 
but that there is also an effect on the reproductive capacity of adult worms. To test 
this hypothesis, and in particular to find out whether this effect on worms is 
transient or irreversible, tile data from the Asubende trial have been re-analyzed 
with the help of ONCHOSIM (see section IV.2). Testing of hypotheses and 
estimation of the relevant parameters have been carried out by comparing model 
calculations with skin microfilaria counts collected from 114 patients for which 
either a complete series of observations during the whole trial period exist or who 
have been re-examined two years after a single treatment. The results of this model 
based analysis strongly suggest that treatment with ivermectin has three effects: 
Firstly, except in 3% of treatments, microfilariae are completely eliminated shortly 
after treatment. Secondly, during 10 to 11 months female parasites recover from 
treatment and gradually resume Mf production. Thirdly, after recovery the Mf 
production stabilizes at a level which is 30% lower than before treatment. This 
latter irreversible effect of treatment, earlier only found after multiple treatments at 
intervals of less than 6 months, has important implications for public health 
strategies designed to eliminate onchocerciasis as a significant health hazard. 
Within the second objective of this thesis, the use of the model for aiding 
decision making in OCP, two questions of interest were: (1) How long should 
vector control be continued in the central area of OCP to prevent recrudescence of 
the disease after cessation of operations; (2) Could this required duration of control 
be shortened in areas where vector control was accompanied by large scale iver-
mectin treatment. Both questions are addressed in chapter V. Ivermectin was 
registered for human use in 1987 and, hence, in those areas where OCP started 
control between 1975 and 1977 the drug did not play an important role in reducing 
transmission. For these areas the policy was that larviciding alone should accom-
plish the elimination of the parasite. 
Section V.l reports how, by repeatedly simulating periods of vector control in the 
range of 9 to 15 years, the ensuing risk and dynamics of recrudescence of the 
infection in an area has been predicted for various conditions. In these simulations, 
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uncertainty about a number of important confounding parameters was explicitly 
taken into account. These parameters include the pre- and post-control fly biting rate 
in the area, variation in exposure between individuals, the parasite lifespan, and the 
relation between skin microfilarial load and vector infection. The model predicted 
that, in the absence of immigration of infected humans or invasion of infected flies, 
14 years of full scale vector control are required to reduce the risk of recrudescence 
to less than 1 %. The risk depends in particular on the vector biting rate and this has 
implications for the planning of post-Iarviciding surveillance. The predictions 
suggest that recrudescence will be a relatively slow process, its rate depending on 
the duration of vector control. Even if vector control were stopped too early after 
some 12 to 13 years in a highly endemic area, it would take more than two decades 
before the intensity of infection in the community reaches levels of public health 
importance. This latter result only holds true for recrudescence as a result of purely 
local transmission. A faster increase could be expected in case of importation of the 
infection through immigrant humans or flies. 
In contrast to the original OCP area, in the extension areas aerial larviciding has 
been supplemented with annual ivermectin treatment, mainly to achieve a better 
control of morbidity. The purpose of the study reported in section V.2 is to 
determine whether and to what extent the addition of ivermectin allows an earlier 
cessation of vector control than originally recommended for the prevention of 
recrudescence. In this study, simulation results were analyzed by means of logistic 
regression to obtain estinl3tes of the recrudescence risk for certain combinations of 
the duration of vector control, the number of annual treatments, and the percentage 
of the population treated per round (coverage). Model predictions suggest that, 
dependent on the pre-control endemicity of the area and the treatment coverage, 
large scale annual treatment allows considerable reductions in the required duration 
of vector control. Taking into account the uncertainty about the efficacy of iver-
mectin, the guideline is derived that, provided the coverage is at least 65% and 
importation of infection from elsewhere is absent, 12 years of combined control will 
be sufficient to reduce the risk of recrudescence to below I % even in the most 
afflicted areas. 
The conclusion seems justified that the development and application of 
ONCHOSIM has both contributed to a better knowledge of the dynamics of the 
parasite and the effects of interventions, and to decision making about control 
policies within OCP. Apart from the applications mentioned in chapter V, the model 
has also been used to aid the design of strategies for the detection and control of 
recrudescence, should it unfortunately occur in one of the areas of OCP. The use of 
ONCHOSIM has not been restricted to practical questions of OCP. Recently, the 
model has been extended to enable assessment of the risk of resistance to ivermectin 
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in situations where the drug is used intensively for long periods of time. Further. 
anticipating the development of a macrofilaricide (a drug which kills adult worms). 
simulations of population treatment with several hypothetical drugs have been 
carried out. These simulations revealed that effectiveness of chemotherapy based 
interventions not only depends on the efficacy of the drug. but also largely on the 
pattern of compliance with treatment. To enable the use of ONCHOSIM outside 
OCP. a user-friendly version of the computer program has been developed. 
Together with the reported usefulness of modelling for disease control. this distribu-
tion version of the model may stimulate similar initiatives for other parasitic 
diseases. 

Samenvatting en conclusies 
Dit proefschrift handelt over de ontwikkeling en toepassing van een computer model 
waarmee de verspreiding en bestrijding van onchocerciasis of rivierblindheid kan 
worden nagebootst. Voordat het eigenlijke onderwerp aan de orde komt zuHen we 
eerst de nodige achtergrondinformatie geven. 
Onchocerciasis is een parasitaire ziekte die als endemie18 voorkomt in grote 
delen van Afrika (met name het westen en midden) en in Zuid en Midden Amerika. 
De parasiet Onchocerca volvulus is een worm waarvan het vrouwtje een lengte van 
20 tot 50 cm bereikt. De wormen leven groepsgewijs in onderhuidse knobbels. In de 
mens produceert een volwassen vrouwtje miljoenen nakomelingen die micro-
wormen of lIlicrojilariell worden genoemd. Het zijn deze microfilarien (Mf) die de 
ziekteverschijnselen veroorzaken. Zij migreren naar de Imid en geven daar aanIei-
ding tot ondraaglijke jeuk en (onder andere door krabben) huidafwijkingen. Om aan 
te tonen of iemand geinfecteerd is (een produktieve vrouwelijke worm heeft) wordt 
een k1eine huidbiopt (een skin-snip) genomen en wordt onder de microscoop 
gekeken of daar microfilarien in zitten. Hoewel de huidproblemen zeer vervelend 
kunnen zijn, waren de belangrijkste reden om deze parasiet te bestrijden de oogaf-
wijkingen die het gevolg zijn van het binnendringen van microfilarien in de oogbol. 
Deze oogaf\vijkingen hebben in eerste instantie een verminderd gezichtsvermogen of 
een venninderd blikveld19 tot gevolg. Uiteindelijk kulllien ze tot voHedige blind-
heid leiden. Microfilarien kunnen niet zonder meer tot volwassen worm uitgroeien. 
Daartoe moeten ze eerst worden opgeslokt door een vlieg die een bloedmaaUijd 
nuttigt van een mens met microfilarien in de huid. In zo'n vlieg (van het geslacht 
Sillluliulll, ook wei 'blacktlies' genoemd) kan een microfilaria overgaan in het larve-
stadium. De larve wordt na enige dagen infectieus. Ais een vlieg met infectieuze 
larven opnieuw een bloedmaaltijd gebruikt (bij een willekeurige andere persoon) dan 
kunnen deze larven worden overgedragen op die persoon en uitgroeien tot een 
nieuwe volwassen worm. De rijping tot worm duurt ongeveer een jaar. De naam 
rivierblindheid heeft te maken met de broedplaatsen van de Sill1uliulll-vlieg (de 
vector20). Voor hun ontwikkeling zijn de vliegen-Iarven afl13nkelijk van het zuur-
18 Er is speake van cen endemie als een ziekte, in afwezigheid van bestrijdings-maatregelen, 
altijd in een gebied aanwezig is en cen aanzienlijk aaolat mensen treft. lndien een ziekte met 
kortere of tangere tussenpozen kortstondig toeslaat wordl er gesproken van cen epidemic. 
19 Het blikveld is datgene wat met 'vanuit de ooghoeken' ziet. Bij onchocerciasis kan dit 
sterk verminderd zijn zodat het lijkt alsof men door cen koker of cen sleutelgat kijkt. 
20 Ben organisme dat een infectie (parasiet) van de ene mens op de andere overbrengt 
wordt 'vector' genoemd. Bij onchocerciasis is dit een vlieg. Bij malaria een mug. Bij 
schistosomiasis (bilharzia) een waterslak. 
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stofrijke water van snelstromende rivieren. 
Bestrijdillg van de ziekte kan op twee manieren. Door de vlieg te bestrijden kan 
worden voorkomen dat deze de parasiet overdraagt (vector-bestrijding). Door 
medicijnen toe te dienen die de microfilarien (of zelfs de volwassen wormell) doden 
kan worden voorkomen dat patienten blind worden en wordt tevens de overdracht 
(transmissie) verminderd21 • Vector-bestrijding geschiedt vrijwel uitsluitend door 
met behulp van chemicalien het larve-stadium van de vlieg in de rivier te doden. 
Hiervoor zijn een aantal zgn. larvicidell beschikbaar die betrekkelijk veilig zijn voor 
de overige diersoorten in het water. Voor behandeling van patienten is het medicijn 
ivermectille beschikbaar. Dit oraal toe te dienen medicijn elinJineert vrijwel aile 
microfilarien met eon enkele dosis en vermindert de produktiviteit van de volwassen 
vrouwUes. Door ivermectine jaarlijks toe te dienen kan het ziekteproces een halt 
worden toegeroepen. 
Sinds 1975 wordt de ziekte in West Afrika op grote schaal bestreden door het 
Ol/chocerciasis COlltl'Ole Programme il/ West Africa (OCP) , een ziekte-bestrijdings 
programma dat gecoordineerd wordt door de Wereld Gezondheids Organisatie 
(World Health Organization, WHO) en dat gefinancierd wordt door een aantal 
westerse landen waaronder Nederland. Tot 1987, het jaar waarin ivermectine werd 
geregistreerd voor gebruik als medicijn voor onchocerciasis, werd de bestrijding 
uitsluitend gedaan door met behulp van helikopters en vliegtuigen larviciden in de 
belangrijkste rivieren van de 7 deelnemende landen22 te deponeren. Dit bleek zeer 
succesvol en leidde tot een teruggang in het aantal gei'nfecteerde personen en een 
sterke daling in de mate waarin mensen getnfecteerd zijn (het aantal parasieten per 
persoon). Tevens werden er nog maar zelden patienten volledig blind. Het probleem 
van het OCP was (en is) echter dat de bestrijdings-activiteiten zich over een lange 
periode moeten uitstrekken willen ze een duurzaam effect op de volksgezondheid 
hebben. De maxinJale levensduur van de volwassen parasiet werd aanvankelijk op 
20 jaar geschat, en men moest er dus voor zorgen dat gedurende 20 jaar geen 
nieuwe infecties ontstonden om er zeker van te zijn dat de parasiet uit het gebied 
werd uitgeroeid23 . Dit betekent een even zo lange periode van intensieve vliegen-
bestrijding, en dat kan aileen maar door grote investeringen in hoogwaardige 
21 Indien cen persoon geen microfilarien meer heeft kan cen bijtende vlieg oak niet meee 
gei'nfecteerd worden. Ais veel personen behandeld worden zal dit dus gunstige gevoJgen hebben 
voar de totaJe infectie-druk in cen gebied. 
22 Burkina Faso (voocheen Opper Volta), Mali, IVQorkust, Ghana, Togo, Benin en Niger. 
Later zijn hier oak (deJen van) Senegal. Guinee, Guillee-Bissau en Sierra Leone bijgekomen. 
23 Immers, zo'n nieuwe infectie (lees: parasiet) kan weer 20 jaar actief blijven. 
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technologie (gespecialiseerde helikopters, nieuwe larviciden), door een strakke 
vertic ale organisatie, en door een goed gekwalificeerde staf uit diverse disciplines 
(entomologen24 , (oog-)artsen, epidemiologen, economen, (bio-)statistici, mana-
gers, etc.) niet aIleen voor het plannen en uitvoeren van de bestrijding maar ook 
voor het evalueren van de effecten. 
Met name dit laatste, het evalueren van de effecten van bestrijding, is niet 
eenvoudig in het geval van een infectieziekte die het gevolg is van het samenspel 
van drie organismen: de mens, de vlieg en de parasie!. Gegevens verzameld 
gedurende de eerste 8 jaren van het OCP gaven bij oppervlakkige beschouwing niet 
zo'n heel florissant beeld van de bestrijdings resultaten. Er was weliswaar een 
teruggang in het percentage ge[nfecteerde personen25 (Mj-prevatenlie) , maar deze 
werd toch onbevredigend geach!. Gestimuleerd door deze bevindingen zijn de 
gegevens nogmaals geanalyseerd, maar ditmaal met behulp van een speciaal voor dit 
doel ontwikkeld wiskundig model. Dit model beschrijft het verloop van een 
parasieten-populatie (met gemengde leeftijden) in de bevolking onder de veronder-
stelling dat er op een gegeven moment (= de start van het OCP) geen nieuwe 
infecties meer bijkomen en er dus aIleen nog maar parasieten kunnen doodgaan. De 
berekeningen van dit model werden vergeleken me~ de waargenomen trends en 
daaruit bleek dat de geringe teruggang in Mf-prevalentie gedurende de eerste jaren 
volstrekt in overeenstemming is met wat verwacht mag worden bij een parasiet met 
een lange levensduur en waarvan de meeste patienten er (veel) meer dan een 
hebben. De belangrijkste conclusie was dan ook dat prevatelllie (% ge[nfecteerden) 
een ongevoelige maat is voor het succes van bestrijding. In plaats daarvan dient men 
te kijken naar de trend in de illlellSileil van infectie (het gemiddelde aantal micro fila-
rien per skin-snip). Modelberekeningen suggereerden tevens dat de gemiddelde 
levensduur van de parasiet ongeveer 10 jaar is, hetgeen een stuk korter is dan de 
eerder genoemde 20 jaar. 
Aangezien de levensduur van de parasiet (of nog beter: de duur van het reproduk-
tieve leven van volwassen vrouwUes) zeer bepalend is voor de noodzakelijke duur 
van ziekte-bestrijding, werd het noodzakelijk geacht een tweede model te ontwikke-
len dat deze reproduktieve levensduur in groter detail beschrijft. Omdat met name 
de varialie in deze levensduur van belang is, was het niet mogelijk het eerste (zgn. 
24Insekt-kundigen. 
25 Het percentage mensen met een positieve skin-snip (of weI een skin-snip waarin tenminste 
een microfilara wordt aangetroffen). 
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'force-ofillfectioll') model uit te breiden26 en werd een nieuw model ontwikkeld 
dat gebaseerd was op de techniek van lIlicrosilllulatie. Bij microsimulatie worden 
hypothetische illdividuele mensen en (in dit geval) illdividuele parasieten nagebootst 
en in de tijd gevolgd. Mensen worden op een gegeven moment geboren, krijgen op 
gezette tijden nieuwe parasieten die een bepaalde tijd leven, en sterven op een 
gegeven moment. Die gebeurtenissen en de momenten waarop ze plaatsvinden 
worden bepaald door waarschijnlijkbeids-verdelingen27• Een belangrijke waar-
schijnJijkbeids verdeling in het nieuwe model is de verdeling van de levensduur van 
O. volvullls. Het microsimulatie model (gedoopt als 'host-parasite' model; onvel 
gastheer-parasiet model) werd voornamelijk voor twee doeleinden gebruikt: (1) een 
betere schatting verkrijgen van de reproduktieve levensduur van de parasiet (dit 
komt uitvoerig aan de orde in hoofdstuk m28); (2) voor verschillende endemici-
teits niveaus29 de trend in prevalentie en intensiteit voorspellen en de voorspellin-
gen vergelijken met waarnemingen in verschillende dorpen. Met dit laatste kon men 
veel makkelijker dan voorheen die gebieden op het spoor komen waar de bestrijding 
niet bevredigend was. Model voorspellingen suggereerden dat na 14 tot 15 jaar 
bestrijding zowel intensiteit als prevalentie tot vrijwel nul lOuden zijn gereduceerd. 
Dit laatste gaf aanJeiding tot de brandende vraag: hoe lang moeten de zeer 
kostbare bestrijdings-activiteiten van het ocp nog doorgaan om de oorspronkelijke 
doelstellingen te halen: (1) het elimineren van onchocerciasis als gezondheids 
probleem en (2) er voor zorgen dat de infectie niet terugkeert na afloop van de 
26 Het force-aI-infection ('infectie-druk') model is cen puur wiskundig model waarvoor cen 
analytische oplossing te herleiden valt. Indien men ingewikkelde veronderstellingen wiI toetsen 
wordt het bijbehorende model dikwijls te ingewikkeld om nog op te lossen en moet men de 
toevlucht nemen tot numerieke technieken of simulatie technieken. 
27 Een waarschijnlijkheids-verdeHng geeft aan welke waarden cen bepaalde variabele kan 
aalmemen (bijv. de levensduur van cen parasiet, of de tijd tussen opeenvolgende nieuwe 
infecties bij een bepaalde infectie-druk) en hoe waarschijnlijk elk van die waarden is. 
28 In hoofdstuk III wordt weliswaar de opvolger van het host-parasite model gebruikt 
(ONCHOSIM) maar dit model is voor wat betreft de beschrijving van de parasitaire levensduur 
identiek. 
29 Met het endemiciteits niveau (of kortweg de endemiciteit) wordt de ernst van de infectie 
in een dorp of gebicd bedoeld. Het wordt vooral in relatieve zin gcbruikt: hoog- vs. laag-
endemisch. Voor onchocerciasis wordt de regel gehantecrd dat cen dorp met een Mf-prevalentie 
van meer dan 60% hoog-endemisch (hyper endemic) wordt genoemd. 
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beslrijding30. Ook voor hel beanlwoorden van deze vraag achlle men hel zinvol 
om modelberekeningen uil Ie voeren. Echler, in beide eerdere modeUen speelde de 
verspreiding van de ziekle via de vlieg geen rol. Beide modeUen beschreven de 
trends gedurende de aj\vezigheid van de veclor lerwijl er juisl berekeningen nodig 
waren voor de implicalies van de lerugkeer van de vlieg. Daarom werd er een 
nieuw model onlwikkeld dal de complele Iransmissie van onchocerciasis beschrijft 
en waarmee de effeclen van zowel veclor-beslrijding als medicijn-behandeling op de 
Iransmissie kon worden nageboolst. Oil model, ONCHOSIM, is gebaseerd op 
dezelfde microsimulalie-Ieclmiek als hel host-parasite model. Oil proefschrift 
beschrijft de ontwikkeling en loepassing van ONCHOSIM. 
ONCHOSIM 
ONCHOSIM is een sloehasliseh micl'Osimulalie model. Het is slochaslisch omdal 
kansen en variabilileil een belangrijke rol spelen. Het is een simulalie model omdat 
numerieke lechnieken gebruikl worden am berekeningen Ie doen met hel model. Hel 
is een microsimulalie model omdat hel gebaseerd is op het naboolsen van individue-
Ie levens-geschiedenissen (van mensen en parasielen). Het model wordt beschreven 
in hoofdstuk II. Een slrikl formeel-wiskundige beschrijving wordt gegeven in sec lie 
11.2. Doordal daar oak aUe gebruikle parameler-waarden worden vermeld kan deze 
sectie - in Iheorie - worden gebruikl om ONCHOSIM Ie reproduceren. Een senli-
formele (meer verhalende) beschrijving wordl gegeven in seclie 11.1. Deze seclie 
geeft niel aUeen een overzichl van paramelers en variabelen, en hoe deze gerela-
leerd zijn, maar beschrijft oak hoe het model gelmplemenleerd is in een compuler 
progrannna31 . Een van de belangrijkste slochaslische factoren in ONCHOSIM is 
de variatie in de frequentie waarmee personen door vliegen gebeten worden. De 
mate waarin dil varieerl noemen we exposure helerogel1ileil. Door het model te 
30 Ervaringen met vroegere, meer lokale, bestrijding leerden dat vrijwel onmiddellijk (op 
z'n laatst het volgende natte seizoen) na het stoppen van vector-bestrijding de Simulium vliegen 
hun vroegere territoria weer in gebruik nemen en dus ook weer mensen gaan bijten. Het is dan 
dus zaak dat die mensen geen of bijna geen microfilarien meet in hun huid hebben. 
31 Fonneel zijn 'model' en 'computer simulatie progranmla' (zie titel van sectie 11.1) twee 
verschillende dingen: het model beschrijft de samenhang tussen parameters (bijv. de gemiddelde 
levensduur van een worm-parasiet) en variabelen (bijv. het aantal wormen in een mens) terwijl 
het computer programma gebruikt wordt am op basis van dit model berekeningen en voorspel-
tingen te doen. In de praktijk worden de begrippen door elkaar gehaald en beide met 'model' 
aangeduid. 
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fitten32 aan evaluatie gegevens van verschillende dorpen is gebleken dat verschil-
len tussen dorpen verklaard kunnen worden uit verschillen in de gemiddelde bijt-
frequentie (die op zich weer bepaald wordt door onder andere de produktiviteit van 
de Simulium broedplaatsen en de afstand van het dorp tot een broedplaats) en 
verschillen in exposure heterogeniteit. 
Reproduklieve levellsduur vall Onchocerca volvulus 
Het bovengenoemde fitten van ONCHOSIM aan evaluatie gegevens is op een 
gedetailleerde manier uitgevoerd met de gegevens van 4 dorpen in het centrale OCP 
gebied (waar vanaf 1975 vliegenbestrijding is toegepast). In deze dorpen is geduren-
de 14 jaar met tussenpozen van 2 tot 7.5 jaar een skin-snip genomen van een zo 
groat mogelijk deel van de bevolking (een epidemiologische survey). Voor de 
analyse van deze gegevens is voor ieder dorp eerst een cohort gevormd van 
personen die bij de eerste survey volwassen waren (20 jaar en ouder) en die aan aile 
onderzoeken hebben deelgenomen. Voor iedere survey zijn de gegevens van zo'n 
cohort weergegeven in de vorm van een frequentie-verdeling van microfilaria 
tellingen33 . Precies hetzelfde soort frequentie verdelingen kan oak door ONCHO-
SIM worden geproduceerd, en door de mate van overeenstemming tussen berekende 
en waargenomen verdeling (m.b. v. een x2-criterium) te bepalen kan een bepaalde 
veronderstelling worden getoetst. De te toetsen veronderstellingen betroffen de 
gemiddelde reproduktieve levensduur van O. vo/vulus en de mate waarin deze 
levensduur tussen parasieten varieert. Door een reeks van waarden te toetsen aan de 
gegevens van de vier dorpen kon worden geschat dat de gemiddelde leveruduur 
varieert tussen 9 tot 11 jaar terwijl de variabiliteit van de levensduur dusdanig is dat 
95% van de parasieten sterft v66r de leeftijd van 13 tot 14 jaar. De schattings 
procedure en de resultaten worden gepresenteerd in hoofdstuk III. 
Parasilologisehe effeelell vall ivermeelille 
Voor een goed voorspellend model is het niet aileen van belang dat het model een 
adequate beschrijving geeft van de dynamiek van de parasiet in de vlieg en de mens. 
Het is ook van groat belang dat betrouwbare veronderstellingen worden gedaan over 
32 Het fitten van cen model is het proces waarbij veor parameters cen dusdanige numerieke 
waarde wordt gezocht dat de uitkornst van het model zo goed mogelijk overeenstemt met 
waarnemingen. Dit toekeIlllcn van waarden wordt mcestal met cen standaard procedure gedaan. 
Bij een of twee parameters kan het vaak oak door 'trial and error'. Yoor de mate van 
Qvereenstemming tusseo model en waarnemingen bestaan statistische criteria. 
33 In het OCP heeft men de gewoonte om persanen in te deleD volgens cen geomelrische 
reeks, d.w.z. personen die 0, I, 2-3, 4-7, 8-15, 16-31, 32-63, 64-127, 128-255, en meer dan 
256 Mf per skin-snip hebben. 
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de effecten van bestrijdings-maatregelen. Vaal' de effecten van vector bestrijding ligt 
dat vrij eenvoudig. Het doden van vliegen-Iarven heefl maar een effect en dat is een 
verminderd aantal beten. Voor het centrale OCP gebied is Vaal' de meeste rivieren 
vastgesteld dat de bijt-frequentie tot nul is gereduceerd. Vaal' de effecten van 
ivennectine behandeling ligt het een stuk ingewikkelder. Voor de registratie van het 
medicijn was al door veldstudies komen vast te staan dat ivermectine meer doet dan 
aileen maar microfilarien doden. Na behandeIing duurde het enige tijd Vaal' er weer 
Mf in de Imid konden worden aangetoond en oak langere tijd daarna bleef de Mf-
spiegel lager dan voor behandeling. Dit deed vermoeden dat ivermectine oak een 
effect heeft op de produktie-capaciteit van de vrouwelijke worm. Daarbij is dan 
natuurlijk de vraag van welke aard dit effect is. Is het tijdelijk en produceert de 
worm na verloop van tijd weer normaal, of is het een permanent effect, misschien 
weI omdat een zeker percentage van de wormen wordt gedood. Om deze vraag te 
onderzoeken zijn een aantal mogelijke effecten van toediening in ONCHOSIM 
'ingebouwd' en getoetst door modelberekeningen te vergelijken met de resultaten 
van een grote veldstudie in Asubende (een cluster van dorpen aan de Pru-rivier in 
Ghana). In deze veldstudie werd gedurende 5 jaar jaarlijks aan zoveel mogelijk 
dorpsbewoners ivermectine toegediend. Na elke behandeling werd tenminste een 
keel', maar soms weI drie keel' een epidemiologische survey gedaan waarin het 
aantal Mf pel' skin-snip bepaald werd. Sectie IV.! geeft een uitvoerige beschrijving 
van de organisatie van de veldstudie en van de resultaten van de surveys. Het bleek 
dat onder de personen die in aile 5 ronden het medicijn geslikt hadden, de Mf-
telling een jaar na de laatste behandeling gemiddeld nag maar 7% was van de telling 
voor de eerste behandeling. Oak het effect van een eukele behandeling was al 
aanzienlijk: 2 tot 4 jaar erna is de Mf-telling nag maar 55% van de telling voor 
behandeling. De analyse van deze gegevens met behulp van ONCHOSIM is 
beschreven in sectie IV.2. Vit deze analyse komt naar voren dat de trends in de Mf-
tellingen uitsluitend verklaard kunnen worden met de veronderstelling dat elke 
behandeling de produktiviteit van vrouwelijke wormen permanent reduceert met 
ongeveer 30% (of dat elke behandeling 30% van de vrouwelijke wormen doodt). 
Het is duideIijk dat dit gegeven van groat belang is vaal' de verwachte effectiviteit 
van massa-behandeling34 met ivermectine. 
34 Bij massa-behandeling wordt het medicijn aan zoveel mogelijk mensen in een bepaalde 
gemeenschap (dorp) toegediend zonder eerst vast Ie stellen of men wei eehl gei"nfeeteerd is. Dit 
is natuurlijk aIleen maar zlnvol als een ziekte hoog-endemiseh is (bijna iedereen heeft het) en 
het is aileen maar loegeslaan als het medicijn geen ernstige bijwerkingen heeft. De tegenhanger 
is doelgerichte behandeling, waarbij eerst een diagnose wordt gedaan en pas daarna wordl 
behandeld. 
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De vereiste dllllr van vector bestrijding 
Zoals gezegd was de eerste reden voor de ontwikkeling van ONCHOSIM de 
ondersteuning bij de beslissing over de noodzakelijke duur van vector bestrijding. 
Bestrijding van de vlieg moest zolang worden volgehouden dat het risico op een 
opleving van de infectie in de populatie (recrudescence) na terugkeer van de vliegen 
verwaarloosbaar klein was. Men realiseerde zich daarbij dat te vroeg stoppen op 
termijn kon leiden tot een volledig ongedaan maken van al de inspanningen en 
kosten die men zich al getroost had. Met behulp van ONCHOSIM is het recrudes-
cence-risico berekend voor verschillende periodes vector bestrijdillg (van 9 tot 15 
jaar). Deze berekening is gedaan voor twee (voormalig) hyper-endemische dorpen in 
het centrale OCP gebied. Ben van die dorpen (Tiercoura, Burkina Faso) had vaar 
aanvang van de bestrijding een van de hoogste infectie-niveaus ooit vastgesteld in de 
OCP. Daarnaast werden bij de simulaties ook nog de meest ongunstige (maar met 
het oog op waarnemingen nog net realistische) veronderstellingen gedaan over de 
levensduur van de parasiet35 (zie hoofdstuk III), de efficientie waarmee vliegen 
microfilarien kunnen opnemen bij lage Mf-dichtheden in de huid van de mens36, 
en de mate waarin de blootstelling aan vliegenbeten varieert in het dorp37. VOOI' 
een bepaalde duur van vector bestrijding in een dorp (en een bepaalde combinatie 
35 Die veronderstelling die er vanui! gaat dat 5 % van de wormen ouder kan worden dan 15 
jaar. 
36 Deze 'efficient ie' is cen belangrijke factor in de transmissie van de parasiet. Uit 
experimenten - zie de appendix bij seetie V.l - is gebJeken dat het aantal O. volvulus larven dat 
zich na ceo bloedmaaltijd in de vlieg ontwikkelt op cen kromlijnige manier samenhangt met de 
Mf-dichtheid in de huid van de mens waarvan de bloedmaailijd genuttigd wordt. Bij afwezig-
heid van Mf in de huid ontwikkeld zich uiteraard geen larve in de vlieg. Bij toenemende Mf-
dichtheid oeemt het aantal larven in de vlieg aanvankelijk sterk toe, maar bij hoge Mf-dichtheid 
wordt die toename steeds geringer. Bij dichtheden hager dan 150 Mf per skin-snip stijgt het 
aantal larven nauwelijks meer (verzadiging). In model-termen is dit het belangrijkste dichtheids 
regulerende proces. De statistische analyse van de genoemde experimentele gegevens leidde tot 
een schatting van de wiskundige relatie waarmee dit kromlijnige verband beschreven kon 
worden. Zoals met de meeste biologische waarnemingen is er echter niet slechts een zo'o relatie 
denkbaar. Naast de relatie die het best past zijn er oak nag andere mogelijk. Bij een van die 
andere mogelijkheden is de vlieg beter in staat am larven tot ontwikkeling te brengen bij lage 
(bijna nul) Mf-dichtheden in de huid. Die rnogelijke relatie is uitgekozen als 'ongunstige' 
veronderstelling bij de berekening van het recrudescence risico. 
37 Er kao wiskundig worden aangetoond dat variatie in blootstelling (exposure-
heterogeneity) stabiliserend werkt op een endemie. Voor een eventuele recrudescence is deze 
heterogeniteit oak een belangrijke risico factor. Immers bij een grate variatie heh je eeo aantal 
mensen die relatief veel wormen bevatten en die ook na vele jaren bestrijding nag steeds relatief 
veel Mf in de huid hebben. Zij kulUlen bij terugkeer van de vliegen de hele infectie weer op 
gang brengen. 
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van bovengenoemde factoren) werd het recrudescence risico berekend door deze 
strategie 50 keer te simuleren en vervolgens te tellen in hoeveel gevallen het model 
een recrudescence liet zien38. Sectie V.I laat zien dat in het hoogst geInfecteerde 
dorp het risico snel daalt als bestrijding langer dumt dan 12 jaar. Bchter, pas tussen 
13 en 14 jaar bestrijding reduceert het risico tot bijna nul. De analyse gaf aanleiding 
tot de richtlijn dat 14 jaar vliegenbestrijding voldoende is om het recrudescence 
risico tot minder dan 1 % terug te brengen, zelfs onder de meest ongunstige 
omstandigheden wat betreft endemiciteit en andere risico factoren. Twee belangrijke 
randvoorwaarden bij het hanteren van deze richdijn zijn dat de vector bestrijding 
100% effectief is geweest (geen vliegenbeten tijdens de bestrijding) en dat er geen 
immigratie heeft plaatsgevonden van of wei gelnfecteerde personen of gei'nfecteerde 
vliegen. Het model voorspelt ook dat, mocht recrudescence toch optreden, het 
telllninste 20 jaar duurt voordat de intensiteit van infectie een niveau bereikt dat 
gevaar oplevert voor de volksgelOndheid. 
De vereisle duur van gecoll1billeerde beslrijdillg 
De richtlijn voor de vereiste duur van vector-bestrijding geldt aileen voor die 
gebieden waar geen andere bestrijdings-maatregelen zijn genomen. Dit is inderdaad 
het geval voor het centrale (oorspronkelijke) OCP gebied. Bchter, tussen 1988 en 
1990 is het OCP gebied aanzienlijk uitgebreid lOwel in westelijke als zuidelijke 
richting. In deze extellsion areas is vanaf het begin vector bestrijding gecombineerd 
met jaarlijkse massa-behandeling met ivermectine, vooral om een snellere afname in 
morbiditeit39 te bewerken. Het is duidelijk dat op die manier de infectie niveaus 
sneller dalen dan met vector bestrijding aileen. Het is daarom van belang om voor 
deze gebieden aparte richtlijnen te formuleren voor de vereiste duur van, in dit 
geval gecombineerde, bestrijding. Ook hiervoor zijn simulaties met ONCHOSIM 
gebruikt. Het bepalen van recrudescence risico's is hier echter aanzienlijk ingewik-
kelder. Immers, gegeven de endemiciteit en gegeven bepaalde risico-factoren (zie 
scctie V.I), wordt dat risico nu niet bepaald door een maar door drie factoren: de 
dUllr van vector-bestrijding, het aantal massa-behandelingen, en het percentage 
daadwerkelijk behandelde mensen. In sectie V.2 wordt uitgelegd hoe dit is aange-
pakt met behulp van de statistische techniek van logistische regressie. Hoewel het 
niet goed mogelijk is om met zoveel factoren tot een eenduidige richtlijn te komen, 
kon worden vastgesteld dat in die gebieden waar gedurende de hele periode vector . 
bestrijding en jaarlijkse behandeling worden gecombineerd, en waar steeds tenmin-
38 Als recrudescence in II gevallen optreedt is he! risico (11/50) X 100%. 
39 Het geheel aan ziekteverschijnselen. Bij onchocerciasis huidafwijkingen, oog-Iesies en 
blindheid. 
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ste 65% van de mensen behandeld wordt, 12 jaren bestrijding voldoende moet zijn 
om het recrudescence risico tot bijna nul te reduceren. Ook hier geldt de belangrijke 
randvoorwaarde dat de vector bestrijding zeer succesvol moet zijn geweest en er 
geen import van de infectie van buitenaf moet hebben plaatsgevonden. Een andere 
voorwaarde is dat niet bepaalde personen of groepen van personen systematisch 
onbehandeld blijven. 
COl/elllsies 
1. Het ontwikkelen van een model voor de verspreiding en bestrijding van 
onchocerciasis (rivierblindheid) is zinvol geweest omdat het heeft geholpen bij 
de interpretatie van epidemiologische gegevens van het OCP en omdat het 
heeft geholpen bij een rationele af\veging van de effekten van verschillende 
interventies en daarmee ondersteuning heeft verleend aan de besluitvorming 
rond interventies. 
2. Het feit dat dit model - ONCHOSIM - een microsimulatie model is heeft in 
belangrijke mate bijgedragen aan de toepasbaarheid van het model op de 
beleidsvragen. Microsimulatie modellen zijn dermate flexibel dat veronderstel-
lingen aangepast kunnen worden zonder de hele model structuur aan te passen. 
Tevens kunnen in zulke modellen allerlei complicaties in beschouwing worden 
genomen (zoals migratie, deelnamepatronen bij massa·behandeling, etc.). en 
kunnen specifieke strategieen (behandelingen of surveys met oruegelmatige 
intervallen, selektieve behandeling) worden nagebootst. 
3. De gedetailleerde analyse met behulp van ONCHOSIM van trends gedurende 
vector bestrijding in vier dorpen in het OCP gebied heeft geresulteerd in een 
schatting van de reproduktieve levensduur van de parasiet Ol/chocerca volvlIllls 
in de West-Afrikaanse savalme. Deze levensduur is gemiddeld 9 tot 11 jaar 
terwijl 95% van de parasieten sterft v66r de leeftijd van 13 tot 14 jaar. 
4. De analyse van de resultaten van een veldstudie van 5 opeenvolgende jaarlijkse 
behandelingen met ivermectine heeft aan het licht gebracht dat, behalve het 
doden van microfilarien, iedere behandeling een permanente reductie van de 
produktiviteit van vrouwelijke parasieten met 30% tot gevo]g heeft. 
5. De duur van vector bestrijding die vereist is om een opleving van de ziekte te 
voorkomen in het savanne gebied van West Afrika is 14 jaar. Deze richtlijn 
geldt aileen als de bestrijding volledig effectief is en er geen import van de 
infectie van buitenaf plaatsvindt. 
6. Indien vector bestrijding gecombineerde wordt met jaarlijkse massa-behande-
ling met ivermectine (waarbij steeds tenminste 65 % van de bevolking behan-
deld word!) kan de vereiste duur van bestrijding worden verkort tot 12 jaar . 
• 
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